|
3
|
LDH |
isolated CHD: VSD/ASD |
unknown |
|
4
|
CK |
isolated CHD: VSD/ASD |
unknown |
|
5
|
CK‐MB |
isolated CHD: VSD/ASD |
unknown |
|
6
|
hsa_circRNA_004183 |
isolated CHD: VSD/ASD |
unknown |
|
7
|
hsa_circRNA_079265 |
isolated CHD: VSD/ASD |
unknown |
|
8
|
hsa_circRNA_105039 |
isolated CHD: VSD/ASD |
unknown |
|
11
|
Average number devices attached per observation |
NA: NA |
unknown |
|
16
|
total brain volumes |
isolated CHD/non-isolated CHD: BVP/D-TGA/AAA/DORV/TGA/HLHS/AVSD/VSD/PA/VSD/TOF/TA/other |
unknown |
|
17
|
total brain volumes |
isolated CHD/non-isolated CHD: BVP/D-TGA/AAA/DORV/TGA/HLHS/AVSD/VSD/PA/VSD/TOF/TA/other |
unknown |
|
18
|
The Baley III cognitive composite score (CCS) |
isolated CHD/non-isolated CHD: BVP/D-TGA/AAA/DORV/TGA/HLHS/AVSD/VSD/PA/VSD/TOF/TA/other |
unknown |
|
19
|
the motor composite score |
isolated CHD/non-isolated CHD: BVP/D-TGA/AAA/DORV/TGA/HLHS/AVSD/VSD/PA/VSD/TOF/TA/other |
unknown |
|
24
|
VO2 Max |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
unknown |
|
25
|
9 and 13-hydroxyoctadecadienoic acid level (9:13-HODE) |
NA: NA |
unknown |
|
26
|
9:13-HODE at start of CPB (at post 2-24 hours CPB)/VIS |
NA: NA |
unknown |
|
27
|
9:13-HODE at End CPB at (2-24hr and 24-48hr post-CPB)/VIS |
NA: NA |
unknown |
|
28
|
9:13-HODE at start and end of CPB/milrinone use |
NA: NA |
unknown |
|
29
|
WBC count |
NA: NA |
unknown |
|
30
|
Cell-free plasma hemoglobin levels |
NA: NA |
unknown |
|
31
|
The ratio of 9:13-HODE at both start and end of CPB/cell-free plasma hemoglobin |
NA: NA |
unknown |
|
32
|
Cell-free plasma hemoglobin levels/milrinone use |
NA: NA |
unknown |
|
33
|
Cell-free plasma hemoglobin levels/VIS at 0-48 hr post-CPB |
NA: NA |
unknown |
|
34
|
C-index of CHDFI |
isolated CHD: TOF/VSD/CoA/AVS/PVS/TGA/AVD/ASD/MI/UVH/DORV/ccTGA/EA of the tricuspid valve/AVI/ASD/other |
unknown |
|
35
|
Cord blood homocysteine |
NA: NA |
unknown |
|
36
|
Cord blood folate |
NA: NA |
unknown |
|
38
|
birth weight |
NA: NA |
unknown |
|
40
|
Arterial cord blood PH value |
NA: NA |
unknown |
|
41
|
short sleep duration |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
unknown |
|
42
|
short sleep duration |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
unknown |
|
43
|
poor sleep quality |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
unknown |
|
44
|
poor sleep quality |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
unknown |
|
45
|
poor sleep |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
unknown |
|
46
|
poor sleep |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
unknown |
|
47
|
daytime nap |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
unknown |
|
48
|
daytime nap without poor sleep (simple CHD offspring) |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
unknown |
|
51
|
daytime nap without poor sleep (severe CHD offspring) |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
unknown |
|
55
|
Diabetes mellitus(percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
unknown |
|
56
|
Dyslipidemia(percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
unknown |
|
57
|
Smoking(percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
unknown |
|
79
|
days weaning |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
80
|
Days on dopamine |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
81
|
Days on milrinone |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
82
|
Days on fentanyl |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
83
|
Days on midazolam |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
84
|
Total days of ventilation |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
85
|
PICU length of stay |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
86
|
Extubation success rate |
isolated CHD: ALCAPA/HAA/AS/AVC/DORV/EA/HLHS/PA/Shone's Complex/TAPVR/TGV/TOF/TA |
unknown |
|
87
|
Catheter Ablation |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
unknown |
|
93
|
higher systolic PAP |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
unknown |
|
94
|
larger main PA(pulmonary artery) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
unknown |
|
97
|
CRP |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
unknown |
|
99
|
troponin I |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
unknown |
|
101
|
Cardiac denial of impact score |
NA: NA |
unknown |
|
102
|
Barriers to care: skill |
NA: NA |
unknown |
|
103
|
Barriers to care: marginalization |
NA: NA |
unknown |
|
104
|
Barriers to care: expectations |
NA: NA |
unknown |
|
105
|
Barriers to care: knowledge and beliefs |
NA: NA |
unknown |
|
106
|
Barriers to care: pragmatics |
NA: NA |
unknown |
|
107
|
Anxiety sensitivity index |
NA: NA |
unknown |
|
108
|
Anxiety score |
NA: NA |
unknown |
|
109
|
Physical functioning domain |
NA: NA |
unknown |
|
110
|
Physical limitations domain |
NA: NA |
unknown |
|
111
|
Emotional limitations domain |
NA: NA |
unknown |
|
112
|
Energy domain |
NA: NA |
unknown |
|
113
|
Emotional well-being domain |
NA: NA |
unknown |
|
114
|
Social domain |
NA: NA |
unknown |
|
115
|
Pain domain |
NA: NA |
unknown |
|
116
|
General health domain |
NA: NA |
unknown |
|
117
|
the growth rate of the Heschl’s gyrus |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
118
|
the growth rate of the anterior planum temporale |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
119
|
LCS (Bayley-III Language Composite Score) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
120
|
LCS at 12 months of age |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
121
|
LCS(Regression model, step 1) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
122
|
LCS(Regression model, step 2) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
123
|
longer hospitalization |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
124
|
LCS (Bayley-III Language Composite Score) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
125
|
Bayley-III Motor Composite Score |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
126
|
Bayley-III Motor Composite Score |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
127
|
Growth, left PT (planum temporale) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
128
|
Growth, left PT (planum temporale) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
129
|
Growth, left PT (planum temporale) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
130
|
Growth, left PT (planum temporale) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
131
|
SES(socioeconomic status) |
isolated CHD/non-isolated CHD: D-TGA/IAA/CoA/TAAH/U-AVSD/VSD/PA, VSD |
unknown |
|
132
|
patients with RACHS 4 |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
unknown |
|
137
|
open sternum |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
unknown |
|
140
|
length of stay in the pediatric intensive care unit (PICU) |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
unknown |
|
141
|
mechanical ventilation duration |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
unknown |
|
142
|
Associated infection |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
unknown |
|
143
|
Postponed sternal closure |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
unknown |
|
144
|
Re-intubation |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
unknown |
|
145
|
without pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
unknown |
|
147
|
without pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
unknown |
|
149
|
without pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
unknown |
|
151
|
without maternal insulin use |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
unknown |
|
153
|
without maternal insulin use |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
unknown |
|
155
|
paternal race (white non-Hispanic) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
unknown |
|
157
|
paternal race (white non-Hispanic) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
unknown |
|
161
|
Head circumference |
isolated CHD/non-isolated CHD: TGA, IVS/TGA, VSD/TOF/TOF, PA/TA/TAPVC/EA/VSD, IAA/CoA, HAA/other/PA, IVS/HLHS/DORV/CoA |
unknown |
|
162
|
Placental weight |
isolated CHD/non-isolated CHD: TGA, IVS/TGA, VSD/TOF/TOF, PA/TA/TAPVC/EA/VSD, IAA/CoA, HAA/other/PA, IVS/HLHS/DORV/CoA |
unknown |
|
163
|
normal placenta |
isolated CHD/non-isolated CHD: TGA, IVS/TGA, VSD/TOF/TOF, PA/TA/TAPVC/EA/VSD, IAA/CoA, HAA/other/PA, IVS/HLHS/DORV/CoA |
unknown |
|
166
|
FVC(forced vital capacity) |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
167
|
predicted FVC |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
168
|
Z score FVC |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
169
|
FEV1(Forced expiratory vomumn in 1s) |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
170
|
predicted FEV1 |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
171
|
Z score FEV1 |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
172
|
Peak VO2 |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
173
|
predicted VO2(max) |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
174
|
VE/VCO2 slope |
isolated CHD: TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
unknown |
|
195
|
Patient rights and information |
NA: NA |
unknown |
|
196
|
Health Outcomes |
NA: NA |
unknown |
|
197
|
Prevention |
NA: NA |
unknown |
|
198
|
Pharmaceuticals |
NA: NA |
unknown |
|
199
|
pulmonary vascular resistance (PVR)/systemic vascular resistance (SVR) at baseline |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/APSD/VSD, PDA/ASD, PDA/ASD, VSD/AVSD/PAH |
unknown |
|
200
|
Pulmonary vascular resistance index (PVRI) at baseline |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/APSD/VSD, PDA/ASD, PDA/ASD, VSD/AVSD/PAH |
unknown |
|
201
|
pulmonary vascular resistance (PVR)/systemic vascular resistance (SVR) after Acute vasoreactivity test(AVT) |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/APSD/VSD, PDA/ASD, PDA/ASD, VSD/AVSD/PAH |
unknown |
|
202
|
Pulmonary vascular resistance index (PVRI) after Acute vasoreactivity test(AVT) |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/APSD/VSD, PDA/ASD, PDA/ASD, VSD/AVSD/PAH |
unknown |
|
222
|
seraphin(tolerability) |
isolated CHD: ASD/VSD/PTA |
unknown |
|
223
|
seraphin(frequency of adverse events) |
isolated CHD: ASD/VSD/PTA |
unknown |
|
227
|
creatinine |
isolated CHD: CHD with PAH |
unknown |
|
230
|
mean pulmonary artery pressure(mPAP) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
231
|
mean pulmonary artery pressure(mPAP) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
232
|
right ventricular diameter(RVD) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
233
|
right ventricular diameter(RVD) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
234
|
pulmonary vascular resistance(PVR) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
235
|
pulmonary vascular resistance(PVR) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
236
|
pulmonary vascular resistance/systemic vascular resistance(PVR/SVR) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
237
|
pulmonary vascular resistance/systemic vascular resistance(PVR/SVR) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
238
|
P-wave Dispersion(PWD) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
239
|
QT dispersion(QTd) |
isolated CHD/non-isolated CHD: VSD/AVC/PDA/TGA/ASD/ASD, VSD |
unknown |
|
240
|
Surgical risk(RACHS) scores |
isolated CHD: DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
unknown |
|
241
|
delayed sternal closure |
isolated CHD: DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
unknown |
|
242
|
extra corporeal membrane oxygenation(ECMO) use with seizures |
isolated CHD: DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
unknown |
|
243
|
pediatric intensive care unit(PICU) length of stay |
isolated CHD: DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
unknown |
|
244
|
total length of stay |
isolated CHD: DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
unknown |
|
245
|
clinical seizure |
isolated CHD: DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
unknown |
|
246
|
epilepsy |
isolated CHD: DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
unknown |
|
247
|
age |
isolated CHD/non-isolated CHD: AS/CoA/ASD, VSD, AVSD/TGA/TOF/PS/UVH |
unknown |
|
248
|
Height |
isolated CHD/non-isolated CHD: AS/CoA/ASD, VSD, AVSD/TGA/TOF/PS/UVH |
unknown |
|
249
|
Height |
isolated CHD/non-isolated CHD: AS/CoA/ASD, VSD, AVSD/TGA/TOF/PS/UVH |
unknown |
|
250
|
cIMT of CoA |
isolated CHD: CoA |
unknown |
|
251
|
cIMT of TGA |
isolated CHD: TGA |
unknown |
|
252
|
Carotid intima-media thickness(cIMT) |
isolated CHD/non-isolated CHD: AS/CoA/ASD, VSD, AVSD/TGA/TOF/PS/UVH |
unknown |
|
253
|
cSBP(Center systolic blood pressure) |
isolated CHD/non-isolated CHD: AS/CoA/ASD, VSD, AVSD/TGA/TOF/PS/UVH |
unknown |
|
269
|
SpO2 |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
270
|
IL-6 concentration |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
271
|
pNF-H |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
272
|
IL-6 and SpO2 |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
273
|
pNF-H and SpO |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
274
|
derutaion of mechanical ventilation |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
275
|
mechanical ventilation and SpO2 |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
276
|
PICU LOS |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
277
|
hospital LOS |
isolated CHD/non-isolated CHD: HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
unknown |
|
278
|
altitude |
isolated CHD/non-isolated CHD: PDA/ASD/VSD/ASD, PDA/AS/ASD, VSD/VSD, PDA/CoA/PS/MVP/PS/SV |
unknown |
|
279
|
sex |
isolated CHD/non-isolated CHD: PDA/ASD/VSD/ASD, PDA/AS/ASD, VSD/VSD, PDA/CoA/PS/MVP/PS/SV |
unknown |
|
281
|
Trial of labor attempted |
isolated CHD: C-CHD |
unknown |
|
288
|
Birthweight |
isolated CHD: C-CHD |
unknown |
|
300
|
Histroy of prior cesarean birth |
isolated CHD: C-CHD |
unknown |
|
301
|
History of preterm birth |
isolated CHD: C-CHD |
unknown |
|
302
|
gestational age at delivery |
isolated CHD: C-CHD |
unknown |
|
304
|
antenatal corticosteroids |
isolated CHD: C-CHD |
unknown |
|
305
|
malpresentation |
isolated CHD: C-CHD |
unknown |
|
307
|
surfactant administration |
isolated CHD: C-CHD |
unknown |
|
308
|
antibiotics for suspected sepsis |
isolated CHD: C-CHD |
unknown |
|
309
|
TM(Thrombomodulin) |
isolated CHD: CHD with PAH |
unknown |
|
310
|
t-PA(tissue-type plasminogen activator) |
isolated CHD: CHD with PAH |
unknown |
|
311
|
β-TG |
isolated CHD: CHD with PAH |
unknown |
|
312
|
P-selection |
isolated CHD: CHD with PAH |
unknown |
|
313
|
VWF:Ag |
isolated CHD: CHD with PAH |
unknown |
|
314
|
β-TG with Tadalafil administration |
isolated CHD: CHD with PAH |
unknown |
|
315
|
t-PA with Tadalafil administration |
isolated CHD: CHD with PAH |
unknown |
|
316
|
TM with Tadalafil administration |
isolated CHD: CHD with PAH |
unknown |
|
317
|
P-selection with sildenafil treatment |
isolated CHD: CHD with PAH |
unknown |
|
318
|
VWF:Ag with sildenafil treatment |
isolated CHD: CHD with PAH |
unknown |
|
319
|
6-MWD |
isolated CHD: CHD with PAH |
unknown |
|
320
|
6-MWD |
isolated CHD: CHD with PAH |
unknown |
|
321
|
hematocrit level |
isolated CHD: CHD with PAH |
unknown |
|
322
|
hematocrit level |
isolated CHD: CHD with PAH |
unknown |
|
323
|
hemoglobin level |
isolated CHD: CHD with PAH |
unknown |
|
324
|
hemoglobin level |
isolated CHD: CHD with PAH |
unknown |
|
325
|
health-related quality |
isolated CHD: CHD with PAH |
unknown |
|
326
|
health-related quality |
isolated CHD: CHD with PAH |
unknown |
|
327
|
MPV value |
isolated CHD: PA/TGA/DORV/SV/TOF/TA |
unknown |
|
331
|
B7-H3 |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
unknown |
|
332
|
NT pro-BNP |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
unknown |
|
338
|
antenatal detection |
non-isolated CHD: D-TGA, IVS/D-TGA, VSD/AAO, IVS/AAO, VSD |
unknown |
|
339
|
neonate mortality in 9 years |
non-isolated CHD: D-TGA, IVS/D-TGA, VSD/AAO, IVS/AAO, VSD |
unknown |
|
340
|
mortality |
non-isolated CHD: D-TGA, IVS/D-TGA, VSD/AAO, IVS/AAO, VSD |
unknown |
|
341
|
birth outside the surgical center |
non-isolated CHD: D-TGA, IVS/D-TGA, VSD/AAO, IVS/AAO, VSD |
unknown |
|
342
|
hours of mechanical ventilation |
non-isolated CHD: D-TGA, IVS/D-TGA, VSD/AAO, IVS/AAO, VSD |
unknown |
|
343
|
short durations of hospital stay |
non-isolated CHD: D-TGA, IVS/D-TGA, VSD/AAO, IVS/AAO, VSD |
unknown |
|
344
|
Age |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
345
|
BMI |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
346
|
Hip-to-waist-ratio |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
347
|
systolic BP |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
348
|
Diastolic BP |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
349
|
Triglyceride |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
350
|
HDL cholesterol |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
351
|
PROCAM quick check |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
352
|
PROCAM health check |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
353
|
PROCAM quick check and sex |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
354
|
PROCAM health check and sex |
isolated CHD: AS/CoA/AV/ASD/PS/EA/TOF/TGA/other |
unknown |
|
362
|
health-related quality of life (HRQoL)---Physical functions |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
unknown |
|
363
|
health-related quality of life (HRQoL)---General health |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
unknown |
|
364
|
health-related quality of life (HRQoL)---Physical component summary |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
unknown |
|
373
|
Single ventricle anatomy with thrombosis |
isolated CHD: HRHS/HLHS/other |
unknown |
|
374
|
Peak lactate in first 24 hours |
isolated CHD: HRHS/HLHS/other |
unknown |
|
375
|
12 hr Vasoactive-Ventilation-Renal(VVR) score |
isolated CHD: HRHS/HLHS/other |
unknown |
|
376
|
postoperative platelet transfusions |
isolated CHD: HRHS/HLHS/other |
unknown |
|
377
|
fresh frozen plasma (FFP) exposure |
isolated CHD: HRHS/HLHS/other |
unknown |
|
379
|
total duration of central venous catheter (CVC) |
isolated CHD: HRHS/HLHS/other |
unknown |
|
380
|
Left Thoracotomy on the Prevalence of a High Thoracic Curve |
isolated CHD/non-isolated CHD: TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
unknown |
|
381
|
Right Thoracotomy on the Prevalence of a High Thoracic Curve |
isolated CHD/non-isolated CHD: TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
unknown |
|
382
|
Bilateral Thoracotomy on the Prevalence of a High Thoracic Curve |
isolated CHD/non-isolated CHD: TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
unknown |
|
383
|
Right Thoracotomy on the Convex Side of a High Thoracic Curve |
isolated CHD/non-isolated CHD: TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
unknown |
|
384
|
Female:male ratio (no. of patients) with ≥45° Scoliosis |
isolated CHD/non-isolated CHD: TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
unknown |
|
385
|
Number of surgical procedures |
isolated CHD/non-isolated CHD: TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
unknown |
|
386
|
Cardiomegaly(cardiothoracic ratio>55%)(no. of patients) |
isolated CHD/non-isolated CHD: TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
unknown |
|
387
|
prone domain of the Alberta Infant Motor Scale(P-AIMS) |
NA: NA |
unknown |
|
388
|
Hospital stay before 18 months |
NA: NA |
unknown |
|
389
|
predicted FEV1(volume of air exhaled in first second of forced expiration) |
non-isolated CHD: NA |
unknown |
|
390
|
predicted FVC(forced vital capacity) |
non-isolated CHD: NA |
unknown |
|
391
|
predicted peak VO2 |
isolated CHD: TOF |
unknown |
|
392
|
predicted FEV1 |
isolated CHD: TOF |
unknown |
|
393
|
predicted FVC(forced vital capacity) |
isolated CHD: TOF |
unknown |
|
394
|
VE/VCO2 slope |
isolated CHD: TOF |
unknown |
|
395
|
Peak VO2 (ml/kg/min) |
isolated CHD: TOF |
unknown |
|
396
|
predicted peak heart rate |
isolated CHD: TOF |
unknown |
|
397
|
Pacemaker (% with) |
isolated CHD: TOF |
unknown |
|
398
|
VO2 at VAT (% pred) |
isolated CHD: TOF |
unknown |
|
407
|
Abnormal background pattern (BGP), 12-48 h after surgery |
NA: BVP/BVP-AAO/SV |
unknown |
|
408
|
ictal discharges |
NA: BVP/BVP-AAO/SV |
unknown |
|
409
|
Soluble suppression of tumorogenicity 2 (sST2) |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
410
|
Patients with Fontan palliation or Eisenmenger physiology (%) |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
411
|
NYHA class III/IV |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
412
|
Ejection fraction of SV |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
413
|
Endsystolic volume of SV |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
414
|
estimated GFR |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
415
|
γGT levels |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
416
|
Albumin |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
417
|
NT-proBNP levels |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
418
|
sST2 levels |
isolated CHD/non-isolated CHD: CRHD/other/SRV/EIS/complex CHD |
unknown |
|
426
|
total health risk score |
non-isolated CHD: complex CHD |
unknown |
|
427
|
Linear Analog Scale Quality of Life(LAS QOL) |
non-isolated CHD: complex CHD |
unknown |
|
428
|
Satisfaction of with Life Scale(SWLS) |
non-isolated CHD: complex CHD |
unknown |
|
429
|
Mental component Summary(MCS) |
non-isolated CHD: complex CHD |
unknown |
|
431
|
adjusted total hospital charges |
isolated CHD: TGA/TOF/VSD/DORV/ECD/PV/TA/EA/HLHS/CoA/IAA/other |
unknown |
|
432
|
length of stay |
isolated CHD: TGA/TOF/VSD/DORV/ECD/PV/TA/EA/HLHS/CoA/IAA/other |
unknown |
|
433
|
readmission score |
isolated CHD: TGA/TOF/VSD/DORV/ECD/PV/TA/EA/HLHS/CoA/IAA/other |
unknown |
|
434
|
complication rate |
isolated CHD: TGA/TOF/VSD/DORV/ECD/PV/TA/EA/HLHS/CoA/IAA/other |
unknown |
|
435
|
infections associated with implantation |
isolated CHD: TGA/TOF/VSD/DORV/ECD/PV/TA/EA/HLHS/CoA/IAA/other |
unknown |
|
436
|
Dysrhythmias |
isolated CHD: TGA/TOF/VSD/DORV/ECD/PV/TA/EA/HLHS/CoA/IAA/other |
unknown |
|
437
|
Mean platelet volume (MPV) |
NA: CHD with PAH |
unknown |
|
438
|
platelet distribution width (PDW) |
NA: CHD with PAH |
unknown |
|
439
|
Mean platelet volume (MPV) |
NA: CHD with PAH |
unknown |
|
440
|
platecrit |
NA: CHD with PAH |
unknown |
|
441
|
platelet distribution width (PDW) |
NA: CHD with PAH |
unknown |
|
442
|
overweight |
isolated CHD: VSD/MVD/ASD/BAV/PS/PDA/AS/TOF/CoA/ASD/EA/AVSD/SMVR/IAA/DCRV/TR/IAA/DTA/PAPVR/PVS/ALCAPA/AVR/TGA/SV/DOV/PA/TA/TAS |
unknown |
|
443
|
obese |
isolated CHD: VSD/MVD/ASD/BAV/PS/PDA/AS/TOF/CoA/ASD/EA/AVSD/SMVR/IAA/DCRV/TR/IAA/DTA/PAPVR/PVS/ALCAPA/AVR/TGA/SV/DOV/PA/TA/TAS |
unknown |
|
444
|
Physically active (age-specific guidelines) |
isolated CHD: VSD/MVD/ASD/BAV/PS/PDA/AS/TOF/CoA/ASD/EA/AVSD/SMVR/IAA/DCRV/TR/IAA/DTA/PAPVR/PVS/ALCAPA/AVR/TGA/SV/DOV/PA/TA/TAS |
unknown |
|
445
|
poor health(cardiovasscular health) |
isolated CHD: VSD/MVD/ASD/BAV/PS/PDA/AS/TOF/CoA/ASD/EA/AVSD/SMVR/IAA/DCRV/TR/IAA/DTA/PAPVR/PVS/ALCAPA/AVR/TGA/SV/DOV/PA/TA/TAS |
unknown |
|
446
|
intermediate health(cardiovasscular health) |
isolated CHD: VSD/MVD/ASD/BAV/PS/PDA/AS/TOF/CoA/ASD/EA/AVSD/SMVR/IAA/DCRV/TR/IAA/DTA/PAPVR/PVS/ALCAPA/AVR/TGA/SV/DOV/PA/TA/TAS |
unknown |
|
454
|
Total novel variants |
isolated CHD/non-isolated CHD: SD/AVSD/MOT/OL/FSV/HTX/other |
unknown |
|
455
|
‘rare’ (minor allele frequency: MAF<0.01) |
isolated CHD/non-isolated CHD: SD/AVSD/MOT/OL/FSV/HTX/other |
unknown |
|
456
|
‘low’ (MAF<0.01) |
isolated CHD/non-isolated CHD: SD/AVSD/MOT/OL/FSV/other |
unknown |
|
457
|
‘low’ (MAF<0.05) |
isolated CHD/non-isolated CHD: SD/AVSD/MOT/OL/FSV/HTX/other |
unknown |
|
458
|
illness identity (engulfment) |
NA: NA |
unknown |
|
459
|
prevalence of postoperative intestinal perforation |
isolated CHD/non-isolated CHD: TOF/ASD, VSD |
unknown |
|
460
|
Recipient age of CHD(with or without ventricular assist device,VAD) |
NA: NA |
unknown |
|
461
|
Infants(percent) |
NA: NA |
unknown |
|
462
|
Functional status <50%(percent) |
NA: NA |
unknown |
|
463
|
Panel reactive antibodies >10%(percent) |
NA: NA |
unknown |
|
464
|
Dialysis support(percent) |
NA: NA |
unknown |
|
465
|
Intravenous inotropic support(percent) |
NA: NA |
unknown |
|
466
|
ventilator support(percent) |
NA: NA |
unknown |
|
467
|
Clinical infection(percent) |
NA: NA |
unknown |
|
474
|
Number of operations |
isolated CHD/non-isolated CHD: TGA/TOF/DORV/VSD, CoA/PA, VSD/AVSD |
unknown |
|
475
|
right ventricular ejection fraction (RVEF)(%) |
isolated CHD/non-isolated CHD: TGA/TOF/DORV/VSD, CoA/PA, VSD/AVSD |
unknown |
|
476
|
RVEDV(right ventricular end-diastolic volume from the normal value) (% of normal) |
isolated CHD/non-isolated CHD: TGA/TOF/DORV/VSD, CoA/PA, VSD/AVSD |
unknown |
|
477
|
GSE(General Self-Efficacy) |
NA: NA |
unknown |
|
478
|
GSE(General Self-Efficacy) |
NA: NA |
unknown |
|
479
|
female sex |
isolated CHD/non-isolated CHD: NA |
unknown |
|
480
|
not having a job (Job seeking, unemployed or disability) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
485
|
severe systemic ventricle dilation |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
unknown |
|
488
|
No. (intra-atrial re-entrant tachycardia)IART induced |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
unknown |
|
489
|
IART type: CTI/both/non-CTI |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
unknown |
|
499
|
age |
isolated CHD/non-isolated CHD: Left UVH/Right UVH/UVH/TA |
unknown |
|
500
|
more cardiac surgeries prior to heart transplant |
isolated CHD/non-isolated CHD: Left UVH/Right UVH/UVH/TA |
unknown |
|
501
|
percentage of cardiovascular risk factors |
isolated CHD/non-isolated CHD: Left UVH/Right UVH/UVH/TA |
unknown |
|
502
|
left ventricle ejection fraction |
isolated CHD/non-isolated CHD: Left UVH/Right UVH/UVH/TA |
unknown |
|
503
|
extracorporeal circulation time (ECT) |
isolated CHD/non-isolated CHD: Left UVH/Right UVH/UVH/TA |
unknown |
|
504
|
intubation time |
isolated CHD/non-isolated CHD: Left UVH/Right UVH/UVH/TA |
unknown |
|
505
|
primary graft failure |
isolated CHD/non-isolated CHD: Left UVH/Right UVH/UVH/TA |
unknown |
|
509
|
6 year motor problems |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
unknown |
|
512
|
T‑box transcription factor 1 (TBX1) expression |
isolated CHD: Triatial heart/EA/SV/VSD/TOF/PS/ECD |
unknown |
|
514
|
The C-index |
NA: NA |
unknown |
|
515
|
caveolin-1 |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, PFO/other |
unknown |
|
516
|
filamin A expression |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, PFO/other |
unknown |
|
517
|
cathepsin D combined with macrophagocytes counts |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, PFO/other |
unknown |
|
518
|
glutathione S-transferase mu1 (GSTM1) expression |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, PFO/other |
unknown |
|
520
|
percent predicted peak expiratory flow rate(PEFR) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
522
|
percent predicted forced expiratory flow rate at 50% of forced vital capacity(FEF50) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
524
|
percent predicted forced expiratory volume in 1 s(FEV1) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
526
|
forced vital capacity(FVC) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
527
|
breathless with lower 6-minute walk distance |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
528
|
Endothelin-1 |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
529
|
Endothelin-1 |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
530
|
interleukin (IL)-β |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
531
|
interleukin (IL)-β |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
532
|
interleukin (IL)-IL-6 |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
533
|
interleukin (IL)-IL-6 |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
534
|
interleukin (IL)-IL-8 |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
535
|
interleukin (IL)-IL-8 |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
536
|
tumor necrosis factor(TNF) α |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
537
|
vascular endothelial growth factor(VEGF) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
538
|
vascular endothelial growth factor(VEGF) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unknown |
|
544
|
Hemoglobin |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
unknown |
|
545
|
Apoferritin |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
unknown |
|
547
|
Female sex |
isolated CHD: PDA/ASD/VSD |
unknown |
|
554
|
IUS-R(Intolerance of Uncertainty Scale-Revised) Total Score |
NA: NA |
unknown |
|
555
|
Treatment Experience |
NA: NA |
unknown |
|
556
|
Symptom effects |
NA: NA |
unknown |
|
557
|
Separation anxiety |
NA: NA |
unknown |
|
558
|
Physical injury fears |
NA: NA |
unknown |
|
559
|
BNP (brain natriuretic peptide) |
NA: NA |
unknown |
|
560
|
pro-BNP (pro-brain natriuretic peptid) |
NA: NA |
unknown |
|
561
|
scTnI (sensitive cardiac troponin I) |
NA: NA |
unknown |
|
562
|
hsTnT (high-sensitive troponin T) |
NA: NA |
unknown |
|
563
|
scTnI (sensitive cardiac troponin I) |
NA: NA |
unknown |
|
564
|
hsTnT (high-sensitive troponin T) |
NA: NA |
unknown |
|
565
|
Lower level of New York heart association class(NYHA) |
NA: NA |
unknown |
|
566
|
presence of siblings |
NA: NA |
unknown |
|
567
|
mother’s emotional warmth |
NA: NA |
unknown |
|
568
|
major complications with younger age |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
570
|
died with younger age |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
571
|
longer procedures |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
572
|
minor complications with younger patients |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
573
|
prolonged procedure time |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
574
|
fluoroscopy times |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
576
|
Cyanotic patients |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
577
|
ventricular outflow obstructions |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
unknown |
|
578
|
Deep Gray matter(GM) volumn |
isolated CHD: SV |
unknown |
|
579
|
White matter(WM) volumn |
isolated CHD: SV |
unknown |
|
580
|
Gray matter(GM) volumn |
isolated CHD: SV |
unknown |
|
581
|
Deep Gray matter(GM) volumn |
isolated CHD: SV |
unknown |
|
582
|
White matter(WM) volumn |
isolated CHD: SV |
unknown |
|
583
|
CSF volume |
isolated CHD: SV |
unknown |
|
587
|
Mother age |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
588
|
Father age |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
589
|
offspring age |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
590
|
In vitro fertilization |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
591
|
parental periconceptional exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
592
|
genotype of AhR p.Arg554Lys(Arg/Arg) |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
593
|
Lys allele distribuctions of AhR p.Arg554Lys |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
596
|
Arg/Arg without maternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
600
|
Arg/Arg without maternal smoking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
604
|
Arg/Arg without paternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
608
|
Arg/Arg without paternal smoking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
unknown |
|
612
|
SPO2 |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
613
|
N-terminal pro-B-type natriuretic peptide(NT-proBNP) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
614
|
cardiac troponin I(CTnI) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
615
|
RV-SV |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
616
|
total pulmonary resistance(TRP) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
617
|
total pulmonary resistance index(TRPI) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
618
|
pulmonary vascular resistance(PVR) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
619
|
pulmonary vascular resistance index(PVRi) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
620
|
mean pulmonary artery pressure(mPAP) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
621
|
systolic pulmonary artery pressure(SPAP) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
622
|
diastolic pulmonary artery pressure(DPAP) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
623
|
6-MWD |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
624
|
Borg scale |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
625
|
correlation between pre-treatment MPI T/B ratio value with Borg scale |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
626
|
correlation between pre-treatment MPI T/B ratio value with SPO2 |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
627
|
correlation between pre-treatment MPI T/B ratio value with TRP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
628
|
correlation between pre-treatment MPI T/B ratio value with TRPI |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
629
|
correlation between pre-treatment MPI T/B ratio value with PVR |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
630
|
correlation between pre-treatment MPI T/B ratio value with PVRI |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
631
|
correlation between pre-treatment MPI T/B ratio value with cardiac output(CO) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
632
|
correlation between pre-treatment MPI T/B ratio value with cardiac index(CI) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
633
|
correlation between pre-treatment MPI T/B ratio value with RV-SV |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
634
|
correlation between pre-treatment MPI T/B ratio value with mPAP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
635
|
correlation between pre-treatment MPI T/B ratio value with SPAP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
636
|
correlation between pre-treatment MPI T/B ratio value with DPAP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
637
|
correlation between post-treatment MPI T/B ratio value with TRP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
638
|
correlation between post-treatment MPI T/B ratio value with TRPI |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
639
|
correlation between post-treatment MPI T/B ratio value with PVR |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
640
|
correlation between post-treatment MPI T/B ratio value with PVRI |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
641
|
correlation between post-treatment MPI T/B ratio value with mPAP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
642
|
correlation between post-treatment MPI T/B ratio value with sPAP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
643
|
correlation between post-treatment MPI T/B ratio value with dPAP |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
644
|
pre-treatment MPI T/B ratio in moderate/severe PAH patients |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
645
|
post-treatment MPI T/B ratio in PAH patients(moderate/severe:mild) |
isolated CHD: VSD with PAH/ASD with PAH/PDA with PAH |
unknown |
|
646
|
Ectopic atrial tachycardia(EAT) |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
unknown |
|
647
|
Age |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
unknown |
|
648
|
Weight |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
unknown |
|
649
|
cardiopulmonary bypass time(CPB time) |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
unknown |
|
650
|
Single ventricle(SV) |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
unknown |
|
651
|
Open chest |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
unknown |
|
652
|
STAT category |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
unknown |
|
658
|
NYHA decreased cardiac function class≥2 |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
unknown |
|
660
|
term delivery |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
unknown |
|
661
|
iatrogenic abortion |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
unknown |
|
662
|
neonate weight |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
unknown |
|
663
|
small for gestational age infant(SGA) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
unknown |
|
664
|
infective endocarditis(IE) |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
unknown |
|
665
|
incidence of IE in complex CHD |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
unknown |
|
666
|
incidence of IE in VSD |
isolated CHD: VSD |
unknown |
|
667
|
BAV post aortic valve replacement (AVR) |
isolated CHD: BAV |
unknown |
|
676
|
average haem levels-all time points |
isolated CHD/non-isolated CHD: NA |
unknown |
|
677
|
haem levels-presurgery |
isolated CHD/non-isolated CHD: NA |
unknown |
|
678
|
haem levels-6h postsurgery |
isolated CHD/non-isolated CHD: NA |
unknown |
|
679
|
haem levels- postoperatively |
isolated CHD/non-isolated CHD: NA |
unknown |
|
680
|
central shunt produre |
isolated CHD/non-isolated CHD: NA |
unknown |
|
681
|
Tetralogy of Fallot repair |
isolated CHD/non-isolated CHD: NA |
unknown |
|
682
|
Red blood cell transfusions |
isolated CHD/non-isolated CHD: NA |
unknown |
|
683
|
No. of RBCs transfusions |
isolated CHD/non-isolated CHD: NA |
unknown |
|
684
|
Volume of RBCs transfusions |
isolated CHD/non-isolated CHD: NA |
unknown |
|
693
|
disease factor in Patient-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
694
|
educational impairment factor in Patient-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
695
|
poor self-esteem in Patient-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
696
|
anxiety in Patient-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
697
|
patient posttraumatic stress in Patient-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
698
|
parent posttraumatic tress in Patient-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
699
|
disease factor in Parent-proxy-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
700
|
educational impairment in Parent-proxy-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
701
|
greater parental medical stress in Parent-proxy-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
702
|
poorer child self-esteem in Parent-proxy-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
703
|
child internalizing problems in Parent-proxy-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
704
|
parent posttraumatic stress in Parent-proxy-reported PCQLI |
non-isolated CHD: complex CHD |
unknown |
|
705
|
Hemoglobin |
isolated CHD: CHD with PAH/EA |
unknown |
|
706
|
Partial pressure of oxygen |
isolated CHD: CHD with PAH/EA |
unknown |
|
707
|
mean pulmonary arterial pressure(mPAP) |
isolated CHD: CHD with PAH/EA |
unknown |
|
708
|
NT-proBNP |
isolated CHD: CHD with PAH/EA |
unknown |
|
709
|
big-Endothelin |
isolated CHD: CHD with PAH/EA |
unknown |
|
710
|
WHO function class |
isolated CHD: CHD with PAH/EA |
unknown |
|
711
|
6-minute walking distance(6-MWD) |
isolated CHD: CHD with PAH/EA |
unknown |
|
712
|
left ventricular end-diastolic diameter |
isolated CHD: CHD with PAH/EA |
unknown |
|
713
|
total bilirubin |
isolated CHD: CHD with PAH/EA |
unknown |
|
714
|
NT-proBNP |
isolated CHD: CHD with PAH/EA |
unknown |
|
715
|
Oxygen saturation |
isolated CHD: CHD with PAH/EA |
unknown |
|
725
|
Cp<1.04ml/mmHg(survival curve) |
isolated CHD: CHD with PAH/EA |
unknown |
|
732
|
post-operative brain injury |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
733
|
post-operative stroke |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
734
|
post-op duration of mechanical ventilation |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
735
|
mean global brain volumes , TBV(all pre and post-operative data) |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
736
|
mean regional brain volumn, GM(all pre and post-operative data) |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
737
|
mean regional brain volumn, Deep GM(all pre and post-operative data) |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
738
|
rate of brain growth in white and gray matter |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
739
|
rate of growth globally and in white and deep gray matter |
isolated CHD/non-isolated CHD: HLHS/TGA/TGA, VSD |
unknown |
|
750
|
Homoarginine(hArg) levels |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
751
|
γGT levels |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
752
|
NYHA class |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
753
|
NT-proBNP level |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
754
|
Albumin |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
755
|
NYHA class |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
756
|
hArg levels |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
757
|
NT-proBNP level |
isolated CHD: CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
unknown |
|
771
|
growth differentiation factor-15(GDF-15) |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
772
|
GDF-15 |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
773
|
uric acid |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
774
|
NT-proBNP |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
775
|
pulmonary artery systolic pressure(PASP) |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
776
|
mean pulmonary arterial pressure(mPAP) |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
777
|
pulmonary blood flow/systemic blood folw(Qp/Qs) |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
778
|
oxygen saturation(SVo2) |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
779
|
pulmonary vascular resistance(PVR) |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
780
|
NT-proBNP |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
781
|
GDF-15 plus NT-proBNP |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
782
|
GDF-15 |
isolated CHD/non-isolated CHD: CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
unknown |
|
783
|
age |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
784
|
with prescribed mediations |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
785
|
with symptoms |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
786
|
with cormorbidity |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
787
|
quality of life(Linear analog scale, LAS) |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
788
|
satisfaction with life scale(SWLS) |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
789
|
physical component summary score(PCS) |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
790
|
mental componet summary score(MCS) |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
unknown |
|
795
|
Peak oxygen uptake (%predicted) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
797
|
beta-blocker |
isolated CHD/non-isolated CHD: NA |
unknown |
|
799
|
forced expiratory volume in the first second(FEV1)% |
isolated CHD/non-isolated CHD: NA |
unknown |
|
819
|
mean Right atrial pressure (mRAP) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
820
|
Pulmonary artery systolic pressure (PASP) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
821
|
Pulmonary vascular resistance (PVR) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
822
|
mPAP(mmHg) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
823
|
endothelin receptor antagonism (ERAs)(%) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
824
|
phosphodiesterase (PDE )-5 inhibitors (%) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
825
|
Galectin‐3 (μmol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
826
|
Galectin‐3 (μmol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
827
|
ET-1(ng/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
828
|
BNP(pg/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
829
|
BNP(pg/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
830
|
BNP(pg/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
831
|
ET-1(ng/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
832
|
ET-1(ng/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
833
|
NO(umol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
834
|
NO(umol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
835
|
ADMA(ng/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
836
|
ADMA(ng/ml) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
837
|
Galectin-3(umol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
838
|
Galectin-3(umol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
839
|
Uric acid(umol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
840
|
Uric acid(umol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
841
|
Uric acid(umol/L) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
842
|
mPAP(mmHg) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
843
|
mPAP(mmHg) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
845
|
Systemic Atrioventricular Valve (SAVV) , shunts |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
846
|
Arrhythmia |
isolated CHD: AVSD/ccTGA |
unknown |
|
847
|
Arrhythmia |
isolated CHD/non-isolated CHD: ccTGA/MS, MR |
unknown |
|
848
|
Previous cardiac surgeries--AVSD repair |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
849
|
Previous cardiac surgeries--AVSD repair |
isolated CHD/non-isolated CHD: AVSD/MS, MR |
unknown |
|
850
|
Preoperative TTE--Systemic ventricle dysfunction |
isolated CHD: AVSD/ccTGA |
unknown |
|
851
|
Preoperative TTE--Systemic ventricle dysfunction |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
852
|
Preoperative TTE--Systemic ventricle EF |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
853
|
Preoperative TTE--Systemic ventricle EF |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
854
|
SAVV repair (Commissuroplasty, Cleft closure, Leaflet resection, Annuloplasty) |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
855
|
SAVV repair (Commissuroplasty, Cleft closure, Leaflet resection, Annuloplasty) |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
856
|
SAVV replacement (Mechanical, Bioprosthetic) |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
857
|
SAVV replacement (Mechanical, Bioprosthetic) |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
858
|
Predischarge TTE-- Systemic ventricle dysfunction |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
859
|
Predischarge TTE-- Systemic ventricle dysfunction |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
860
|
Predischarge TTE--Systemic ventricle EF |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
861
|
Predischarge TTE--SAVV regurgitation |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
862
|
Predischarge TTE--SAVV regurgitation |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
863
|
Latest Echo--Systemic ventricle EF (%) |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
864
|
Latest Echo--Systemic ventricle EF (%) |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
865
|
Latest Echo--SAVVR grade |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
866
|
Latest Echo--SAVVR grade |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
unknown |
|
868
|
Correlation between interquartile range(IQR) and 18-month Cognition score |
isolated CHD: HLHS/TOF/TGA |
unknown |
|
869
|
Correlation between interquartile range and 18-month Motor scores (IQR vs. Motor) |
isolated CHD: HLHS/TOF/TGA |
unknown |
|
870
|
IQR and GA at fetal testing-- predicted Cognition |
isolated CHD: HLHS/TOF/TGA |
unknown |
|
871
|
IQR and GA at fetal testing-- predicted Cognition |
isolated CHD: HLHS/TOF/TGA |
unknown |
|
872
|
IQR using dummy variables for CHD subgroups--IQR vs. Motor |
isolated CHD: HLHS/TOF/TGA |
unknown |
|
873
|
Haemoglobin(Hb) (g/dL) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
874
|
INR (international normalized ratio of prothrombin time) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
875
|
Diagnostic data--O2 pre-operation (%) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
876
|
Diagnostic data--PA pre-operation (mmHg) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
877
|
before corrective surgery--CD62P (soluble platelet selectin) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
878
|
before corrective surgery--CD62P (soluble platelet selectin) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
879
|
before corrective surgery--IGF-1 (insulin-like growth factor-1) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
880
|
before corrective surgery--IGF-1 (insulin-like growth factor-1) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
881
|
24–48 hours after corrective surgery--BNP (brain natriuretic peptide) (pg/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
882
|
24–48 hours after corrective surgery--BNP (brain natriuretic peptide) (pg/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
883
|
24–48 hours after corrective surgery--CD62E (soluble endothelium selectin) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
884
|
24–48 hours after corrective surgery--CD62L (soluble leukocyte selectin) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
885
|
24–48 hours after corrective surgery--CD62L (soluble leukocyte selectin) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
886
|
24–48 hours after corrective surgery--IGF-1 (insulin-like growth factor-1) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
887
|
24–48 hours after corrective surgery--IGF-1 (insulin-like growth factor-1) (ng/ml) |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
888
|
weight--Pre-operation Z scores |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
889
|
Weight--Statistical significance pre- vs post surgery |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
890
|
Length--Pre-operation Z scores |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
891
|
weight--Pre-operation Z scores |
isolated CHD/non-isolated CHD: TOF/PAH/VSD/ASD/VSD, ASD/PDA/VSD, ASD, PDA/VSD, CoA/ECD |
unknown |
|
895
|
age (x±s, d) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
896
|
body weights (x±s, kg) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
897
|
sex (n, %) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
898
|
serum creatinine levels (x±s, mg/dL) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
899
|
vasoactive-inotropic score (x±s, d) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
900
|
durations of intraoperative extracorporeal circulation (x±s, min) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
901
|
durations of aortic occlusion (x±s, min) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
902
|
transfusion volume (x±s, mL) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
904
|
duration of mechanical ventilation (h) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
905
|
length of stay in the intensive care unit (ICU) (x±s, h) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
906
|
length of hospital stay (x±s, d) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
907
|
application rate of extracorporeal membrane oxygenation n(%) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
908
|
30-day mortality rate n(%) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
910
|
levels of cumulative fluid overload 3 days after surgery (x±s, %) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
911
|
children with cumulative fluid overload >5% at 2 days after surgery--incidence rate of low cardiac output syndrome (%) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
912
|
children with cumulative fluid overload >5% at 2 days after surgery--duration of mechanical ventilation (x±s, h) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
913
|
children with cumulative fluid overload >5% at 2 days after surgery--length of stay in the ICU (x±s, h) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
914
|
children with cumulative fluid overload >5% at 2 days after surgery--length of hospital stay (x±s, d) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
915
|
children with cumulative fluid overload >5% at 2 days after surgery--30d mortality rate (%) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
unknown |
|
916
|
daily steps (steps/d) |
NA: NA |
unknown |
|
917
|
The mean bias for daily steps (steps/d) |
NA: NA |
unknown |
|
918
|
Between-device differences in wear time |
NA: NA |
unknown |
|
919
|
FIGN +94762G>C(Genotype: GG) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
922
|
FIGN +94762G>C(allele: G) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
924
|
FIGN +94762G>C(Genotype: GG) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
927
|
FIGN +94762G>C(allele: G) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
929
|
FIGN +94762G>C(Genotype: GG) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
932
|
FIGN +94762G>C(allele: G) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
934
|
FIGN +94762G>C(Genotype: GG) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
937
|
FIGN +94762G>C(allele: G) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
939
|
folate concentration(ng/ml) |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
940
|
folate concentration(ng/ml) |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
unknown |
|
941
|
Cerebral rSO2 25 min before cardiopulmonary resuscitation |
non-isolated CHD: PA, IVS |
unknown |
|
942
|
Cerebral rSO2--30 minutes before cardiopulmonary resuscitation |
non-isolated CHD: DORV, TGA, VSD, HAA |
unknown |
|
943
|
renal rSO2--30 minutes before cardiopulmonary resuscitation |
non-isolated CHD: DORV, TGA, VSD, HAA |
unknown |
|
944
|
Occipitofrontalcircumference (cm) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
945
|
Occipitofrontalcircumference (cm) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
946
|
Mid-arm circumference (cm) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
947
|
Mid-arm circumference (cm) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
948
|
Mid-chestcircumference (cm) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
949
|
Weight for age z-score |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
950
|
Weight for age z-score |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
951
|
Height for age z-score |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
952
|
Weight for Height z score |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
953
|
Weight for Height z score |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
954
|
Serum antigliadin IgA (IU/ml) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
955
|
Serum antigliadin IgM (IU/ml) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
956
|
Serum calcium (mg/dl) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
957
|
Serum alkaline phosphatase (IU/l) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
958
|
HB (gm/dl) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
959
|
Serum iron (mcg/dl) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
960
|
Serum TIBC (mcg/dl) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
961
|
Correlations between Serum antigliadin IgM and Height/age z-score |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
962
|
Correlations between Serum antigliadin IgM and Serum calcium |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
963
|
Correlations between Serum antigliadin IgG and Weight/age z-score |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
964
|
Correlations between Serum antigliadin IgG and Serum alkaline phosphatase |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
unknown |
|
976
|
NT-proBNP, N-terminal pro–brain natriuretic peptide--Intercept |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
977
|
NT-proBNP--Time points (Before surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
978
|
NT-proBNP--Time points (1 h after surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
979
|
NT-proBNP--Time points (12 h after surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
980
|
NT-proBNP--Age (Neonates <30 d) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
981
|
NT-proBNP--Age (Infants <1 y) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
982
|
NT-proBNP--RACHS-1 (≤2) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
983
|
NT-proBNP--DHCA (no) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
984
|
NT-proBNP--Serum creatinine, mmol/L (Postoperative) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
985
|
NT-proBNP--Weight, kg |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
986
|
NT-proBNP–brain natriuretic peptide--Intercept |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
987
|
NT-proBNP--Time points (Before surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
988
|
NT-proBNP--Time points (1 h after surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
989
|
NT-proBNP--Time points (12 h after surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
990
|
NT-proBNP--Age (Neonates <30 d) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
991
|
NT-proBNP--Age (Infants <1 y) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
992
|
NT-proBNP--RACHS-1 (≤2) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
993
|
NT-proBNP--DHCA (no) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
994
|
NT-proBNP--Serum creatinine, mmol/L (Postoperative) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
995
|
NT-proBNP--CPB time, min |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
996
|
NT-proBNP--Weight, kg |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
997
|
The second submodel Log(NT-proBNP) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
998
|
The second submodel Log(NT-proBNP)--1 h after surgery |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
999
|
The second submodel Log(NT-proBNP)--12 h after surgery |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1000
|
The second submodel Log(NT-proBNP) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1001
|
(NT-proBNP)--Time points (12 h after surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1002
|
Log(NT-proBNP)--RACHS-1 (≤2) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1003
|
Log(NT-proBNP)--DHCA |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1004
|
The second submodel Log(NT-proBNP) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1005
|
Log(NT-proBNP)--Time points (12 h after surgery) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1006
|
Log(NT-proBNP)--RACHS-1 (≤2) |
isolated CHD: VSD/ASD/TAPVR/TOF/TGA/PA/ASD/CoA/DORV/IAA/PS/other |
unknown |
|
1007
|
Age (years) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
unknown |
|
1008
|
Beta-blocker, n (%) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
unknown |
|
1009
|
peak oxygen uptake |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
unknown |
|
1010
|
physical health-related quality of life (HrQoL) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
unknown |
|
1011
|
mental health-related quality of life (HrQoL) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
unknown |
|
1024
|
Age (years) |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1025
|
Time since initial arrhythmia (years) |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1026
|
Prior catheter ablation |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1027
|
Prior maze procedure |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1028
|
Prior DCCV |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1029
|
AAD class use at time of DCCV--Class I |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1030
|
AAD class use at time of DCCV--Class II |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1031
|
AAD class use at time of DCCV--Class III |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1032
|
DCCV--Inpatient |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1033
|
DCCV--TEE guidance |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1034
|
DCCV--Failed cardioversion |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1035
|
Anticoagulation or antiplatelet therapy--Antiplatelet agent |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1036
|
Anticoagulation or antiplatelet therapy--NOAC |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1037
|
Echocardiography--LV (systemic) ejectionfraction <35% |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1038
|
procedural failurerate |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1044
|
arrhythmia recurrence rate at 60 months |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
unknown |
|
1061
|
Longer total duration of intubation |
isolated CHD: HLHS/TOF/TGA |
unknown |
|
1062
|
number of days withholding enteral feeds |
isolated CHD: HLHS/TOF/TGA |
unknown |
|
1063
|
Age (years) |
NA: NA |
unknown |
|
1064
|
Age groups (%) (0–1 years) |
NA: NA |
unknown |
|
1065
|
Age groups (%) (1–18 years) |
NA: NA |
unknown |
|
1066
|
Type of disease--Q20 |
NA: NA |
unknown |
|
1067
|
Type of disease--Q21 |
NA: NA |
unknown |
|
1068
|
Type of disease--Q22 |
NA: NA |
unknown |
|
1069
|
Type of disease--Q23 |
NA: NA |
unknown |
|
1070
|
Type of disease--Q24 |
NA: NA |
unknown |
|
1071
|
Type of disease--Q25 |
NA: NA |
unknown |
|
1072
|
Length of stay(LOS) (days) |
NA: NA |
unknown |
|
1073
|
Nationality (%)--Not Swiss |
NA: NA |
unknown |
|
1074
|
Nationality (%)--Swiss |
NA: NA |
unknown |
|
1075
|
Canton of origin--Vaud |
NA: NA |
unknown |
|
1076
|
Canton of origin--Neighbour |
NA: NA |
unknown |
|
1077
|
Canton of origin--Other |
NA: NA |
unknown |
|
1078
|
LOS > 14 days (%)--No |
NA: NA |
unknown |
|
1079
|
LOS > 14 days (%)--Yes |
NA: NA |
unknown |
|
1080
|
Day of discharge--Sunday |
NA: NA |
unknown |
|
1081
|
Day of discharge--Monday |
NA: NA |
unknown |
|
1082
|
Day of discharge--Tuesday |
NA: NA |
unknown |
|
1083
|
Day of discharge--Wednesday |
NA: NA |
unknown |
|
1084
|
Day of discharge--Thursday |
NA: NA |
unknown |
|
1085
|
Day of discharge--Friday |
NA: NA |
unknown |
|
1086
|
Day of discharge--Saturday |
NA: NA |
unknown |
|
1087
|
Surgery--Yes/No(Multivariate analysis of the factors associated with read- mission at 30 days for CHD) |
NA: NA |
unknown |
|
1088
|
Canton of origin--Other(Multivariate analysis of the factors associated with read- mission at 30 days for CHD) |
NA: NA |
unknown |
|
1089
|
LOS > 14 days--Yes/No(Multivariate analysis of the factors associated with read- mission at 30 days for CHD) |
NA: NA |
unknown |
|
1090
|
Age--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1091
|
Weight, kg--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1092
|
aortic cross-clamping (ACC), min--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1093
|
cardiopulmonary bypass (CPB) time, min--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1094
|
Aristotle score--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1095
|
Duration of MV, h--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1096
|
Stay at PICU, d--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1097
|
Mortality--All patients |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1098
|
Duration of MV, h--Patients < 30 d |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1099
|
Stay at PICU, d--Patients < 30 d |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
unknown |
|
1106
|
Age (months)--≥72 hr (medium Prolonged Mechanical Ventilation, PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD, PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA, PAH/other |
unknown |
|
1107
|
Weight (Kg)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1108
|
Type of congenital anomaly(Cyanotic)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1109
|
Type of congenital anomaly(Non-cyanotic)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1110
|
Pulmonary hypertension (No%)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1111
|
CBP time (minutes)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1112
|
AOX time (minutes)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1113
|
Preoperative MV--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1114
|
ICU stay (hours)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1115
|
MV duration (hours)--≥72 hr (medium PMV ) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1116
|
Age (months)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1117
|
Weight (Kg)≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1118
|
Type of congenital anomaly(Cyanotic)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1119
|
Type of congenital anomaly(Non-cyanotic)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1120
|
CBP time (minutes)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1121
|
AOX time (minutes)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1122
|
Hypothermia during surgery(mild)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1123
|
Preoperative MV--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1124
|
ICU stay (hours)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1125
|
MV duration (hours)--≥7 Days (extended PMV) |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1126
|
Delayed sternal closure--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1127
|
Re-intubation--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1128
|
Heart failure--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1129
|
Residual anomaly--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1130
|
Sepsis--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1131
|
Positive blood culture--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1132
|
Respiratory complications--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1133
|
Pneumonia--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1134
|
Pneumothorax--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1135
|
Atelectasis--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1136
|
Pleural effusion--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1137
|
Pleural hemorrhages--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1138
|
Postoperative PH--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1139
|
Renal failure--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1140
|
Lactate Level≥4.2--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1141
|
Death--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1142
|
Delayed sternal closure--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1143
|
Re-intubation--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1144
|
Heart failure--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1145
|
Residual anomaly--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1146
|
Sepsis--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1147
|
Positive blood culture--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1148
|
Respiratory complications--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1149
|
Pneumonia--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1150
|
Pneumothorax--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1151
|
Atelectasis--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1152
|
Pleural effusion--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1153
|
Pleural hemorrhages--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1154
|
Renal failure--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1155
|
Lactate Level≥4.2--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1156
|
Death--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1157
|
Dopamine--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1158
|
Dobutamine--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1159
|
Epinephrine--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1160
|
VIS: Vasoactive Inotropic Score--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1161
|
Dopamine--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1162
|
Dobutamine--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1163
|
Epinephrine--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1164
|
VIS: Vasoactive Inotropic Score--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
unknown |
|
1177
|
Weight, kg |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1178
|
Preop. PCO2, mmHg |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1179
|
Preop. EF(%) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1180
|
Postop. Serum globulin (g/L) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1181
|
Aortic cross clamp time (min) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1182
|
Cardiopulmonary bypass time(CPB time) (min) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1183
|
Operation time (min) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1184
|
Intraop. blood loss (mL/kg) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1185
|
Intraop. blood transfusion amount (mL/kg) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1186
|
Postop. blood loss (mL/kg) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1187
|
Postop. blood transfusion amount (mL/kg) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1188
|
Postop. serum albumin (g/L) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1189
|
Postop. serum creatinine (μmol/L) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1190
|
Postop. b-type natriuretic peptide (Pg/mL) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1191
|
Postop. procalcitonin (ng/mL) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1192
|
Postop. c-reactive protein (mg/L) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1193
|
Postop. prealbumin (mg/L) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1194
|
Postop. initial lactic acid level (mmol/L) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1195
|
Postop.maximum increasing rate of lactic acid (mmol·L-1·h-1) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1196
|
Age (>3 months/<3 months) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1197
|
Pulmonary hypertension (mild/moderate/severe) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1198
|
Preop.lung infection (no/yes) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1199
|
Preop. coagulation abnormalities (no/yes) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1200
|
Ventilation associated pneumonia (no/yes) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1201
|
Death (no/yes) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1202
|
Ventilation time (day) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1203
|
ICU stay (day) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1204
|
ACC time (min) (I vs II) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1205
|
ACC time (min) (I vs III) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1206
|
ACC time (min) (I vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1207
|
ACC time (min) (II vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1208
|
CPB time (min) (I vs II) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1209
|
CPB time (min) (I vs III) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1210
|
CPB time (min) (I vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1211
|
CPB time (min) (II vs III) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1212
|
CPB time (min) (II vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1213
|
Postop. PCT (ng/mL) (I vs III) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1214
|
Postop. PCT (ng/mL) (I vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1215
|
Postop. PCT (ng/mL) (II vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1216
|
Postop. CRP (mg/L) (I vs II) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1217
|
Postop. CRP (mg/L) (I vs III) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1218
|
Postop. CRP (mg/L) (I vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1219
|
Postop. CRP (mg/L) (II vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1220
|
Postop. CRP (mg/L) (III vs IV) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
unknown |
|
1232
|
Ventilator days |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
unknown |
|
1233
|
CICU(cardiovascular ICU) days |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
unknown |
|
1240
|
Memory deficits( GMI≤85) |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unknown |
|
1241
|
Worse verbal memory |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unknown |
|
1242
|
Worse attention |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unknown |
|
1243
|
General recognition index |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unknown |
|
1244
|
Worse working memory |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unknown |
|
1245
|
male gender(GMI scores 1 SD below normal) |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unknown |
|
1249
|
total brain volume |
isolated CHD/non-isolated CHD: TGA/TOF/TOF, PA/TOF, TA/VSD/AVC |
unknown |
|
1250
|
cerebral white matter volume |
isolated CHD/non-isolated CHD: TGA/TOF/TOF, PA/TOF, TA/VSD/AVC |
unknown |
|
1251
|
brainstem volume |
isolated CHD/non-isolated CHD: TGA/TOF/TOF, PA/TOF, TA/VSD/AVC |
unknown |
|
1252
|
MacArthur-Bates Communicative Development Inventory (CDI) language development |
isolated CHD/non-isolated CHD: TGA/TOF/TOF, PA/TOF, TA/VSD/AVC |
unknown |
|
1253
|
miR-19a level |
isolated CHD: VSD |
unknown |
|
1266
|
Mechanical ventilation |
NA: NA |
unknown |
|
1267
|
Duration of intensive care stay |
NA: NA |
unknown |
|
1268
|
abnormal postoperative background pattern [burst suppression (BS), continuous low voltage(CLV), flat tracing(FT)] |
NA: NA |
unknown |
|
1269
|
Return to SWC (Sleep-wake cycle) |
NA: NA |
unknown |
|
1270
|
QRS-duration |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
unknown |
|
1290
|
Behavioral Regulation Index T score(Brief parent-report) |
isolated CHD: SV |
unknown |
|
1291
|
Metacognition Index T score(Brief parent-report) |
isolated CHD: SV |
unknown |
|
1292
|
GEC T score(Brief self-report) |
isolated CHD: SV |
unknown |
|
1293
|
Behavioral Regulation Index T score(Brief self-report) |
isolated CHD: SV |
unknown |
|
1294
|
ADHD diagnosis，lifetime |
isolated CHD: SV |
unknown |
|
1295
|
Total severity score |
isolated CHD: SV |
unknown |
|
1297
|
ADHD Inattentive T score |
isolated CHD: SV |
unknown |
|
1298
|
Total Posttraumatic Symptom score |
isolated CHD: SV |
unknown |
|
1299
|
lower BMI |
isolated CHD/non-isolated CHD: TOF/PA/RVOTO |
unknown |
|
1300
|
lower resting oxygen saturation |
isolated CHD/non-isolated CHD: VSD/PA, VSD/ASD/PDA/DORV, AC/TA/AVSD/SV/ccTGA, VSD |
unknown |
|
1301
|
Haemoglobin |
isolated CHD/non-isolated CHD: VSD/PA, VSD/ASD/PDA/DORV, AC/TA/AVSD/SV/ccTGA, VSD |
unknown |
|
1302
|
inotropes |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1303
|
number of cardiac procedures before stroke diagnosis |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1304
|
Mechanical ventilation |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1305
|
extracorporeal membrane oxygenation(ECMO) at time of diagnosis |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1306
|
seizure with stroke |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1307
|
parenchymal hemorrhage |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1309
|
central lines |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1310
|
days from procedure to stroke |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1311
|
extracorporeal membrane oxygenation(ECMO) at diagnosis |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1312
|
recent arrest |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
unknown |
|
1314
|
left ventricular systolic dysfunction |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1315
|
right ventricular systolic dysfunction |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1316
|
premature ventricular contractions (PVCs) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1317
|
exercise-induced PVCs |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1318
|
previous shunt |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1319
|
reintervention |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1320
|
duration of post-surgical follow-up |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1321
|
age at the time of surgical repair |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
unknown |
|
1323
|
hippocampal volumes |
isolated CHD/non-isolated CHD: ASD, VSD/non C-CHD/TGA/other |
unknown |
|
1324
|
hippocampal volumes |
isolated CHD/non-isolated CHD: ASD, VSD/non C-CHD/TGA/other |
unknown |
|
1325
|
total IQ in CHD patients |
isolated CHD/non-isolated CHD: ASD, VSD/non C-CHD/TGA/other |
unknown |
|
1326
|
working memory in CHD patients |
isolated CHD/non-isolated CHD: ASD, VSD/non C-CHD/TGA/other |
unknown |
|
1327
|
verbal comprehension in CHD patients |
isolated CHD/non-isolated CHD: ASD, VSD/non C-CHD/TGA/other |
unknown |
|
1328
|
QRS duration |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
unknown |
|
1329
|
QT dispersion |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
unknown |
|
1335
|
Mean age at implantation |
isolated CHD/non-isolated CHD: TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
unknown |
|
1336
|
Appropriate therapy (shock or ATP) |
isolated CHD/non-isolated CHD: TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
unknown |
|
1337
|
Inappropriate therapy (shock or ATP) |
isolated CHD/non-isolated CHD: TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
unknown |
|
1338
|
No therapy delivered (shock or ATP) |
isolated CHD/non-isolated CHD: TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
unknown |
|
1339
|
Appropriate shock |
isolated CHD/non-isolated CHD: TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
unknown |
|
1340
|
No shock |
isolated CHD/non-isolated CHD: TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
unknown |
|
1341
|
fungal infection after cardiac surgery with CHD children |
isolated CHD: PA, VSD/DORV, CoA/TOF/VSD, ASDII/AVSD, HF |
unknown |
|
1342
|
Aortic cross-clamp time (min) |
isolated CHD: D-TGA/VSD/CHD with PAH |
unknown |
|
1345
|
ICU stay |
isolated CHD: D-TGA/VSD/CHD with PAH |
unknown |
|
1346
|
post-operative hospitalization time |
isolated CHD: D-TGA/VSD/CHD with PAH |
unknown |
|
1347
|
Volumn of transfusions |
isolated CHD: D-TGA/VSD/CHD with PAH |
unknown |
|
1356
|
correlations between MMP-2 and peak heart rate |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1357
|
correlations between MMP-2 and peak workload |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1358
|
correlation between MMP2 and peak oxygen uptake |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1359
|
correlations between MMP-2 and carbon dioxide equivalent |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1360
|
correlations between MMP-2 and NT-proBNP |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1361
|
correlations between MMP-2 and NYHA functional class,II-III |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1362
|
correlations between MMP-2 and aortic valve peak velocity |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1363
|
correlations between MMP-2 and left ventricular(LV) systolic dysfunction, 0-1 |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1364
|
correlations between MMP-2 and right ventricular(RV) , systolic dysfunction, 0-1 |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1365
|
correlations between MMP-2 and E' wave velocity<8cm/s |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1366
|
correlations between MMP-2 and E/E' ratio≥13 |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1367
|
correlations between MMP-2 and LV deceleration time |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1368
|
correlations between MMP-2 and LV dysfunction |
isolated CHD: TOF |
unknown |
|
1369
|
correlations between MMP-2 and RV dysfunction |
isolated CHD: TOF |
unknown |
|
1370
|
correlations between MMP-2 and E/E' ratio |
isolated CHD: TOF |
unknown |
|
1371
|
correlations between MMP-2 and LV deceleration time |
isolated CHD: TOF |
unknown |
|
1372
|
correlation between MMP9 and peak oxygen uptake |
isolated CHD: TOF |
unknown |
|
1373
|
peak workload |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1374
|
carbon dioxide equivalent |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1375
|
LV deceleration time |
isolated CHD/non-isolated CHD: TOF/PA, VSD/CoA/AS/TGA/ccTGA/UVH |
unknown |
|
1376
|
cardical index(CI) |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1377
|
NYHA functional class |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1378
|
Left ventricular ejection fraction(LVEF) |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1379
|
Left ventricular end diastolic volume index |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1380
|
Right ventricular ejection fraction(RVEF) |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1381
|
Right ventricular end systolic volume index(RVESVi) |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1382
|
pulmonic regurgitant fraction |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1383
|
right ventricular regurgitant volume |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1384
|
cardiac related hospitalizations |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1385
|
cardiac interventions |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1388
|
Left ventricular ejection fraction(LVEF) |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1389
|
Right ventricular ejection fraction(RVEF) |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1390
|
Right ventricular end systolic volume index(RVESVi) |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1391
|
right ventricular regurgitant volume |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
unknown |
|
1392
|
depression symptom(time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1393
|
Loneliness(time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1394
|
physical appearance(time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1395
|
communication (time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1396
|
physical funtioning(time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1397
|
emotional functioning (time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1398
|
social functioning(time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1399
|
cognitive functioning (time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1400
|
cardiac symptoms(time 1) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1401
|
Loneliness(time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1402
|
social functioning(time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1403
|
cognitive functioning (time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1404
|
depression symptom(time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1405
|
cardiac symptoms(time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1406
|
physical appearance(time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1407
|
communication (time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1408
|
emotional functioning (time 2) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
1409
|
gestational age at delivery |
isolated CHD/non-isolated CHD: TGA/TGA, VSD/AAO/PO |
unknown |
|
1410
|
birth weight |
isolated CHD/non-isolated CHD: TGA/TGA, VSD/AAO/PO |
unknown |
|
1411
|
preoperative brain injury |
isolated CHD/non-isolated CHD: TGA/TGA, VSD/AAO/PO |
unknown |
|
1412
|
change in fractional anlsotropy(FA) of white matter |
isolated CHD/non-isolated CHD: TGA/TGA, VSD/AAO/PO |
unknown |
|
1413
|
change in apparent diffusion coefficient(ADC) of grey matter |
isolated CHD/non-isolated CHD: TGA/TGA, VSD/AAO/PO |
unknown |
|
1414
|
age of SVP patients underwent surgery |
isolated CHD: AAO/PO |
unknown |
|
1415
|
Hypertension(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
unknown |
|
1416
|
Hypertriglyceridemia(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
unknown |
|
1417
|
Reduced high-density lipoprotein(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
unknown |
|
1418
|
Fasting hyperglycemia(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
unknown |
|
1419
|
body mass index(BMI)(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
unknown |
|
1421
|
metabolic syndrome in patients with central obesity(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
unknown |
|
1426
|
single ventricle score |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
unknown |
|
1427
|
risk of neonatal death for a single ventricle score |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
unknown |
|
1429
|
preoperative mPAP |
isolated CHD: CHD with PAH |
unknown |
|
1430
|
postoperative mPAP |
isolated CHD: CHD with PAH |
unknown |
|
1431
|
postoperative mPAP |
isolated CHD: CHD with PAH |
unknown |
|
1432
|
postoperative mPAP |
isolated CHD: CHD with PAH |
unknown |
|
1433
|
postoperative mPAP |
isolated CHD: CHD with PAH |
unknown |
|
1434
|
postoperative mPAP |
isolated CHD: CHD with PAH |
unknown |
|
1435
|
mean medium thickness percent |
isolated CHD: CHD with PAH |
unknown |
|
1436
|
mean medium area percent |
isolated CHD: CHD with PAH |
unknown |
|
1437
|
mean medium thickness percent |
isolated CHD: CHD with PAH |
unknown |
|
1438
|
mean medium area percent |
isolated CHD: CHD with PAH |
unknown |
|
1439
|
mean medium thickness percent |
isolated CHD: CHD with PAH |
unknown |
|
1440
|
Transgelin |
isolated CHD: CHD with PAH |
unknown |
|
1441
|
Transgelin |
isolated CHD: CHD with PAH |
unknown |
|
1442
|
filamin A |
isolated CHD: CHD with PAH |
unknown |
|
1443
|
filamin A |
isolated CHD: CHD with PAH |
unknown |
|
1444
|
B-type natriuretic peptide(BNP) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1445
|
BNP |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1446
|
pulmonary artery systolic pressure(PASP) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1447
|
pulmonary artery diastolic pressure(PADP) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1448
|
right ventricular systolic pressure(RVSP) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1449
|
mPAP |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1450
|
pulmonary artery flow(Qp) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1451
|
pulmonary arterial resistance(Rp) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1452
|
pulmonary-to-systemic resistance ratio(Rp/Rs) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1453
|
plasma connective tissue growth factor(CTGF) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1454
|
plasma connective tissue growth factor(CTGF) |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1455
|
plasma CTGF |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1456
|
plasma CTGF |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1457
|
plasma CTGF |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1458
|
plasma CTGF and BNP |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1459
|
plasma CTGF and Oxygen saturation |
isolated CHD/non-isolated CHD: VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
unknown |
|
1466
|
mean mental developmental index(MDI) at 6 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1467
|
mean psychomotor developmental index(PDI) at 12 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1468
|
mean mental developmental index(MDI) at 6 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1469
|
mean psychomotor developmental index(PDI) at 6 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1470
|
mean mental developmental index(MDI) at 6 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1471
|
mean psychomotor developmental index(PDI) at 6 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1472
|
mean psychomotor developmental index(PDI) at 12 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1473
|
length-for-age z score at 6 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1474
|
head circumeference-for-age z score at 3 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1475
|
hospital length of stay |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1476
|
length-for-age z score at 3 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1477
|
device assisted feeding at 3 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1478
|
device-assisted feeding at 3 months |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1479
|
weight-for-age z score |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1480
|
length-for-age z score |
isolated CHD: HLHS/TGA/CoA/DILV/TOF/DORV/TA |
unknown |
|
1481
|
prenatal diagnosis |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1482
|
prenatal diagnosis |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1483
|
admission at 1 day of age or less |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1484
|
admission at 1 day of age or less |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1485
|
serum creatinine |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1486
|
serum lactate |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1487
|
blood glucose |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1488
|
pH |
isolated CHD: HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
unknown |
|
1489
|
serum creatinine of TGA patients |
isolated CHD: TGA |
unknown |
|
1490
|
serum lactate of HLHS patients |
isolated CHD: HLHS |
unknown |
|
1491
|
serum creatinine of HLHS patients |
isolated CHD: HLHS |
unknown |
|
1492
|
PH -admission of TGA |
isolated CHD: HLHS |
unknown |
|
1494
|
serum glucose |
isolated CHD: TOF |
unknown |
|
1510
|
NT pro-BNP |
isolated CHD: PA/ccTGA/VSD/NA/SV/ES/PAH/CoA/EA/TGA/TOF/ASD/AVSD/TA/PS/AVD |
unknown |
|
1511
|
survivor with different NT pro-BNP |
isolated CHD: PA/ccTGA/VSD/NA/SV/ES/PAH/CoA/EA/TGA/TOF/ASD/AVSD/TA/PS/AVD |
unknown |
|
1513
|
GDF-15 level in sex |
isolated CHD/non-isolated CHD: AS/AC/TOF, PA, VSD/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1515
|
GDF-15 level in different NYHA functional class |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1516
|
GDF-15 level in different cardiac medication |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1517
|
GDF-15 level of different sinus rhythm |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1518
|
GDF-15 level in different pulmonary pressure |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1519
|
NT-proBNP |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1520
|
hs-TNT |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1521
|
hs-CRP |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1522
|
haemoglobin |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
unknown |
|
1530
|
ECG parameters--QRS duration (ms) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1531
|
ECG parameters--QTc (ms) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1532
|
Medication--Diuretics |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1533
|
Medication--b-Blockers |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1534
|
Medication--ACEIs/ARBs |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1535
|
Medication--Digoxin |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1536
|
Medication--Warfarin |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1537
|
Medication--Anti-arrhythmics |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1538
|
Complexity--Complex disease |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1539
|
ECG parameters--QRS duration (ms) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
unknown |
|
1547
|
P-selectin candidate gene SNPs---825T/C:TT |
isolated CHD: ASD/PDA/VSD |
unknown |
|
1550
|
P-selectin candidate gene SNPs---825T/C:TT |
isolated CHD: ASD/PDA/VSD |
unknown |
|
1553
|
plasma P-selectin concentration |
isolated CHD: ASD/PDA/VSD |
unknown |
|
1554
|
plasma P-selectin concentration |
isolated CHD: ASD/PDA/VSD |
unknown |
|
1555
|
P-selectin expression in different SNPs in PAH-CHD |
isolated CHD: ASD/PDA/VSD |
unknown |
|
1556
|
P-selectin expression in different SNPs in CHD |
isolated CHD: ASD/PDA/VSD |
unknown |
|
1557
|
P-selectin expression in different SNPs in controls |
isolated CHD: ASD/PDA/VSD |
unknown |
|
1558
|
Body weight at operation (kg) |
isolated CHD/non-isolated CHD: TGA, VSD/PA, VSD/AVSD, ccTGA, MA/CoA, VSD/D-TGA, VSD/ccTGA/DORV, MA, PS/TAPVR |
unknown |
|
1559
|
Interval, Dx to TDML(thoracic duct mass ligation) (d) |
isolated CHD/non-isolated CHD: TGA, VSD/PA, VSD/AVSD, ccTGA, MA/CoA, VSD/D-TGA, VSD/ccTGA/DORV, MA, PS/TAPVR |
unknown |
|
1560
|
Types of initial operation--Arterial switch |
isolated CHD/non-isolated CHD: TGA, VSD/PA, VSD/AVSD, ccTGA, MA/CoA, VSD/D-TGA, VSD/ccTGA/DORV, MA, PS/TAPVR |
unknown |
|
1561
|
Pre-TDML side of the pleural effusion |
isolated CHD/non-isolated CHD: TGA, VSD/PA, VSD/AVSD, ccTGA, MA/CoA, VSD/D-TGA, VSD/ccTGA/DORV, MA, PS/TAPVR |
unknown |
|
1562
|
the amount of pleural drainage before and after the initial TDML |
isolated CHD/non-isolated CHD: TGA, VSD/PA, VSD/AVSD, ccTGA, MA/CoA, VSD/D-TGA, VSD/ccTGA/DORV, MA, PS/TAPVR |
unknown |
|
1569
|
Mean total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
unknown |
|
1570
|
Systolic BP--CHD before ET |
NA: NA |
unknown |
|
1571
|
Diastolic BP--CHD before ET |
NA: NA |
unknown |
|
1573
|
Sex(Regression of maximum exercise time to independent variables) |
NA: NA |
unknown |
|
1574
|
Peak VE/VCO2(Regression of maximum exercise time to independent variables) |
NA: NA |
unknown |
|
1575
|
Relative BMI(Regression of maximum exercise time to independent variables) |
NA: NA |
unknown |
|
1586
|
6-MWD (m) |
isolated CHD: ASD/VSD/PDA/other |
unknown |
|
1587
|
PVR (dyn·s/cm5) |
isolated CHD: ASD/VSD/PDA/other |
unknown |
|
1588
|
NT-pro-BNP (pg/mL) |
isolated CHD: ASD/VSD/PDA/other |
unknown |
|
1589
|
WHO FC--Improved (%) |
isolated CHD: ASD/VSD/PDA/other |
unknown |
|
1590
|
WHO FC--Stabilised (%) |
isolated CHD: ASD/VSD/PDA/other |
unknown |
|
1591
|
WHO FC--Worsened (%) |
isolated CHD: ASD/VSD/PDA/other |
unknown |
|
1592
|
Anxiety symptoms |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1593
|
Alcohol use--None |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1594
|
Alcohol use--1–6 drinks/ week |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1595
|
Alcohol use--≥7 drinks/ week |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1596
|
AD/AA Meds (antidepressant/antianxiety medications) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1597
|
Current smoking tobacco use |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1598
|
Worried about health |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1599
|
Psychiatric care/counseling |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unknown |
|
1604
|
prevalence of CHD |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1605
|
Total-Age (0-<1 months) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1606
|
Total- Birthweight(<2500 g) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1607
|
Total- Gestational age (<37 weeks) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1608
|
Maternal characteristics:Total- Age (<20 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1609
|
Maternal characteristics:Total- Age (≥40 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1610
|
History of mother with CHD |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1611
|
History of father with CHD |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1612
|
Education of mother (<13 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1613
|
Education of father (<13 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1614
|
Family income (<1000 yuan/month) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1629
|
Sex |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
unknown |
|
1630
|
BPD Z-score (biparietal diameter) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1631
|
BPD<p5 |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1632
|
HC Z-score (head circumference) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1633
|
HC<p5 |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1634
|
EFW<p10 (estimated fetal weight) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1635
|
MCA-PI Z-score (middle cerebral artery) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1636
|
MCA<p5 |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1637
|
CPR Z-score |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1638
|
CPR<p5 |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1639
|
Frontal FMBV Z-score |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1640
|
Frontal FMBV>p95 |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1641
|
Brain volumetry--TBV (cm3) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1642
|
Brain volumetry--TICV (cm3) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1643
|
Brain volumetry--Left opercular volume/TICV |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1644
|
Brain volumetry--Right opercular volume/TICV |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1645
|
Brain volumetry--Total opercular volume/TICV |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1646
|
Brain cortical development--Left insula depth/BPD |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1647
|
Brain cortical development--Left parietoccipital fissure depth/BPD |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1648
|
Brain cortical development--Right parietoccipital fissure depth/BPD |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1649
|
Brain cortical development--Left cingulate fissure depth/BPD |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1650
|
Brain cortical development--Right cingulate fissure depth/BPD |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1651
|
Brain cortical development--Left calcarine fissure depth/BPD |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1652
|
Brain cortical development--Right calcarine fissure depth/BPD |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1653
|
Brain metabolic profile--Frontal area--Ino/Cho(inositol/choline) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1654
|
Brain metabolic profile--Frontal area--NAA/Cho(N-acetylaspartate/choline) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1655
|
Brain metabolic profile--Frontal area--Cho/Cr(choline/creatine) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1656
|
Brain metabolic profile--Basal ganglia--Ino/Cho(inositol/choline) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1657
|
Brain metabolic profile--Basal ganglia--NAA/Cho(N-acetylaspartate/choline) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1658
|
Brain metabolic profile--Basal ganglia--Cho/Cr(choline/creatine) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1659
|
Birth weight<p10 |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1660
|
Head circumference (mm) |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1661
|
Days in NICU |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1662
|
Neonatal death |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1663
|
Cognitive |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1664
|
Language |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1665
|
Motor |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1666
|
Abnormal motor area |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1667
|
Social–emotional |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1668
|
Abnormal socioemotional area |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1669
|
Adaptive |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1670
|
Abnormal adaptive area |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1671
|
Average score |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1672
|
MCA-PI Z-score |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1673
|
HC Z-score |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1674
|
CPR Z-score |
isolated CHD/non-isolated CHD: AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
unknown |
|
1675
|
Gender of children |
NA: NA |
unknown |
|
1676
|
Occupation |
NA: NA |
unknown |
|
1677
|
Family history with CHD--Yes/No |
NA: NA |
unknown |
|
1678
|
History of abortion--Yes/No |
NA: NA |
unknown |
|
1679
|
history of adverse pregnancy--Yes/No |
NA: NA |
unknown |
|
1680
|
Early pregnancy health-Healthy/Illness |
NA: NA |
unknown |
|
1681
|
Fetus during pregnancy--Normal/Abnormal |
NA: NA |
unknown |
|
1682
|
Pesticide exposure--Yes/No |
NA: NA |
unknown |
|
1683
|
Drug exposure--Yes/No |
NA: NA |
unknown |
|
1684
|
SNPs in mothers: MTHFR gene rs1801131:AA |
NA: NA |
unknown |
|
1687
|
relationship between in matching pair mother and chlidren:rs 1801133 CC(mother) |
NA: NA |
unknown |
|
1688
|
relationship between in matching pair mother and chlidren:rs 1801131 AA(mother) |
NA: NA |
unknown |
|
1689
|
relationship between in matching pair mother and chlidren:rs 1805087 AA(mother) |
NA: NA |
unknown |
|
1690
|
relationship between in matching pair mother and chlidren:rs 2124459 CC(mother) |
NA: NA |
unknown |
|
1691
|
relationship between in matching pair mother and chlidren:rs 2850144 CC(mother) |
NA: NA |
unknown |
|
1692
|
SNPs in children: MTHFR gene rs1801131:AA |
NA: NA |
unknown |
|
1696
|
Height (cm) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1697
|
Height (cm) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1698
|
Weight (kg) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1699
|
Weight (kg) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1700
|
BMI (kg/m2) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1701
|
BMI (kg/m2) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1702
|
PASP(pulmonary artery systolic pressure) (mmHg) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1703
|
PADP(pulmonary artery diastolic pressure) (mmHg) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1704
|
RVSP(right ventricular systolic prssure) (mmHg) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1705
|
MPAP(mean puomonary arterial hypertension) (mmHg) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1706
|
RVDT(right vertricle diameter) (mm) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1707
|
PATD(pulmonary artery trunk diameter) (mm) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1708
|
correlations: Acylated ghrelin--BMI |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1709
|
correlations: Acylated ghrelin--PASP |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1710
|
correlations: Acylated ghrelin--PADP |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1711
|
correlations: Acylated ghrelin--RVSP |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1712
|
correlations: Acylated ghrelin--MPAP |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1713
|
correlations: Acylated ghrelin--RVDT |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1714
|
correlations: Acylated ghrelin--PATD |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1715
|
correlations: Acylated ghrelin--ET-1(endothelin-1) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1716
|
correlations: Acylated ghrelin--NO(nitric oxide) |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1717
|
correlations: ET-1--PASP |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1718
|
correlations: ET-1--RVDP |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1719
|
correlations: NO--PASP |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1720
|
correlations: NO--RVD |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1721
|
plasma-acylated ghrelin levels |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1722
|
ET-1 |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1723
|
NO |
isolated CHD: VSD/ASD/PDA/other |
unknown |
|
1730
|
Age at surgery, d |
NA: NA |
unknown |
|
1731
|
Weight, kg |
NA: NA |
unknown |
|
1732
|
Height, cm |
NA: NA |
unknown |
|
1733
|
BSA |
NA: NA |
unknown |
|
1734
|
RACHS-1 category |
NA: NA |
unknown |
|
1735
|
CPB time, min |
NA: NA |
unknown |
|
1736
|
Cross clamp time, min |
NA: NA |
unknown |
|
1737
|
Laboratories on PCICU admission--pH |
NA: NA |
unknown |
|
1738
|
Laboratories on PCICU admission--PCO2 |
NA: NA |
unknown |
|
1739
|
Laboratories on PCICU admission--PO2 |
NA: NA |
unknown |
|
1740
|
Lactate |
NA: NA |
unknown |
|
1741
|
Hematocrit |
NA: NA |
unknown |
|
1742
|
Ionized calcium |
NA: NA |
unknown |
|
1743
|
Infusions--Calcium chloride |
NA: NA |
unknown |
|
1744
|
Infusions--Dopamine |
NA: NA |
unknown |
|
1745
|
Infusions--Epinephrine |
NA: NA |
unknown |
|
1746
|
Infusions--Nipride |
NA: NA |
unknown |
|
1747
|
Infusions--Aminocaproic acid |
NA: NA |
unknown |
|
1754
|
Age at surgery--after propensity score matching |
NA: NA |
unknown |
|
1755
|
BSA--after propensity score matching |
NA: NA |
unknown |
|
1756
|
Aminocaproic acid(infusions on PCICU admission)--after propensity score matching |
NA: NA |
unknown |
|
1760
|
Men-Height (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1761
|
Men-Weight (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1762
|
Men-BMI (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1763
|
Men-Height (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1764
|
Men-Height (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1765
|
Women-Height (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1766
|
Men-Height (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1767
|
Men-Weight (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1768
|
Men-BMI (Complex lesions 18–40 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1769
|
Men-Height (Simple lesions 18–50 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1770
|
Men-Weight (Simple lesions 18–50 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1771
|
Men-BMI (Simple lesions 18–50 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1772
|
Women-Height(Simple lesions 18–50 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1773
|
Men-Weight (Simple lesions 18–50 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1774
|
Men-BMI (Simple lesions 18–50 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1775
|
Women-Height(Simple lesions 18–50 years) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1776
|
Underweight BMI < 18.5 (Men) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1777
|
Underweight BMI < 18.5 (Men) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1778
|
Obesity BMI ≥ 30 (Women) |
isolated CHD/non-isolated CHD: TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
unknown |
|
1781
|
final GFR--hematocrit (hct) |
isolated CHD: TOF/PA/VSD/DORV/PS |
unknown |
|
1783
|
hemoglobin B, Hb (g/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1784
|
hematocrit, Hct (%) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1785
|
hematocrit, Hct (%) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1786
|
hematocrit, Hct (%) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1787
|
uric acid, UA (umol/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1788
|
uric acid, UA (umol/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1789
|
uric acid, UA (umol/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1790
|
pulmonary artery diameter, PA (mm) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1791
|
pulmonary artery diameter, PA (mm) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1792
|
the peak velocity of tricuspid regurgitation, TRV (m/s) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1793
|
the peak velocity of tricuspid regurgitation, TRV (m/s) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1794
|
the peak velocity of tricuspid regurgitation, TRV (m/s) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1795
|
the peak velocity of tricuspid regurgitation, TRV (m/s) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1796
|
SPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1797
|
SPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1798
|
SPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1799
|
DPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1800
|
DPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1801
|
DPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1802
|
MPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1803
|
MPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1804
|
MPAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1805
|
RAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1806
|
RAP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1807
|
RVP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1808
|
RVP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1809
|
RVP (mmHg) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1810
|
PVR (dyne s cm-5) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1811
|
PVR (dyne s cm-5) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1812
|
PVRi (dyne s cm) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1813
|
PVRi (dyne s cm) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1814
|
Qp (L/min/m2) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1815
|
Qs (L/min/m2) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1816
|
Qp/Qs (L/min/m2) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1817
|
Left-to-right shunt (L/min) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1818
|
MVsat (%) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1819
|
MVsat (%) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1820
|
ADMA (umol/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1821
|
ADMA (umol/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1822
|
ADMA (umol/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1823
|
ADMA (umol/L) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1825
|
Age |
NA: NA |
unknown |
|
1826
|
RACHS-1 ranking |
NA: NA |
unknown |
|
1827
|
cardiopulmonary bypass (CPB) time (minutes) |
NA: NA |
unknown |
|
1828
|
Baseline creatinine(Cr) (mg/dL) |
NA: NA |
unknown |
|
1829
|
Baseline creatinine(Cr) -based GFR (mL/min/1.73 m2) |
NA: NA |
unknown |
|
1830
|
serum CysC on PODS2 (post operative day 2) |
NA: NA |
unknown |
|
1831
|
Urine output |
NA: NA |
unknown |
|
1832
|
abbreviated Cr clearance based on a 4-hour urine collection |
NA: NA |
unknown |
|
1833
|
troponin T (TnT) |
isolated CHD: TOF/CAVC/TGA/VSD/TAPVR/ASD |
unknown |
|
1834
|
CK-MB |
isolated CHD: TOF/CAVC/TGA/VSD/TAPVR/ASD |
unknown |
|
1835
|
temporary third degree atrioventricular (AV) block |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
unknown |
|
1838
|
surgical procedures in proximity to the AV block node |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
unknown |
|
1840
|
Systolic pulmonary artery pressure |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/AS/PDA/VSD, PDA/DORV, VSD/AVSD/ES |
unknown |
|
1841
|
6- minute walking distance |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/AS/PDA/VSD, PDA/DORV, VSD/AVSD/ES |
unknown |
|
1842
|
6- minute walking distance |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/AS/PDA/VSD, PDA/DORV, VSD/AVSD/ES |
unknown |
|
1843
|
6- minute walking distance |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/AS/PDA/VSD, PDA/DORV, VSD/AVSD/ES |
unknown |
|
1844
|
New York heart functional classification |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/AS/PDA/VSD, PDA/DORV, VSD/AVSD/ES |
unknown |
|
1845
|
New York heart functional classification |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/AS/PDA/VSD, PDA/DORV, VSD/AVSD/ES |
unknown |
|
1846
|
New York heart functional classification |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/AS/PDA/VSD, PDA/DORV, VSD/AVSD/ES |
unknown |
|
1847
|
lower device acceptance |
NA: NA |
unknown |
|
1848
|
reported worse quality of life |
NA: NA |
unknown |
|
1849
|
higher prevalence of depression |
NA: NA |
unknown |
|
1850
|
lower mental health scores(SF36—Mental Component Summary) |
NA: NA |
unknown |
|
1851
|
higher levels of anxiety(HADS-A) |
NA: NA |
unknown |
|
1852
|
higher levels of depression(HADS-D)( (Hospital Anxiety and Depression Scale-Depression subscale) |
NA: NA |
unknown |
|
1856
|
anxiety |
NA: NA |
unknown |
|
1857
|
depression |
NA: NA |
unknown |
|
1861
|
acyanotic heart disease |
NA: A-CHD |
unknown |
|
1862
|
Time from surgery(within prior 14 days) |
NA: NA |
unknown |
|
1864
|
age |
NA: NA |
unknown |
|
1872
|
ASD |
isolated CHD: ASD |
unknown |
|
1876
|
HFSS with different outcomes |
isolated CHD/non-isolated CHD: TOF/RV/EA/other |
unknown |
|
1880
|
cerebellar volume |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1881
|
thalamus volume |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1882
|
diagnostic category |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1883
|
HLHS |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1884
|
aortic hypoplasia |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1885
|
TGA |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1886
|
TOF |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1887
|
TIV (total intracranial brain volume) /EFW (estimated fetal weight) |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1888
|
FLV (frontal lobes volume) /EFW (estimated fetal weight) |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1889
|
TV (thalamus volume) /EFW (estimated fetal weight) |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1890
|
CV (cerebellar volume)/EFW(estimated fetal weight) |
isolated CHD/non-isolated CHD: HLHS/AH/AS/TOF/VPS/PA, IVS/TA/TGA/TA/AVSD |
unknown |
|
1894
|
number of procedures |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
unknown |
|
1895
|
age |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
unknown |
|
1896
|
intestinal fatty acid–binding protein(FABP)concentrations |
isolated CHD/non-isolated CHD: TOF/SD/AVC/AS/SS/CoA, HAA/MV/TAPVR/PS/PA/PI/DORV/EA |
unknown |
|
1897
|
correlation between early changes in plasma concentrations of intestinal FABP 2 and CPB duration |
isolated CHD/non-isolated CHD: TOF/SD/AVC/AS/SS/CoA, HAA/MV/TAPVR/PS/PA/PI/DORV/EA |
unknown |
|
1898
|
correlation between claudin 3 and symptoms of feeding intolerance |
isolated CHD/non-isolated CHD: TOF/SD/AVC/AS/SS/CoA, HAA/MV/TAPVR/PS/PA/PI/DORV/EA |
unknown |
|
1899
|
correlation between intestinal FABP 2 and symptoms of feeding intolerance |
isolated CHD/non-isolated CHD: TOF/SD/AVC/AS/SS/CoA, HAA/MV/TAPVR/PS/PA/PI/DORV/EA |
unknown |
|
1900
|
correlation between dual sugar permeability test ratio and symptoms of feeding intolerance |
isolated CHD/non-isolated CHD: TOF/SD/AVC/AS/SS/CoA, HAA/MV/TAPVR/PS/PA/PI/DORV/EA |
unknown |
|
1901
|
correlation between intestinal fatty acid–binding protein and VIS |
isolated CHD/non-isolated CHD: TOF/SD/AVC/AS/SS/CoA, HAA/MV/TAPVR/PS/PA/PI/DORV/EA |
unknown |
|
1902
|
correlation between Citrulline and larger arteriovenous oxygen saturation difference |
isolated CHD/non-isolated CHD: TOF/SD/AVC/AS/SS/CoA, HAA/MV/TAPVR/PS/PA/PI/DORV/EA |
unknown |
|
1903
|
interventricular dyssynchrony(IVD) |
isolated CHD: TOF/ASD/VSD |
unknown |
|
1904
|
interventricular dyssynchrony(IVD) |
isolated CHD: TOF/ASD/VSD |
unknown |
|
1905
|
Absolute RV strain |
isolated CHD: TOF/ASD/VSD |
unknown |
|
1906
|
Right ventricular strain (%) |
isolated CHD: TOF/ASD/VSD |
unknown |
|
1907
|
interventricular dyssynchrony(IVD) |
isolated CHD: TOF/ASD/VSD |
unknown |
|
1908
|
Right ventricular strain (%) |
isolated CHD: TOF/ASD/VSD |
unknown |
|
1909
|
interventricular dyssynchrony(IVD) |
isolated CHD: TOF/ASD/VSD |
unknown |
|
1910
|
preconceptual folic acid supplementation period |
NA: NA |
unknown |
|
1911
|
Educational status |
NA: NA |
unknown |
|
1912
|
subject reported receiving counseling on folic acid supplementation |
NA: NA |
unknown |
|
1913
|
educational status |
NA: NA |
unknown |
|
1914
|
Educational status of recurrence risk counseling |
NA: NA |
unknown |
|
1915
|
Complexity of CHD |
NA: NA |
unknown |
|
1922
|
the history of aorto-pulmonary shunt |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
unknown |
|
1923
|
age |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
unknown |
|
1924
|
height |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
unknown |
|
1925
|
the history of direct aortic surgery |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
unknown |
|
1928
|
Cyanosis |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
unknown |
|
1929
|
Hemoglobin (g/dl) |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
unknown |
|
1935
|
fast blood glucose level(FPG) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/MA/PA/other |
unknown |
|
1936
|
FPG |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1937
|
lower FPG |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1938
|
lower FPG |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1939
|
lower FPG |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1940
|
area under the curve of glucose(PG-AUC) |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1941
|
area under the curve of glucose(PG-AUC) |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1942
|
area under the curve of glucose(PG-AUC) |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1943
|
area under the curve of (AUC) of insulin(mU/ml) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/MA/PA/other |
unknown |
|
1944
|
area under the curve of (AUC) of insulin(mU/ml) |
isolated CHD/non-isolated CHD: TOF/TGA/AVD/CoA, IAA/DORV/other |
unknown |
|
1945
|
HbA1c level(%) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/MA/PA/other |
unknown |
|
1946
|
HbA1c level(%) |
isolated CHD/non-isolated CHD: TOF/UVH/VSD/DORV/TGA/other |
unknown |
|
1947
|
predictor of unscheduled hospitalization: Age |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
unknown |
|
1948
|
predictor of unscheduled hospitalization: NYHA class |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
unknown |
|
1972
|
tumor necrosis factor(TNF-α) |
isolated CHD: TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1973
|
tumor necrosis factor(TNF-α) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1974
|
tumor necrosis factor(TNF-α) |
isolated CHD: VSD/ASD/PDA/TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1975
|
interleukin-6(IL-6) |
isolated CHD: TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1976
|
interleukin-6(IL-6) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1977
|
interleukin-6(IL-6) |
isolated CHD: VSD/ASD/PDA/TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1978
|
C-reative protein(CRP) |
isolated CHD: TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1979
|
C-reative protein(CRP) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1980
|
C-reative protein(CRP) |
isolated CHD: VSD/ASD/PDA/TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1981
|
vasoendothelial growth factor(VEGF) |
isolated CHD: TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1982
|
vasoendothelial growth factor(VEGF) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1983
|
vasoendothelial growth factor(VEGF) |
isolated CHD: VSD/ASD/PDA/TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1984
|
troponin T |
isolated CHD: TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1985
|
troponin T |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1986
|
troponin T |
isolated CHD: VSD/ASD/PDA/TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1987
|
creatin kinase MB(CK-MB) |
isolated CHD: TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1988
|
creatin kinase MB(CK-MB) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1989
|
creatin kinase MB(CK-MB) |
isolated CHD: VSD/ASD/PDA/TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1990
|
caspase 3 |
isolated CHD: TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1991
|
caspase 3 |
isolated CHD: VSD/ASD/PDA |
unknown |
|
1992
|
caspase 3 |
isolated CHD: VSD/ASD/PDA/TOF/TA/DORV/PA/PS/TAS/ES |
unknown |
|
1993
|
Hypoxaemia percent(male patients) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
1997
|
Total cholesterol(male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
1999
|
Triglycerides (male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
2002
|
Hypoxaemia percent(female patients)( |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
2003
|
PAH percent(female patients)( |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
2004
|
BMI(female patients) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
2005
|
serum uric acid(female patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
2006
|
serum creatinine(female patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
2008
|
NT-pro-BNP(female patients)(pg/ml) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
unknown |
|
2009
|
age |
isolated CHD/non-isolated CHD: VSD/PDA/VSD, PDA/CoA/VSD/PDA |
unknown |
|
2010
|
area above 4,700m |
isolated CHD/non-isolated CHD: VSD/PDA/VSD, PDA/CoA/VSD/PDA |
unknown |
|
2011
|
left ventricular internal dimensions indexed by body surface areas(LVID/BSA) |
isolated CHD/non-isolated CHD: VSD/PDA/VSD, PDA/CoA/VSD/PDA |
unknown |
|
2013
|
area above 4,700m |
isolated CHD/non-isolated CHD: VSD/PDA/VSD, PDA/CoA/VSD/PDA |
unknown |
|
2014
|
homocysteine level(Hcy) |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2015
|
folic acid level |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2016
|
vitamin B12 level |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2017
|
hydrogen sulfide concentration(H2S) |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2018
|
MTHFR expression |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2019
|
CSE expression |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2020
|
Hcy and H2S(predictor of PH) |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2021
|
Hcy(predictor of PH) |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2022
|
folic (acidpredictor of PH) |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2023
|
vitamin B12(predictor of PH) |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2024
|
hydrogen sulfide concentration(H2S) |
isolated CHD: ASD/VSD/PDA/ES/PAH |
unknown |
|
2025
|
homocysteine level(Hcy) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
unknown |
|
2026
|
hydrogen sulfide concentration(H2S) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
unknown |
|
2027
|
CSE expression |
isolated CHD: VSD/ASD/PDA/PAH/ES |
unknown |
|
2028
|
MTHFR expression |
isolated CHD: VSD/ASD/PDA/PAH/ES |
unknown |
|
2029
|
EF(%) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
unknown |
|
2030
|
FS(%) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
unknown |
|
2034
|
gestational age |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
unknown |
|
2035
|
birthweight |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
unknown |
|
2036
|
mean for maternal distress 6 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
unknown |
|
2039
|
mean for maternal distress 36 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
unknown |
|
2041
|
mean for Child fussiness 6 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
unknown |
|
2045
|
total brain volume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2046
|
white matter volume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2047
|
cortical grey matter |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2048
|
white matter volume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2049
|
surface area temporal lobes |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2050
|
thalmai volume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2053
|
Cortical grey matter volume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2054
|
Surface area limbic cortices/mesocortices |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2055
|
cerebellum volume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2056
|
basal ganglia volume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2057
|
hippocampi vulume |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2058
|
predictor of hippocampal volumes in association with outcome with total IQ |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2059
|
predictor of total white matter in association with verbal comprehension |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2060
|
predictor of hippocampal volumes in association with perceptual reasoning |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2061
|
predictor of cerebellar volumes in association with working memory |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2062
|
predictor of total white matter in association with pure motor |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2063
|
predictor of cerebellar volumes in association with static balance |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2064
|
the mean value of AcTc in the main PA(MPA)-before oxygen administration |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2065
|
the mean value of AcTc in the main PA(MPA)-after oxygen administration |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2066
|
the mean value of InTc in the main PA-before oxygen administration |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2067
|
the mean value of InTc in the main PA-InTc-after oxygen administration |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2068
|
PV-MPA(main pulmonary artery)-before oxygen administration |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2069
|
PV-MPA(main pulmonary artery)--after oxygen administration |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2070
|
MPA(main pulmonary artery) of AcTc |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2071
|
MPA(main pulmonary artery) of InTc |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2072
|
PV(peak velocity) of MPA(main pulmonary artery) |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2073
|
Acceleration of MPA(main pulmonary artery) |
isolated CHD/non-isolated CHD: VSD/AVSD/PDA/ASD/VSD, AVSD |
unknown |
|
2074
|
neutrophil gelatinase-associated lipocalin(NGAL)-before operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2075
|
neutrophil gelatinase-associated lipocalin(NGAL)-immediately after operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2076
|
neutrophil gelatinase-associated lipocalin(NGAL)-after operation for 24h |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2077
|
neutrophil gelatinase-associated lipocalin(NGAL)-before operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2078
|
neutrophil gelatinase-associated lipocalin(NGAL)-immediately after operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2079
|
neutrophil gelatinase-associated lipocalin(NGAL)-after operation for 24h |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2080
|
neutrophil gelatinase-associated lipocalin(NGAL)-before operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2081
|
neutrophil gelatinase-associated lipocalin(NGAL)-after operation at once |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2082
|
neutrophil gelatinase-associated lipocalin(NGAL)-after operation for 24h |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2083
|
neutrophil gelatinase-associated lipocalin(NGAL)-before operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2084
|
neutrophil gelatinase-associated lipocalin(NGAL)-immediately after operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2085
|
neutrophil gelatinase-associated lipocalin(NGAL)-after operation for 24h |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2086
|
neutrophil gelatinase-associated lipocalin(NGAL)-before operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2087
|
neutrophil gelatinase-associated lipocalin(NGAL)-immediately after operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2088
|
neutrophil gelatinase-associated lipocalin(NGAL)-after operation for 24h |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2089
|
neutrophil gelatinase-associated lipocalin(NGAL)-before operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2090
|
neutrophil gelatinase-associated lipocalin(NGAL)-immediately after operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2091
|
neutrophil gelatinase-associated lipocalin(NGAL)-after operation for 24h |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2092
|
length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2093
|
length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2094
|
length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2095
|
length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2096
|
length of tube carring after operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2097
|
length of tube carring after operation |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2098
|
correlation between NGAL before operation and length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2099
|
correlation between NGAL immediately after operation at once and length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2100
|
correlation between NGAL after operation for 24 hour and length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2101
|
correlation between NGAL before operation and degree of PH |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2102
|
correlation between NGAL after operation at once and length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2103
|
correlation between NGAL after operation for 24 hour and length of stay in ICU |
isolated CHD/non-isolated CHD: ASD/VSD/PDA, ASD/VSD |
unknown |
|
2104
|
overall positive score |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2105
|
hyperactivity score |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2106
|
inattention acore |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2107
|
combined score |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2110
|
cardiovascular symptoms |
isolated CHD: AVD |
unknown |
|
2111
|
smoking |
isolated CHD: AVD |
unknown |
|
2112
|
valve surgery |
isolated CHD: AVD |
unknown |
|
2113
|
systolic blood pressure |
isolated CHD: AVD |
unknown |
|
2114
|
educational level(elementary education only) |
isolated CHD: AVD |
unknown |
|
2120
|
PAPs (mm Hg) |
isolated CHD: ASD/TGA |
unknown |
|
2121
|
PAPd (mm Hg) |
isolated CHD: ASD/TGA |
unknown |
|
2122
|
PAPm (mm Hg) |
isolated CHD: ASD/TGA |
unknown |
|
2123
|
PA sat (%) |
isolated CHD: ASD/TGA |
unknown |
|
2124
|
RAm (mm Hg) |
isolated CHD: ASD/TGA |
unknown |
|
2125
|
METs (metabolic equivalents) |
isolated CHD: ASD/TGA |
unknown |
|
2126
|
Exercise O2 saturation (%) |
isolated CHD: ASD/TGA |
unknown |
|
2127
|
Previous cardiac procedure |
NA: NA |
unknown |
|
2128
|
Bypass time, min |
NA: NA |
unknown |
|
2129
|
PRA>10% |
NA: NA |
unknown |
|
2140
|
Physical Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2141
|
Social relationships Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2142
|
Environmental Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2143
|
General QOL Dimensions (quality of life,QOL) |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2144
|
Physical Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2145
|
Psychological Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2146
|
Social relationships Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2147
|
Environmental Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2148
|
General QOL Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2149
|
Physical Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2150
|
Psychological Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2151
|
Social relationships Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2152
|
Environmental Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2153
|
General QOL Dimensions |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2154
|
predictor of a worse general perception of QOL |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2155
|
predictor of a worse QOL on physical dimension |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2156
|
predictor of a worse QOL on psychological dimension |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2157
|
predictor of a worse QOL on environmental dimension |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2158
|
predictor of reporting social problems |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, AS/TGA, PS/TGA, CoA/TOF/CoA, VSD/CoA, AS/VSD, IAA/VSD, PS/VSD, MI/VSD, AS/VSD, ASD/ASD, MA/AVSD/AS/PS, VSD/PS, ASD/SV, PS/SV, PA/PDA/DORV/EA, ASD/PA, VSD/PA, MVP/other |
unknown |
|
2159
|
von Willebrand factor: VWF:Ag (U/dL) |
isolated CHD: TOF/PA/VSD/UVH |
unknown |
|
2160
|
VWF:CB (%) |
isolated CHD: TOF/PA/VSD/UVH |
unknown |
|
2161
|
ADAMTS-13:Ag (ug/mL) |
isolated CHD: TOF/PA/VSD/UVH |
unknown |
|
2163
|
VWF multimers |
isolated CHD: TOF/PA/VSD/UVH |
unknown |
|
2167
|
association between preoperative DTI measures of Fractional anisotropy and preoperative brain injury score (coefficients) |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2168
|
association between preoperative MRSI measures of NAA/choline and preoperative brain injury score ( coefficients) |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2169
|
association between preoperative DTI measures of Fractional anisotropy and postoperative brain injury score(coefficients) |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2170
|
association between postoperative DTI measures of average diffusivity and preoperative brain injury score (coefficients) |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2171
|
association between postoperative MRSI measures of Lactate/choline and properative brain injury (coefficients) |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2172
|
Clinical predictors of brain injury severity：Perinatal variables: SNAP-PE |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2173
|
Clinical predictors of brain injury severity：preoperative variables: Lowest oxygen saturation level (arterial) |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2174
|
Clinical predictors of brain injury severity：preoperative variables: preoperative hypotension |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2175
|
Clinical predictors of brain injury severity：preoperative variables: balloon atrial septostomy |
isolated CHD: TGA/SV/AC/PA/TOF/TA/TAPVC |
unknown |
|
2176
|
BIC value (Bayesian Information Criterion) |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2177
|
entropy |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2178
|
Depressive symptoms (Time 1) |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2179
|
Cardiac symptoms(Time 1) |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2180
|
physical appearance(Time 1) |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2181
|
treatment anxiety(Time 1) |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2182
|
Cognitive problems(Time 1) |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2183
|
Communication(Time 1) |
isolated CHD/non-isolated CHD: HLHS/TOF/DORV/DILV/TA/TGA/CoA/AVSD/ASD/PVA/AVA/LVOTO/AA/VSD/other |
unknown |
|
2184
|
disease complexity |
NA: NA |
unknown |
|
2185
|
disease complexity |
NA: NA |
unknown |
|
2186
|
Clinic location--Colorado |
NA: NA |
unknown |
|
2187
|
Clinic location--Oregon |
NA: NA |
unknown |
|
2188
|
Clinic location--Washington State |
NA: NA |
unknown |
|
2189
|
sex-male |
isolated CHD: HLHS/other |
unknown |
|
2190
|
Birth weight (g) |
isolated CHD: HLHS/other |
unknown |
|
2191
|
BW<2500 g |
isolated CHD: HLHS/other |
unknown |
|
2192
|
Psychomotor Development Index (PDI) |
isolated CHD: HLHS/other |
unknown |
|
2193
|
Mental Development Index (MDI) |
isolated CHD: HLHS/other |
unknown |
|
2195
|
Psychomotor Development Index (PDI) score |
isolated CHD: HLHS/other |
unknown |
|
2196
|
pulmonary vascular resistance (PVR) |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/TGA, VSD/AVSD, PDA/VSD, PFO/PDA, ASD/AVSD/TA/DORV/PDA, ASD |
unknown |
|
2197
|
Qp:Qs ratio |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/TGA, VSD/AVSD, PDA/VSD, PFO/PDA, ASD/AVSD/TA/DORV/PDA, ASD |
unknown |
|
2198
|
velocity-time integral (VTIpv) |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/TGA, VSD/AVSD, PDA/VSD, PFO/PDA, ASD/AVSD/TA/DORV/PDA, ASD |
unknown |
|
2199
|
Illness perceptions: Consequences and relation with male |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2200
|
Illness perceptions: Timeline-cycle and relation with male |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2201
|
Disease complexity: Consequences and relation with disease complexity |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2202
|
Disease complexity:Timeline-cycle and relation with disease complexity |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2203
|
Disease complexity:Emotional representation and relation with disease complexity |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2204
|
Disease complexity: Consequences and relation with disease complexity |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2205
|
Disease complexity:Timeline-cycle and relation with disease complexity |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2206
|
Functional status--Consequences and relation with funcional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2207
|
Functional status--illness coherence and relation with funcional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2208
|
Functional status:Timeline-cycle and relation with functional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2209
|
Functional status:Emotional representation and relation with functional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2210
|
Functional status--Consequences and relation with funcional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2211
|
Functional status:Treatment control and relation with funcional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2212
|
Functional status:Timeline-cycle and relation with functional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2213
|
Functional status:Emotional representation and relation with functional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2214
|
Functional status--Consequences and relation with funcional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2215
|
Functional status--illness coherence and relation with funcional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2216
|
Functional status:Timeline-cycle and relation with functional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2217
|
Functional status:Emotional representation and relation with functional status |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2218
|
predictive value of illness perceptions for QOL of worries:consequences |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2219
|
predictive value of illness perceptions for QOL of physical component summary of the SF-36(PCS):consequences |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2220
|
predictive value of illness perceptions for QOL of symptoms:consequences |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2221
|
predictive value of illness perceptions for QOL of physical component summary of the SF-36(PCS): treatment control |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2222
|
predictive value of illness perceptions for QOL of symptoms: illness coherence |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2223
|
predictive value of illness perceptions for QOL of physical component summary of the SF-36(PCS): timeline-cycle |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2224
|
predictive value of illness perceptions for QOL of symptoms: timeline-cycle |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2225
|
predictive value of illness perceptions for QOL of mental component summary of the SF-36(MCS): emotional representation |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2226
|
predictive value of illness perceptions for QOL of worries: emotional representation |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2227
|
predictive value of illness perceptions for QOL of physical component summary of the SF-36(PCS): emotional representation |
isolated CHD/non-isolated CHD: VSD/ASD/PDA/TOF/PS/BAV/AS/AS/CoA/TGA/ccTGA/other |
unknown |
|
2228
|
Maternal age--20 ~ 24 years |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2229
|
Maternal education level--Junior school |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2230
|
Residence--Suburban |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2231
|
with exposure of housing renovation |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2232
|
Maternal smoking or exposure to ETS--yes |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2233
|
Factory or landfill nearby--yes |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2234
|
Folic acid supplements--yes |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2235
|
Indoor air ventilation--good |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
unknown |
|
2244
|
Age (years) |
isolated CHD: TGA/VSD/ASD/TOF/other |
unknown |
|
2245
|
CPB(cardiopulmonary bypass) time(min) |
isolated CHD: TGA/VSD/ASD/TOF/other |
unknown |
|
2247
|
Physical component summary (% of predicted) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2248
|
Mental component summary (% of predicted) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2249
|
Peak oxygen uptake (% of predicted) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2250
|
association of Physical function with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2251
|
association of Role physical with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2252
|
association of Bodily pain with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2253
|
association of General health with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2254
|
association of Vitality with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2255
|
association of Social function with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2256
|
association of Role emotional with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2257
|
association of Mental health with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2258
|
association of Physical component summary with Sense of coherence(SOC) |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2259
|
association of Mental component summary with Sense of coherence |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2260
|
association of Peak oxygen uptake with Sense of coherence |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2261
|
association of Physical function with Peak oxygen uptake |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2262
|
association of Role physical with Peak oxygen uptake |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2263
|
association of General health with Peak oxygen uptake |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2264
|
association of Vitality with Peak oxygen uptake |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2265
|
association of Physical component summary with Peak oxygen uptake |
isolated CHD/non-isolated CHD: TGA/TOF/EA/PS/PR/CoA/AS/AVSD/ASD/VSD/PDA/other |
unknown |
|
2266
|
Average ABP immediately prior to induction (mmHg)--Systolic-Diastolic |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2267
|
Average ABP immediately after induction (mmHg)--Systolic-Diastolic |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2268
|
Average lowest recorded ABP during case (mmHg)--Systolic-Diastolic |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2269
|
Average ABP on return to ICU (mmHg)--Systolic-Diastolic |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2286
|
Height-In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2287
|
BMI-In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2288
|
Oxygen saturation-In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2289
|
Cyanosis-In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2290
|
NYHA III-IV--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2291
|
Moderate to severe systemic ventricular dysfunction--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2295
|
Pulmonary hypertension--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2296
|
Lung hypoperfusion at birth--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2297
|
Diuretics--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2298
|
Amiodarone--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2299
|
Pulmonary vasodilators--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2301
|
Multiple thoracotomies (≥2)--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2302
|
Multiple sternotomies (≥2)-In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2303
|
Previous surgery for scoliosis-In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2304
|
Lung function test: FEV1, L--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2305
|
Lung function test: FVC, L--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2306
|
Cardiopulmonary exercise test: Ve/Vo2 slope--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2307
|
Cardiothoracic ratio--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2308
|
Lung hypoperfusion at birth--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2309
|
Amiodarone--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2310
|
Surgical history: Previous thoracotomy--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2311
|
Multiple thoracotomies (≥2)--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2312
|
Multiple sternotomies (≥2)-In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2313
|
Lung function test: FEV1, L--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2314
|
Lung function test: FVC, L--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
unknown |
|
2316
|
6-MWD, m |
isolated CHD: VSD/TA/PDA/TGA |
unknown |
|
2317
|
fetal echocardiography (echoCG) |
isolated CHD: VSD/TOF/DORV/CoA/AVSD/TGA/SV/EA/PA/IVS/HLHS/IAA/other |
unknown |
|
2325
|
Duration of postop TCHB (Transient complete heart block) (days) |
NA: NA |
unknown |
|
2326
|
Number of Duration of postoperative TCHB (Transient complete heart block) ≥7 days |
NA: NA |
unknown |
|
2327
|
number of patients recovered AVC within 12 days |
NA: NA |
unknown |
|
2329
|
follow up PR interval(ms) |
NA: NA |
unknown |
|
2330
|
FMD (flow-mediated dilatation) |
NA: NA |
unknown |
|
2331
|
TC (total cholesterol) |
NA: NA |
unknown |
|
2332
|
low-density lipoprotein–cholesterol |
NA: NA |
unknown |
|
2333
|
very low-density lipoprotein–cholesterol |
NA: NA |
unknown |
|
2334
|
transcutaneous oxygen saturation |
NA: NA |
unknown |
|
2335
|
HGB (Hemoglobin) (g/dL) |
NA: NA |
unknown |
|
2336
|
HCT (Hematocrit) (%) |
NA: NA |
unknown |
|
2337
|
PLT (Platelet) count (×103) |
NA: NA |
unknown |
|
2338
|
caesarean delivery rate |
NA: NA |
unknown |
|
2339
|
operative vaginal delivery rate |
NA: NA |
unknown |
|
2341
|
mPAP (mean pulmonary artery pressure) (mmHg) |
NA: CHD with PAH |
unknown |
|
2342
|
PVR (pulmonary vascular resistance) (WU m2) |
NA: CHD with PAH |
unknown |
|
2346
|
Correlation between patients with RLD (Restrictive lung disease) and low exercise duration |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
unknown |
|
2347
|
Correlation between patients with RLD (Restrictive lung disease) and hihger NYHA class |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
unknown |
|
2350
|
percentage of Restrictive lung disease(RLD) in TOF |
isolated CHD: TOF |
unknown |
|
2351
|
percentage of Restrictive lung disease(RLD) in Single ventricle s/p Fontan |
isolated CHD: SV |
unknown |
|
2352
|
percentage of Restrictive lung disease(RLD) in ccTGA |
isolated CHD: ccTGA |
unknown |
|
2353
|
percentage of Restrictive lung disease(RLD) in EA |
isolated CHD: EA |
unknown |
|
2354
|
Percentage of exercise intolerance in TOF |
isolated CHD: TOF |
unknown |
|
2355
|
Percentage of exercise intolerance in Single ventricle s/p Fontan |
isolated CHD: SV |
unknown |
|
2356
|
Percentage of exercise intolerance in EA |
isolated CHD: EA |
unknown |
|
2357
|
cardiopulmonary exercise time(min) |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2358
|
Exercise time |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2359
|
Heart rate(chronotropic index) |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2360
|
peak heart rate (HR) |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2361
|
oxygen uptake(Anaerobic threshold) |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2362
|
peak oxygen uptake (V˙ O2) |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2363
|
Impact of exercise time on birth weight |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2364
|
Impact of peak heart rate (HR) on birth weight |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2365
|
Impact of peak SBP(systolic blood pressure) on birth weight |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2366
|
Impact of peak oxygen uptake (V˙ O2) on birth weight |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2367
|
Impact of Anaerobic threshold (Oxygen uptake) on birth weight |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
unknown |
|
2375
|
3 weeks of 6MWD(6-minute walking distance) |
isolated CHD: CHD with PAH |
unknown |
|
2376
|
15 weeks of 6MWD(6-minute walking distance) |
isolated CHD: CHD with PAH |
unknown |
|
2377
|
Quality of life-score (Bodily pain) |
isolated CHD: CHD with PAH |
unknown |
|
2378
|
peak oxygen consumption |
isolated CHD: CHD with PAH |
unknown |
|
2379
|
Heart Rate Max(/min) |
isolated CHD: CHD with PAH |
unknown |
|
2380
|
maximal workload |
isolated CHD: CHD with PAH |
unknown |
|
2381
|
maximal workload |
isolated CHD: CHD with PAH |
unknown |
|
2382
|
NT-proBNP [pg/mL] |
isolated CHD: CHD with PAH |
unknown |
|
2385
|
threatened abortion in early pregnancy |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, ASD, PDA/VSD, PDA, PAH/TOF/HLHS/CoA/PA, VSD, PS/PS, RVOTO/ASD, MRMV, PMT/PA, VSD/SA, SV, CAVC, HLHS/PDA/CAF/VSD, RVOTO, CoA/AS |
unknown |
|
2388
|
eGFR(ml/min/1.73m2) |
NA: NA |
unknown |
|
2389
|
pulmonary hypertension(>60 mmHg) |
NA: NA |
unknown |
|
2390
|
Logistic EuroSCORE I |
NA: NA |
unknown |
|
2391
|
Previous congenital heart surgery |
NA: NA |
unknown |
|
2393
|
ACC(cortic cross clamp) |
NA: NA |
unknown |
|
2394
|
Socioeconomic status (SES) |
NA: NA |
unknown |
|
2395
|
cardiac disease severity |
NA: NA |
unknown |
|
2396
|
age |
NA: NA |
unknown |
|
2397
|
Male |
NA: NA |
unknown |
|
2398
|
Male of one month of age and younger |
NA: NA |
unknown |
|
2399
|
higher RACHS-1 (risk-adjusted classification for congenital heart surgery) category |
NA: NA |
unknown |
|
2400
|
RACHS-1 category |
NA: NA |
unknown |
|
2401
|
higher RACHS-1 (risk-adjusted classification for congenital heart surgery) category of one month of age and younger |
NA: NA |
unknown |
|
2402
|
RACHS-1 category of one month of age and younger |
NA: NA |
unknown |
|
2403
|
Aristole basic score of one months of age and younger |
NA: NA |
unknown |
|
2404
|
Preoperative SCr (mg/dL) |
NA: NA |
unknown |
|
2405
|
lower preoperative serum creatinine of one month of age and younger |
NA: NA |
unknown |
|
2406
|
Highest SCr (mg/dL) |
NA: NA |
unknown |
|
2407
|
Highest SCr (mg/dL) of one month of age and younger |
NA: NA |
unknown |
|
2408
|
higher preoperative blood urea nitrogen of one month of age and younger |
NA: NA |
unknown |
|
2409
|
longer cardiopulmonary bypass time |
NA: NA |
unknown |
|
2411
|
Aortic cross-clamp time (min) |
NA: NA |
unknown |
|
2412
|
Aortic cross-clamp time (min) of one month of age and younger |
NA: NA |
unknown |
|
2413
|
Circulatory arrest time (min) |
NA: NA |
unknown |
|
2414
|
Circulatory arrest time (min) of one month of age and younger |
NA: NA |
unknown |
|
2415
|
Tmin (℃) |
NA: NA |
unknown |
|
2416
|
Tmin (℃) of one month of age and younger |
NA: NA |
unknown |
|
2417
|
Highest inotropic agent score |
NA: NA |
unknown |
|
2418
|
Highest inotropic agent score of one month of age and younger |
NA: NA |
unknown |
|
2419
|
Diuretics |
NA: NA |
unknown |
|
2420
|
Milrinone |
NA: NA |
unknown |
|
2421
|
Milrinone of one months of 1 month of age and younger |
NA: NA |
unknown |
|
2422
|
Renal replacement |
NA: NA |
unknown |
|
2423
|
Renal replacement of 1month of age and younger |
NA: NA |
unknown |
|
2424
|
Mechanical circulatory support |
NA: NA |
unknown |
|
2427
|
RACHS-1 category |
NA: NA |
unknown |
|
2430
|
Cardiopulmonary bypass >90 min of age and younger |
NA: NA |
unknown |
|
2431
|
Preoperative serum creatinine of age and younger |
NA: NA |
unknown |
|
2432
|
Preoperative serum blood urea nitrogen of age and younger |
NA: NA |
unknown |
|
2433
|
longer duration of ventilation |
NA: NA |
unknown |
|
2434
|
Duration of mechanical ventilation (days) of 1month of age and younger |
NA: NA |
unknown |
|
2435
|
In-hospital mortality |
NA: NA |
unknown |
|
2436
|
lengths of intensive care unit(ICU LOS)(days) |
NA: NA |
unknown |
|
2437
|
hospital length of stay(LOS)(days) |
NA: NA |
unknown |
|
2438
|
lower preoperative serum creatinine of one months of age and younger |
NA: NA |
unknown |
|
2439
|
intensive care unit(ICU) LOS of one months of age and younger |
NA: NA |
unknown |
|
2440
|
hospital lengths of stay of one months of age and younger |
NA: NA |
unknown |
|
2441
|
Relative importance of individual symptom to perceived health：NYHA-II |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2442
|
Relative importance of individual symptom to perceived health：NYHA-III |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2443
|
Relative importance of individual symptom to perceived health：Shortness of breath walking<100 m |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2444
|
Relative importance of individual symptom to perceived health：Orthopnea |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2445
|
Relative importance of individual symptom to perceived health：Edema |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2446
|
Relative importance of individual symptom to perceived health：Palpitations |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2447
|
Relative importance of individual symptom to perceived health：Dizziness |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2448
|
Relative importance of individual symptom to perceived health：Cyanosis during exercise |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
unknown |
|
2459
|
Relationship between symptom distress and perceived health |
NA: NA |
unknown |
|
2474
|
patient age |
isolated CHD/non-isolated CHD: UVH/TA/DILV, PA/DILV, PS/DILV/UVH, TGA/HLHS/DOLV/UAVC/PA, IVS/TOF/PA, VSD/TGA/TGA/AVC/EA/SD/MD/AD, CoA/CoA, VSD/TAPVR/CACA/TOF, AVC/MAD |
unknown |
|
2477
|
Fetuses with two ventricles : PV-Zscore |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2478
|
Fetuses with two ventricles : PV/AoV |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2479
|
Fetuses with two ventricles:PV (pulmonary valve) |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2480
|
Fetuses with two ventricles : Sub PV(subpulmonary valve) region |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2481
|
Fetuses with two ventricles: MPA(main pulmonary artery) |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2482
|
Fetuses with two ventricles : LPA (left pulmonary artery) |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2483
|
Fetuses with two ventricles : RPA (right pulmonary artery) |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2484
|
Prostaglandin use (n (%)) |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2485
|
PV (mm) |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2486
|
PV-Z-score |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2487
|
AoV (mm) |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2488
|
PV/AoV ratio |
isolated CHD/non-isolated CHD: TOF/DORV/PS/UAVC, DORV, PS/UAVC, TOF/UAVC, DORV, TAPVC/DILV, PS/DORV, MS, PS |
unknown |
|
2489
|
Homocysteine |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA/LTRS |
unknown |
|
2490
|
Homocysteine |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA/LTRS |
unknown |
|
2491
|
Homocysteine |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA/LTRS |
unknown |
|
2492
|
ADMA (asymmetric dimethyl arginine) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2493
|
homocysteine |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2494
|
homocysteine |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2495
|
homocysteine |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2496
|
ADMA (asymmetric dimethyl arginine) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2497
|
ADMA (asymmetric dimethyl arginine) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2498
|
RVD1 (right ventricular midcavity diameter) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2499
|
RVD2 (right ventricular long-axis diameter) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2500
|
LVET (left ventricular ejection time) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2501
|
LVET (left ventricular ejection time) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2502
|
LVMPI (left ventricular myocardial performance index) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2503
|
LVMPI (left ventricular myocardial performance index) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2504
|
RVET (right ventricular ejection time) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2505
|
RVMPI (right ventricular myocardial performance index) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2506
|
RVMPI (right ventricular myocardial performance index) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2507
|
TAPSE (tricuspid annular plane systolic excursion) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2508
|
TAPSE (tricuspid annular plane systolic excursion) |
isolated CHD/non-isolated CHD: VSD/TA/PDA/ASD/DORV, MA |
unknown |
|
2509
|
goiter (n,%) |
NA: NA |
unknown |
|
2515
|
correlation between age and BMI |
NA: NA |
unknown |
|
2516
|
correlation between left bronchial cross-sectional area and body surface area |
NA: NA |
unknown |
|
2517
|
correlation between right bronchial cross-sectional area and body surface area |
NA: NA |
unknown |
|
2518
|
bronchial area |
NA: NA |
unknown |
|
2519
|
bronchial area |
NA: NA |
unknown |
|
2520
|
bronchial area |
NA: NA |
unknown |
|
2521
|
bronchial area |
NA: NA |
unknown |
|
2522
|
right bronchial area |
NA: NA |
unknown |
|
2523
|
left bronchial area |
NA: NA |
unknown |
|
2524
|
age (years) |
NA: NA |
unknown |
|
2525
|
goiter (n,%) |
NA: NA |
unknown |
|
2527
|
Weight (kg) |
NA: NA |
unknown |
|
2530
|
mean MCA-PI Z-score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2531
|
mean MCA-PI Z-score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2532
|
correlation between fetal MCA-PI Z-score at the time of first echocardiogram with BSID cognitive score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2533
|
mean BSID cognitive score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2534
|
correlation between neonatal EEG left frontal polar beta power with BSID cognitive score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2535
|
correlation between neonatal EEG right frontal polar beta power with BSID cognitive score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2536
|
correlation between neonatal EEG left frontal polar beta power with MCA-PI Z-score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2537
|
correlation between neonatal EEG left frontal beta power with MCA-PI Z-score |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2538
|
left frontal polar beta power |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2539
|
left frontal beta power |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2540
|
correlation between fetal MCA-PI Z-score, EGG left frontal beta power and BSID |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2541
|
EEG as predictor for 18-month BSID |
isolated CHD: HLHS/TGA/TOF |
unknown |
|
2547
|
CTR level |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
unknown |
|
2548
|
average CTR level |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
unknown |
|
2549
|
average CTR level |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
unknown |
|
2550
|
average CTR level |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
unknown |
|
2551
|
CTR level |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
unknown |
|
2552
|
association between age and CTR |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
unknown |
|
2558
|
VWF:Ag (U/dL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2559
|
VWF:Ag (U/dL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2560
|
t-PA (ng/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2561
|
t-PA (ng/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2562
|
PAI-1 (ng/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2563
|
PAI-1 (ng/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2564
|
P-selectin (ng/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2565
|
P-selectin (ng/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2566
|
IL-6 (pg/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2567
|
IL-6 (pg/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2568
|
IL-10 (pg/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2569
|
IL-10 (pg/mL) |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2570
|
IL-10/TNF-α |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2571
|
correlation between age and t-PA |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2572
|
correlation between clinical presentation with t-PA |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2573
|
correlation between resting SpO2 with t-PA |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2574
|
correlation between Hematocrit with t-PA |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2575
|
correlation between clinical presentation with PAI-1 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2576
|
correlation between clinical presentation with P-selectin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2577
|
correlation between gender with P-selectin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2578
|
correlation between gender with IL-6 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2579
|
correlation between resting SpO2 with PAI-1 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2580
|
correlation between 6-min walk SpO2 with P-selectin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2581
|
correlation between 6-min walk distance with PAI-1 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2582
|
correlation between Hematocrit and P-selectin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2583
|
correlation between Hematocrit and IL-6 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unknown |
|
2608
|
mean cognitive |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2609
|
gross motor |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2610
|
comorbidity rate |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2611
|
multiple procedures with DHCA |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2612
|
age |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2613
|
comorbidity rate |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2614
|
comorbidity rate |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2615
|
rSO2 nadir of less than 20% stauration |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2616
|
born prematurely |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2617
|
comorbidity rate |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2618
|
duration of DHCA |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2619
|
comorbidity rate |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2620
|
length of hospital stay |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2621
|
premature birth |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2622
|
length of hospital stay |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2623
|
rSO2 nadir |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2624
|
birth weight |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2625
|
duration of CICU stay |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2626
|
significant comorbidity |
isolated CHD: AS/VSD/RVOTO/TOF/ASD/VSD |
unknown |
|
2627
|
correlation between fractional increase in creatinine with NIRS mean on POD1 |
NA: NA |
unknown |
|
2628
|
POD1 NIRS cutoff value of <80% |
NA: NA |
unknown |
|
2629
|
rSO2 cutoff value of <75% |
NA: NA |
unknown |
|
2630
|
correlation between Oliguria on POD2 with NIRS nadir |
NA: NA |
unknown |
|
2631
|
correlation between Oliguria on POD2 with NIRS mean |
NA: NA |
unknown |
|
2632
|
correlation between fluid balance on POD2 with NIRS nadir on POD2 |
NA: NA |
unknown |
|
2648
|
Initial lactate (mmol/L) |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
unknown |
|
2656
|
Systolic pulmonary artery pressure |
NA: NA |
unknown |
|
2657
|
Diastolic pulmonary artery pressure |
NA: NA |
unknown |
|
2658
|
Pulse pressure |
NA: NA |
unknown |
|
2659
|
PVR indexed |
NA: NA |
unknown |
|
2660
|
PAC indexed |
NA: NA |
unknown |
|
2661
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Gender (female) |
NA: NA |
unknown |
|
2663
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: SPAP |
NA: NA |
unknown |
|
2664
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: DPAP |
NA: NA |
unknown |
|
2665
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Pulse pressure |
NA: NA |
unknown |
|
2666
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: PVRi |
NA: NA |
unknown |
|
2669
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: PACI |
NA: NA |
unknown |
|
2671
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Right atrial pressure |
NA: NA |
unknown |
|
2673
|
incidence of fetal CHD |
isolated CHD: VSD/PDA/ASD/PS/TOF/TGA/AVSD/TI/SV/DORV/CoA/VAS/TA/PA/TA/HLHS/IAA/EA/other |
unknown |
|
2674
|
Sensitivity (%) |
isolated CHD: VSD/PDA/ASD/PS/TOF/TGA/AVSD/TI/SV/DORV/CoA/VAS/TA/PA/TA/HLHS/IAA/EA/other |
unknown |
|
2675
|
Live newborns |
isolated CHD: VSD/PDA/ASD/PS/TOF/TGA/AVSD/TI/SV/DORV/CoA/VAS/TA/PA/TA/HLHS/IAA/EA/other |
unknown |
|
2676
|
FL (Z score) (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2677
|
EFBW (Z score) (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2678
|
MCA RI <5th percentile (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2679
|
MCA RI <10th percentile (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2680
|
UA RI >90th percentile (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2681
|
MCA RI/UA RI <1 (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2682
|
BPD (Z score) (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2683
|
FL (Z score) (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2684
|
EFBW (Z score) (ultrasound findings at the third trimester) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2685
|
BW (Z score) (physical sizes at birth) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2686
|
BL (Z score) (physical sizes at birth) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2687
|
CC (Z score) (physical sizes at birth) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2688
|
BW (Z score) (physical sizes at birth) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2689
|
BL (Z score) (physical sizes at birth) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2690
|
CC (Z score) (physical sizes at birth) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2691
|
CC (Z score) (physical sizes at birth) |
isolated CHD: PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
unknown |
|
2692
|
6MWD (6-minute walk distance) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2693
|
Borg dyspnea index |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2694
|
SaO2, % |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2695
|
6MWD (6-minute walk distance) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2696
|
WHO functional class |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2697
|
6MWD (6-minute walk distance) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2698
|
WHO functional class |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2699
|
HR (heart rates) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2700
|
Qpi (pulmonary blood flow index) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2701
|
Qsi (systemic blood flow index) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2702
|
PVR (pulmonary vascular resistance) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2703
|
mPAP (mean pulmonary artery pressure) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2704
|
Qpi (pulmonary blood flow index) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2705
|
PVR (pulmonary vascular resistance) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2706
|
PVR/SVR ratio |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2707
|
Qpi (pulmonary blood flow index) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2708
|
PVR (pulmonary vascular resistance) |
isolated CHD: ASD/VSD/PDA |
unknown |
|
2709
|
Correlation between Qp/Qs and the frequency of segmental emphysematous change in right lung |
isolated CHD: ASD/VSD/PDA/CAVSD |
unknown |
|
2710
|
Correlation between Qp/Qs and the frequency of segmental emphysematous change in left lung |
isolated CHD: ASD/VSD/PDA/CAVSD |
unknown |
|
2711
|
Correlation between mPAP and the frequency of segmental emphysema in right lung |
isolated CHD: ASD/VSD/PDA/CAVSD |
unknown |
|
2712
|
Correlation between mPAP and the frequency of segmental emphysema in left lung |
isolated CHD: ASD/VSD/PDA/CAVSD |
unknown |
|
2713
|
body weights |
NA: NA |
unknown |
|
2714
|
heights |
NA: NA |
unknown |
|
2715
|
body weights |
NA: NA |
unknown |
|
2716
|
body weights |
NA: NA |
unknown |
|
2717
|
heights |
NA: NA |
unknown |
|
2720
|
body weights |
NA: NA |
unknown |
|
2723
|
Age at implantation (years) |
isolated CHD: LVOTO/ASD/VSD/AVSD/TGA/TOF/other |
unknown |
|
2725
|
Steroid |
isolated CHD: LVOTO/ASD/VSD/AVSD/TGA/TOF/other |
unknown |
|
2726
|
Overall mortality |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2730
|
Total bypass time (min) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2731
|
Total cross clamp time (min) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2732
|
LOS PICU (days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2733
|
LOS hospital (days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2734
|
Ventilation > 7 days |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2735
|
Cardiac arrest |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2736
|
Peritoneal dialysis |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
unknown |
|
2743
|
Peak oxygen consumption (pV02) |
isolated CHD/non-isolated CHD: TOF/D-TGA, AS |
unknown |
|
2744
|
permanent postoperative complete heart block (CHB) |
isolated CHD/non-isolated CHD: VSD, ASD/VSD, PDA/VSD, RVOTO/TOF/DORV/AVSD/SAS/other |
unknown |
|
2745
|
types of bioprostheses--Mean age |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
unknown |
|
2746
|
types of bioprostheses-- Mean valve size |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
unknown |
|
2747
|
types of bioprostheses-- Mean valve Z-score |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
unknown |
|
2748
|
types of bioprostheses-- Mean FU (Follow-up) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
unknown |
|
2749
|
diagnostic groups--Mean age |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
unknown |
|
2750
|
diagnostic groups--Mean valve size |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
unknown |
|
2751
|
diagnostic groups--Mean valve Z-score |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
unknown |
|
2755
|
O2 saturation (%) |
isolated CHD/non-isolated CHD: VSD/PA, VSD/CAVSD/TOF/D-TGA, VSD/ASD, TAPVR/other |
unknown |
|
2756
|
CPB(cardiopulmonary bypass) time (min) |
isolated CHD/non-isolated CHD: VSD/PA, VSD/CAVSD/TOF/D-TGA, VSD/ASD, TAPVR/other |
unknown |
|
2757
|
ACC (aortic cross-clamp) time (min) |
isolated CHD/non-isolated CHD: VSD/PA, VSD/CAVSD/TOF/D-TGA, VSD/ASD, TAPVR/other |
unknown |
|
2758
|
Preoperative signifi cant arrhythmia (%) |
isolated CHD/non-isolated CHD: VSD/PA, VSD/CAVSD/TOF/D-TGA, VSD/ASD, TAPVR/other |
unknown |
|
2759
|
Maternal age |
NA: NA |
unknown |
|
2760
|
Total cholesterol, mmol/l |
NA: NA |
unknown |
|
2761
|
LDL-cholesterol, mmol/l |
NA: NA |
unknown |
|
2762
|
Total cholesterol/HDL-cholesterol |
NA: NA |
unknown |
|
2763
|
Apolipoprotein B, mg/dl |
NA: NA |
unknown |
|
2764
|
Apolipoprotein B/A-1 |
NA: NA |
unknown |
|
2765
|
Total homocysteine, umol/l |
NA: NA |
unknown |
|
2774
|
Weight (kg) |
isolated CHD: HRHS/HLHS/AVSD/VSD/ASD/CAT/TGA/DORV/TOF/CoA/ALVS/other |
unknown |
|
2775
|
Height (cm) |
isolated CHD: HRHS/HLHS/AVSD/VSD/ASD/CAT/TGA/DORV/TOF/CoA/ALVS/other |
unknown |
|
2776
|
CPB duration (min) |
isolated CHD: HRHS/HLHS/AVSD/VSD/ASD/CAT/TGA/DORV/TOF/CoA/ALVS/other |
unknown |
|
2777
|
x-clamp time (min) |
isolated CHD: HRHS/HLHS/AVSD/VSD/ASD/CAT/TGA/DORV/TOF/CoA/ALVS/other |
unknown |
|
2778
|
Age mean (range), months |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2779
|
Weight mean (range), kg |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2780
|
CPB time, min |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2781
|
Age mean (range), months |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2782
|
Weight mean (range), kg |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2783
|
CPB time, min |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2791
|
correlation between NT-BNP peak values and factors: preoperative NT-BNP level |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2792
|
correlation between NT-BNP peak values and factors: risk adjustment CHD surgery |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2793
|
correlation between NT-BNP peak values and factors: length of CPB |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2794
|
correlation between NT-BNP peak values and factors: age |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2795
|
correlation between NT-BNP peak values and factors: weight of patients |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2796
|
correlation between NT-BNP peak values and factors: maximum inotropic score |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2797
|
correlation between NT-BNP peak values and factors: duration of inotropic drug therapy |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2798
|
correlation between NT-BNP peak values and factors: length of supported mechanical ventilation |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2799
|
correlation between NT-BNP peak values and factors: length of stay in the PICU |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
unknown |
|
2800
|
exposure to black smoke |
isolated CHD: VSD/ASD/TOF/CoA/PVS |
unknown |
|
2801
|
exposure to sulfur dioxide |
isolated CHD: VSD/ASD/TOF/CoA/PVS |
unknown |
|
2802
|
Clinical status: WHO functional class |
isolated CHD: VSD/ASD/AVC/SV |
unknown |
|
2803
|
Exercise tolerance (6MWT): Distance (m) |
isolated CHD: VSD/ASD/AVC/SV |
unknown |
|
2804
|
Exercise tolerance (6MWT): SpO2 post-exercise (%) |
isolated CHD: VSD/ASD/AVC/SV |
unknown |
|
2805
|
Exercise tolerance (6MWT): Borg dyspnoea index |
isolated CHD: VSD/ASD/AVC/SV |
unknown |
|
2806
|
Biochemical parameters: proBNP (pg/ml) |
isolated CHD: VSD/ASD/AVC/SV |
unknown |
|
2807
|
Qp(pulmonary flow) |
isolated CHD: VSD/ASD/AVC/SV |
unknown |
|
2808
|
PVRi(pulmonary vascular resistance index) |
isolated CHD: VSD/ASD/AVC/SV |
unknown |
|
2809
|
Diuretics, mg/kg/day |
isolated CHD: AVC/TA/TOF/HLHS/MS/AC, VSD/UVH, HAA |
unknown |
|
2810
|
Neutrophil gelatinase-associated lipocalin levels (NGAL) |
isolated CHD: AVC/TA/TOF/HLHS/MS/AC, VSD/UVH, HAA |
unknown |
|
2811
|
NGAL levels throughout the first 6 extracorporeal membrane oxygenation days |
isolated CHD: AVC/TA/TOF/HLHS/MS/AC, VSD/UVH, HAA |
unknown |
|
2812
|
Medical history: Cardiac medication before therapeutic intervention and relation with Externalizing |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2813
|
Medical history: Palliative intervention before therapeutic intervention and relation with total problems |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2814
|
Cardiac diagnosis (reference: ventricular septal defect) Atrial septal defect and relation with Externalizing |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2815
|
Cardiac diagnosis (reference: ventricular septal defect) PS(Pulmonary stenosis) and relation with Externalizing |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2816
|
Present medical status Scar judged by physician and relation with Internalizing |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2817
|
Correlation of Internalizing and General Health Questionnaire anxiety and sleeplessness |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2818
|
Correlation of Externalizing and General Health Questionnaire anxiety and sleeplessness |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2819
|
Correlation of Total problems and General Health Questionnaire anxiety and sleeplessness |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2820
|
Correlation of Internalizing and General Health Questionnaire total score |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2821
|
Correlation of Externalizing and General Health Questionnaire total score |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2822
|
Correlation of Total problems and General Health Questionnaire total score |
isolated CHD: ASD/VSD/TGA/PS |
unknown |
|
2823
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2): All data points(ALL) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2824
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):Diagnostic subgroups( TGA) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2825
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):Diagnostic subgroups(HLHS) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2826
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):Diagnostic subgroups(TOF) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2827
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):ScvO2% subgroups( <40%) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2828
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):ScvO2% subgroups( 41-60%) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2829
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):Period subgroups: T0–T2 (preoperative phase) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2830
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):Period subgroups: T3–T5 (early postoperative phase) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2831
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):Period subgroups: T6–T9 (late postoperative phase) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2832
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):PaCO2 subgroups(<31 mmHg) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2833
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):PaCO2 subgroups(>31 and <41 mmHg) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2834
|
correlation between cerebral near-infrared spectroscopy and superior vena cava venous oxygen saturation(ScvO2):PaCO2 subgroups(>41 mmHg) |
isolated CHD: TGA/HLHS/TOF/other |
unknown |
|
2835
|
angiotensin converting enzyme inhibitor (ACEI) |
NA: NA |
unknown |
|
2836
|
Fibrosis Index--Subgroup: ACHD |
NA: NA |
unknown |
|
2837
|
Fibrosis Index--Subgroup: Systemic RV |
NA: NA |
unknown |
|
2838
|
Fibrosis Index--Subgroup: Cyanosis |
NA: NA |
unknown |
|
2839
|
Fibrosis Index--Subgroup: Other congenital |
NA: NA |
unknown |
|
2842
|
initial implantation less than two years and relation with the need for reintervention |
isolated CHD: TOF/TA/D-TGA/ASD/DORV/other |
unknown |
|
2843
|
Weight less than 10 Kg and relation with the need for reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, CBPS/CBPS |
unknown |
|
2844
|
initial post-inflation stent diameter and less than 10 mm relation with the need for reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, BPAS/isolated BPAS |
unknown |
|
2848
|
prevalence of diagnoses: Closed ASD/VSD |
isolated CHD/non-isolated CHD: ASD/VSD/TGA/CoA/other |
unknown |
|
2849
|
prevalence of diagnoses: Open ASD |
isolated CHD/non-isolated CHD: ASD/VSD/TGA/CoA/other |
unknown |
|
2850
|
prevalence of diagnoses: TGA atrial switch |
isolated CHD/non-isolated CHD: ASD/VSD/TGA/CoA/other |
unknown |
|
2851
|
prevalence of diagnoses: Fontan |
isolated CHD/non-isolated CHD: ASD/VSD/TGA/CoA/other |
unknown |
|
2852
|
prevalence of diagnoses: Eisenmenger |
isolated CHD/non-isolated CHD: ASD/VSD/TGA/CoA/other |
unknown |
|
2853
|
prevalence of diagnoses: Cyanotic (non- Eisenmenger) |
isolated CHD/non-isolated CHD: ASD/VSD/TGA/CoA/other |
unknown |
|
2854
|
prevalence of diagnoses: Mechanical valve prostheses |
isolated CHD/non-isolated CHD: ASD/VSD/TGA/CoA/other |
unknown |
|
2855
|
If PVC-derived area BSA ≤0.05: Intercept (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2856
|
If PVC-derived area BSA ≤0.05:PVC-derived area BSA (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2857
|
If PVC-derived area BSA ≤0.05: VTI ratio (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2858
|
If PVC-derived area BSA ＞0.05: Intercept (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2859
|
If PVC-derived area BSA ＞0.05:PVC-derived area BSA (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2860
|
If PVC-derived area BSA ＞0.05: VTI ratio (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2861
|
If PVC-derived area BSA ≤0.05: Intercept (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2862
|
If PVC-derived area BSA ≤0.05:PVC-derived area BSA (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2863
|
If PVC-derived area BSA ≤0.05: VTI ratio (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2864
|
If PVC-derived area BSA ＞0.05: Intercept (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2865
|
If PVC-derived area BSA ＞0.05:PVC-derived area BSA (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2866
|
If PVC-derived area BSA ＞0.05: VTI ratio (Predicting CMR AR Fraction) |
isolated CHD/non-isolated CHD: TOF, TA/VSD/CoA/TGA/other |
unknown |
|
2867
|
CPB time (min) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
unknown |
|
2868
|
Body temperature (℃) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
unknown |
|
2869
|
Troponin-T (ug l-1) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
unknown |
|
2870
|
Intubation time (days) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
unknown |
|
2871
|
Use of noradrenalin number of patients (%) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
unknown |
|
2872
|
PICU stay (days) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
unknown |
|
2876
|
mortality |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
unknown |
|
2880
|
Residual lesions at conception: Any risk factorsa (%) |
NA: NA |
unknown |
|
2881
|
The mean number of risk factors |
NA: NA |
unknown |
|
2882
|
Transcutaneous oxygen saturation |
isolated CHD/non-isolated CHD: ASD, VSD/VSD/ASD/TGA, VSD/TBA |
unknown |
|
2883
|
Mean pulmonary artery pressure |
isolated CHD/non-isolated CHD: ASD, VSD/VSD/ASD/TGA, VSD/TBA |
unknown |
|
2884
|
pulmonary vascular resistance |
isolated CHD/non-isolated CHD: ASD, VSD/VSD/ASD/TGA, VSD/TBA |
unknown |
|
2885
|
%MT (percentage media wall thickness) |
isolated CHD/non-isolated CHD: ASD, VSD/VSD/ASD/TGA, VSD/TBA |
unknown |
|
2886
|
%MS (percentage media wall area) |
isolated CHD/non-isolated CHD: ASD, VSD/VSD/ASD/TGA, VSD/TBA |
unknown |
|
2887
|
APSC (arterioles per square centimeter) |
isolated CHD/non-isolated CHD: ASD, VSD/VSD/ASD/TGA, VSD/TBA |
unknown |
|
2888
|
Gestational age, wks |
isolated CHD/non-isolated CHD: HLHS/DORV, DORV, IAA/AVSD/TA, IAA/DILV/IAA, VSD/TA |
unknown |
|
2889
|
Preprocedure factors: Prostaglandin maximum dose |
isolated CHD/non-isolated CHD: HLHS/DORV, DORV, IAA/AVSD/TA, IAA/DILV/IAA, VSD/TA |
unknown |
|
2890
|
Postprocedure/ICU factors: Unexpected readmission to ICU (%) |
isolated CHD/non-isolated CHD: HLHS/DORV, DORV, IAA/AVSD/TA, IAA/DILV/IAA, VSD/TA |
unknown |
|
2891
|
cardiopulmonary bypass |
isolated CHD/non-isolated CHD: HLHS/TAPVR/TOF/CoA, IAA/TAS/TA/EA/HRHS |
unknown |
|
2892
|
age at full feeds preoperatively |
isolated CHD/non-isolated CHD: HLHS/TAPVR/TOF/CoA, IAA/TAS/TA/EA/HRHS |
unknown |
|
2893
|
age at which feeds initiated preoperatively |
isolated CHD/non-isolated CHD: HLHS/TAPVR/TOF/CoA, IAA/TAS/TA/EA/HRHS |
unknown |
|
2897
|
serum level of VEGF |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2898
|
serum level of VEGF |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2899
|
serum level of VEGF |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2900
|
serum level of PD-ECGF |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2901
|
serum level of PD-ECGF |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2902
|
serum level of PD-ECGF |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2903
|
serum level of Leptin |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2904
|
serum level of Leptin |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2905
|
serum level of Leptin |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2906
|
serum level of VEGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2907
|
serum level of leptin in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2908
|
serum level of leptin in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2909
|
serum levels of VEGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2910
|
serum levels of PD-ECGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2911
|
serum levels of VEGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2912
|
serum levels of VEGF in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2913
|
serum levels of PD-ECGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2914
|
serum levels of PD-ECGF in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2915
|
serum level of leptin in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2916
|
serum level of leptin in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2917
|
serum levels of VEGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2918
|
serum levels of VEGF in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2919
|
serum levels of PD-ECGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2920
|
serum levels of PD-ECGF in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2921
|
serum level of leptin in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2922
|
serum level of leptin in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2923
|
serum levels of VEGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2924
|
serum levels of VEGF in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2925
|
serum levels of PD-ECGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2926
|
serum levels of PD-ECGF in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2927
|
serum level of leptin in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2928
|
serum level of leptin in A-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2929
|
serum levels of VEGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2930
|
serum levels of VEGF in C-CHD patients |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2931
|
serum levels of VEGF in C-CHD patients detected by ECHO |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2932
|
serum levels of PD-ECGF in C-CHD detected by ECHO |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2933
|
serum level of leptin in C-CHD detected by ECHO |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2934
|
serum levels of VEGF in C-CHD patients detected by catheter |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2935
|
serum levels of PD-ECGF in C-CHD detected by catheter |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2936
|
serum level of leptin in C-CHD detected by catheter |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2937
|
correlation between VEGF and PD-ECGF/TP in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2938
|
correlation between VEGF and leptin in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2939
|
correlation between PD-ECGF/TP and leptin in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2940
|
correlation between VEGF and age in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2941
|
correlation between letpin and weight in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2943
|
correlation between VEGF and pulmonary pressure in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2944
|
correlation between VEGF and severity of PS in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2945
|
correlation between PD-ECGF/TP and severity of PS in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2946
|
correlation between leptin and severity of PS in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2947
|
correlation between VEGF and severity of aortic coarctation in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2948
|
correlation between PD-ECGF/TP and severity of aortic coarctation in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2949
|
correlation between leptin and severity of aortic coarctation in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unknown |
|
2950
|
(B-type natriuretic peptide )BNP concentrations |
isolated CHD: TOF/SV/HRV |
unknown |
|
2951
|
(B-type natriuretic peptide )BNP concentrations |
isolated CHD: TOF/SV/HRV |
unknown |
|
2952
|
B-type natriuretic peptide (BNP) concentrations |
isolated CHD: TOF/SV/HRV |
unknown |
|
2953
|
atrial natriuretic peptide (ANP) concentrations |
isolated CHD: TOF/SV/HRV |
unknown |
|
2956
|
PIGF(placental growth factor) |
isolated CHD/non-isolated CHD: NA |
unknown |
|
2959
|
MEE(measured resting energy expenditure) |
isolated CHD/non-isolated CHD: ASD/AVSD/VSD, ASD/AC/TGA/TOF/VSD/PA, VSD/TOF, PA/TAPVC/PA, VSD/TOF, PDA, RAA/PDA, ASD, AC/DORV, VSD, ASD, PS/PA, VSD |
unknown |
|
2960
|
correlation of MEE and Schofield equation |
isolated CHD/non-isolated CHD: ASD/AVSD/VSD, ASD/AC/TGA/TOF/VSD/PA, VSD/TOF, PA/TAPVC/PA, VSD/TOF, PDA, RAA/PDA, ASD, AC/DORV, VSD, ASD, PS/PA, VSD |
unknown |
|
2961
|
correlation of MEE and World Health Organization |
isolated CHD/non-isolated CHD: ASD/AVSD/VSD, ASD/AC/TGA/TOF/VSD/PA, VSD/TOF, PA/TAPVC/PA, VSD/TOF, PDA, RAA/PDA, ASD, AC/DORV, VSD, ASD, PS/PA, VSD |
unknown |
|
2962
|
correlation of MEE and PICU(pediatric intensive care unit) specific formula |
isolated CHD/non-isolated CHD: ASD/AVSD/VSD, ASD/AC/TGA/TOF/VSD/PA, VSD/TOF, PA/TAPVC/PA, VSD/TOF, PDA, RAA/PDA, ASD, AC/DORV, VSD, ASD, PS/PA, VSD |
unknown |
|
2965
|
using warfarin(%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
unknown |
|
2967
|
mortality event rates of hyponatraemic(after 1 year follow up) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
unknown |
|
2970
|
length of ICU stay |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
unknown |
|
2971
|
freedom from complications in postoperative course |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
unknown |
|
2977
|
death rate for adult patients with VSD |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2978
|
death rate for adult patients with PDA |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2979
|
death rate for adult patients with congenital aortic stenosis |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2980
|
death rate for adult patients with CoA |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2981
|
death rate for adult patients with EA |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2982
|
death rate for adult and children patients with TGA |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2983
|
death rate for adult and children patients with TOF |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2984
|
death rate for adult and children patients with PDA |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2985
|
death rate for adult and children patients with congeital aortic stenosis |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2986
|
death rate for adult and children patients with CoA |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2987
|
death rate for adult and children patients with ASD |
isolated CHD: ASD/VSD/PDA/SVAS/SAS/CoA/EA |
unknown |
|
2988
|
venoarterial pCO2 level |
isolated CHD/non-isolated CHD: TOF/VSD/ASD, VSD/ASD/AS/TGA/AVSD |
unknown |
|
2989
|
central venous oxygen saturation(ScvO2)< 70% |
isolated CHD/non-isolated CHD: TOF/VSD/ASD, VSD/ASD/AS/TGA/AVSD |
unknown |
|
2990
|
relationship between DpCO2 and central venous oxygen saturation(ScvO2) |
isolated CHD/non-isolated CHD: TOF/VSD/ASD, VSD/ASD/AS/TGA/AVSD |
unknown |
|
2991
|
FiO2 concentration |
isolated CHD/non-isolated CHD: TGA/PA/PS/CoA/HLHS/other |
unknown |
|
2992
|
relationship between FiO2 at departure and arterial pH on arrival at level III NICU |
isolated CHD/non-isolated CHD: TGA/PA/PS/CoA/HLHS/other |
unknown |
|
2993
|
relationship between FiO2 at departure and oxygen saturation on arrival at level III NICU |
isolated CHD/non-isolated CHD: TGA/PA/PS/CoA/HLHS/other |
unknown |
|
2994
|
inotropic support |
isolated CHD/non-isolated CHD: TGA/PA/PS/CoA/HLHS/other |
unknown |
|
2995
|
arterial PH |
isolated CHD/non-isolated CHD: TGA/PA/PS/CoA/HLHS/other |
unknown |
|
2996
|
pH<7.25 |
isolated CHD/non-isolated CHD: TGA/PA/PS/CoA/HLHS/other |
unknown |
|
2997
|
SpO2 concentration |
isolated CHD/non-isolated CHD: TGA/PA/PS/CoA/HLHS/other |
unknown |
|
2998
|
association between Fontan operation/conversion and severe morbidity |
NA: NA |
unknown |
|
2999
|
association between Cardiopulmonary bypass time(CPB) and severe morbidity |
NA: NA |
unknown |
|
3000
|
association between preoperative hematocrit and severe morbidity |
NA: NA |
unknown |
|
3001
|
association between previous number of operations and severe morbidity |
NA: NA |
unknown |
|
3002
|
association between preoperative congestive heart failure and severe morbidity |
NA: NA |
unknown |
|
3003
|
race(Asian) |
NA: NA |
unknown |
|
3009
|
epicardial/endocardial pacing |
isolated CHD: TOF/VSD |
unknown |
|
3010
|
indexed LV end-diastolic volume (ml/m2) |
isolated CHD: TOF/VSD |
unknown |
|
3011
|
indexed LV end-systolic volume (ml/m2) |
isolated CHD: TOF/VSD |
unknown |
|
3012
|
indexed LV end-systolic volume (ml/m2) |
isolated CHD: TOF/VSD |
unknown |
|
3013
|
LV ejection fraction |
isolated CHD: TOF/VSD |
unknown |
|
3014
|
LV ejection fraction |
isolated CHD: TOF/VSD |
unknown |
|
3015
|
LV systolic dyssynchrony index (SDI) |
isolated CHD: TOF/VSD |
unknown |
|
3016
|
LV systolic dyssynchrony index (SDI) |
isolated CHD: TOF/VSD |
unknown |
|
3017
|
LV systolic dyssynchrony index (SDI) |
isolated CHD: TOF/VSD |
unknown |
|
3021
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3022
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3023
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3024
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3025
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3026
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3027
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3028
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3029
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3030
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3031
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3032
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3033
|
time to minimum regional volume for each of the segments |
isolated CHD: TOF/VSD |
unknown |
|
3034
|
RR interval (ms) |
isolated CHD: TOF/VSD |
unknown |
|
3035
|
LV ejection fraction |
isolated CHD: TOF/VSD |
unknown |
|
3036
|
Pacing mode (VVI/DDD) |
isolated CHD: TOF/VSD |
unknown |
|
3037
|
RR interval (ms) |
isolated CHD: TOF/VSD |
unknown |
|
3038
|
LV systolic dyssynchrony index (SDI) |
isolated CHD: TOF/VSD |
unknown |
|
3039
|
RR interval (ms) |
isolated CHD: TOF/VSD |
unknown |
|
3040
|
correlation between RR interval and LV SDI |
isolated CHD: TOF/VSD |
unknown |
|
3041
|
correlation between RR interval and LV ejection fraction |
isolated CHD: TOF/VSD |
unknown |
|
3044
|
age at surgery (day) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3045
|
age at surgery (day) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3046
|
age at surgery (day) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3047
|
crossclamp time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3048
|
crossclamp time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3049
|
total support time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3050
|
total support time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3051
|
total bypass time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3052
|
total bypass time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3053
|
low-flow bypass time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3054
|
low-flow bypass time (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3055
|
duration of circulatory arrest (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3056
|
duration of circulatory arrest (min), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3057
|
nadir temperature (℃), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3058
|
nadir temperature (℃), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3059
|
highest PCO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3060
|
highest PCO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3061
|
lowest PCO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3062
|
lowest PCO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3063
|
lactate 60 min after bypass, mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3064
|
lactate 60 min after bypass, mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3065
|
12h postoperatively, mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3066
|
12h postoperatively, mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3067
|
24h postoperatively, mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3068
|
24h postoperatively, mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3069
|
lowest PaCO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3070
|
lowest PaCO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3071
|
lowest PaCO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3072
|
lowest PO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3073
|
lowest PO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3074
|
lowest PO2 (mm Hg), mean ± SD |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3075
|
days intubated, median (interquartile range) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3076
|
days intubated, median (interquartile range) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3077
|
any acquired or developmental abnormalities (no. and %) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3078
|
any acquired or developmental abnormalities (no. and %) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3079
|
any acquired or developmental abnormalities (no. and %) |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3080
|
brain mineralization/hemosiderin |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3081
|
brain mineralization/hemosiderin |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3082
|
brain mineralization/hemosiderin |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3083
|
PDI (psychomotor development index) score |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3084
|
association of hemosiderin with lower mean PDI score |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3085
|
association of higher nadir of intraoperative temperature and the presence of hemosiderin |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3086
|
association of higher nadir of postoperative PaCO2 and the presence of hemosiderin |
isolated CHD/non-isolated CHD: TGA, VSD/TOF, PA, TA/VSD |
unknown |
|
3087
|
survival percentage |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
unknown |
|
3088
|
survival percentage |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
unknown |
|
3089
|
association between survival rate with ischemic times |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
unknown |
|
3099
|
systolic blood pressure(SBP) across the stenosis (mm Hg) |
isolated CHD/non-isolated CHD: TOF/PA, IVS, PDA, ASD/CoA |
unknown |
|
3100
|
narrowest diameter of the stenotic vessels (mm) |
isolated CHD/non-isolated CHD: TOF/PA, IVS, PDA, ASD/CoA |
unknown |
|
3101
|
percentage of abnormal screening in best case scenario |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3102
|
percentage of abnormal screening in worst case scenario |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3103
|
percentage of abnormal screening CHD in worst case scenario |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3104
|
proportion of expected abnormal in best case scenario |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3105
|
proportion of expected abnormal in worst case scenario |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3106
|
proportion of expected abnormal in worst case scenario |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3107
|
percentage of missed prenatal screening of CHD |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3108
|
percentage of missed prenatal screening of CHD in the worst case scenario |
isolated CHD/non-isolated CHD: TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
unknown |
|
3109
|
respective percentage in the overall Austrian pediatric background population |
isolated CHD: ASD/VSD/AS/CoA/TGA/TOF/SV/other |
unknown |
|
3116
|
3rd or 4th laceration |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
unknown |
|
3117
|
post-partum hemorrhage |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
unknown |
|
3155
|
age (year) |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/SV/AVSD |
unknown |
|
3156
|
CEC counts in all sampling sites inclduing pulmonary artery, pulmonary vein and peripheral vein |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/SV/AVSD |
unknown |
|
3157
|
CEC counts in all sampling sites inclduing pulmonary artery, pulmonary vein and peripheral vein |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/SV/AVSD |
unknown |
|
3158
|
CEC counts in blood samples |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/SV/AVSD |
unknown |
|
3159
|
CEC counts in blood samples |
isolated CHD/non-isolated CHD: VSD/ASD, VSD/SV/AVSD |
unknown |
|
3160
|
Fluoxetine (SSRI) dose and exposure time during pregnacny |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3161
|
Sertraline (SSRI) dose and exposure time during pregnacny |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3162
|
Paroxetine prescription dose |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3163
|
Fluoxetine prescription dose |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3164
|
Citalopram prescription dose |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3165
|
Venlafaxine prescription dose |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3166
|
Fluoxetine prescription dose |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3167
|
Sertraline prescription dose |
isolated CHD/non-isolated CHD: VSD/VSD, other |
unknown |
|
3168
|
correlation between peak oxygen uptake and physical functioning |
isolated CHD/non-isolated CHD: TGA/TGA, AS/TOF/EA/PS/PR/AS/CoA/other |
unknown |
|
3169
|
correlation between peak oxygen uptake and general health |
isolated CHD/non-isolated CHD: TGA/TGA, AS/TOF/EA/PS/PR/AS/CoA/other |
unknown |
|
3170
|
combined with atrial fibrillation (AF) type of tachyarrhythmias |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3171
|
β-blocker at administration of sotalol (n) |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3172
|
NYHA more than level III (n) |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3173
|
maintenance dose of sotalol |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3174
|
maintenance dose of sotalol |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3175
|
correlation between the dose of sotalol and minimum heart rate (HR) |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3177
|
effects of sotalol on minimum heart rate (HR, beats/min) with Holter ECG |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3178
|
effects of sotalol on maximum heart rate (HR, beats/min) with Holter ECG |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3179
|
effects of sotalol on mean heart rate (HR, beats/min) with Holter ECG |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3180
|
effects of sotalol on maximum heart rate (HR, beats/min) with treadmill |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3181
|
effects of sotalol on QTc in V5 (ms) |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
unknown |
|
3189
|
manifestation of postinterventional IE |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
unknown |
|
3190
|
risk of IE with foreign material implantation |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
unknown |
|
3196
|
age (year) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3197
|
Cyanosis (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3198
|
NYHA class I/II/III/IV (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3199
|
Diuretics (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3200
|
ACEI/ARB (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3201
|
β-blockers (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3202
|
Digoxin (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3203
|
Warfarin (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3204
|
Aspirin (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3205
|
repair or previous stemotomy: single/>=2 (%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3206
|
glomerular filtration rate (GFR) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3207
|
prevalence of moderately and severely reduced glomerular filtration rate (GFR) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3208
|
glomerular filtration rate (GFR) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3209
|
prevalence of moderate or severe GFR impairement |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3210
|
glomerular filtration rate (GFR) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
unknown |
|
3219
|
proportion of high-risk scores on the BASC |
isolated CHD/non-isolated CHD: HLHS/TGA, IVS/TGA, VSD/TOF/TOF, PA/VSD, CoA/VSD, IAA/other |
unknown |
|
3220
|
proportion of high-risk scores on the BASC |
isolated CHD/non-isolated CHD: HLHS/TGA, IVS/TGA, VSD/TOF/TOF, PA/VSD, CoA/VSD, IAA/other |
unknown |
|
3221
|
proportion of high-risk scores on the BASC |
isolated CHD/non-isolated CHD: HLHS/TGA, IVS/TGA, VSD/TOF/TOF, PA/VSD, CoA/VSD, IAA/other |
unknown |
|
3222
|
proportion of high-risk scores on the BASC |
isolated CHD/non-isolated CHD: HLHS/TGA, IVS/TGA, VSD/TOF/TOF, PA/VSD, CoA/VSD, IAA/other |
unknown |
|
3223
|
hospital readimission |
isolated CHD/non-isolated CHD: TA/TGA/TOF/UVH/AVC/HLHS/VSD/ASD/UDSC/APA/TVD/EA/AS/AI/MS/MI/PDA/CoA/AGV/other |
unknown |
|
3224
|
severe CHD lesion |
isolated CHD/non-isolated CHD: TA/TGA/TOF/UVH/AVC/HLHS/VSD/ASD/UDSC/APA/TVD/EA/AS/AI/MS/MI/PDA/CoA/AGV/other |
unknown |
|
3225
|
younger age |
isolated CHD/non-isolated CHD: TA/TGA/TOF/UVH/AVC/HLHS/VSD/ASD/UDSC/APA/TVD/EA/AS/AI/MS/MI/PDA/CoA/AGV/other |
unknown |
|
3226
|
> 1 emergency department visits in the 6 months preceding in the index hospitalization |
isolated CHD/non-isolated CHD: TA/TGA/TOF/UVH/AVC/HLHS/VSD/ASD/UDSC/APA/TVD/EA/AS/AI/MS/MI/PDA/CoA/AGV/other |
unknown |
|
3227
|
length of stay > 14 days |
isolated CHD/non-isolated CHD: TA/TGA/TOF/UVH/AVC/HLHS/VSD/ASD/UDSC/APA/TVD/EA/AS/AI/MS/MI/PDA/CoA/AGV/other |
unknown |
|
3228
|
the presence of > 4 ICD-9 diagnoses (other cardiac diagnoses or comorbid conditions) during the index hospitalization |
isolated CHD/non-isolated CHD: TA/TGA/TOF/UVH/AVC/HLHS/VSD/ASD/UDSC/APA/TVD/EA/AS/AI/MS/MI/PDA/CoA/AGV/other |
unknown |
|
3229
|
hospital discharge on a Friday or a Saturday |
isolated CHD/non-isolated CHD: TA/TGA/TOF/UVH/AVC/HLHS/VSD/ASD/UDSC/APA/TVD/EA/AS/AI/MS/MI/PDA/CoA/AGV/other |
unknown |
|
3230
|
final CVP (cardiovascular profile) score |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
unknown |
|
3235
|
age (months, median ) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3236
|
weight(kg, median) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3237
|
height(cm, median) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3238
|
Surgical complexity (RACHS-1 category I) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3239
|
CPB duration (minutes, median) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3240
|
IS (inotropes score, median) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3241
|
CK-MB (μg/mL, median) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3248
|
death during ICU stay |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3249
|
survivor length of stay (LOS) in ICU |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3250
|
survivor length of stay (LOS) in ICU >= 2days |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unknown |
|
3270
|
body weight (mean&SD) |
NA: NA |
unknown |
|
3271
|
SMWTd (six-minute walk test distance) test after being treated with bosentan for 0-6months |
isolated CHD/non-isolated CHD: ASD/VSD/PAD/AP window/AVSD/SV |
unknown |
|
3272
|
SMWTd test after being treated with bosentan for 6-12months |
isolated CHD/non-isolated CHD: ASD/VSD/PAD/AP window/AVSD/SV |
unknown |
|
3273
|
SMWTd test after being treated with bosentan for 1-2years |
isolated CHD/non-isolated CHD: ASD/VSD/PAD/AP window/AVSD/SV |
unknown |
|
3274
|
arterial saturation (mean(SD)) |
isolated CHD/non-isolated CHD: ASD/VSD/PAD/AP window/AVSD/SV |
unknown |
|
3275
|
VO2peak(mL·kg·min) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3276
|
VO2peak(% of predicted) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3277
|
VO2AT |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3278
|
VE/VCO2peak |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3279
|
VE/VO2AT |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3280
|
N-BNP(pg/mL) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3281
|
Re operation (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3282
|
NYHA class I/II/III/IV (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3283
|
Resting HR (/min) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3284
|
Maximal HR at peak exercise (/min) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3285
|
Peacemaker (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3286
|
β-blocker (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3287
|
Digoxin (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3288
|
ACE inhibitor (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3289
|
Diuretics (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3290
|
VO2peak(mL·kg·min) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3291
|
VO2peak(% of predicted) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3292
|
VO2AT |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3293
|
VE/VCO2peak |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3294
|
VE/VO2AT |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3295
|
N-BNP(pg/mL) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3296
|
NYHA class I/II/III/IV (%) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3297
|
Maximal HR at peak exercise (/min) |
isolated CHD/non-isolated CHD: LTRS/D-TGA/TOF/SV/AVD/PVD/AC/other |
unknown |
|
3298
|
age |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
unknown |
|
3308
|
Symptoms on presentation |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
unknown |
|
3316
|
Hospital mortality |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
unknown |
|
3317
|
mean ICU stay |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3318
|
Logistic Organ Dysfunction System(LODS) |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3319
|
Organ Dysfunction and/or Infection (ODIN) |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3320
|
EuroSCORE |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3321
|
Ontario score |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3322
|
TISS-28 score |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3323
|
theatre time (including elective and emergency surgery) |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3324
|
pre-operative abnormal thyroid function test |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3325
|
elevated creatinine levels |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3326
|
bilirubin levels |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3327
|
complexity of the underlying cardiac diagnosis |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3328
|
history of cardiac arrhythmia |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3329
|
need for emergency admission |
isolated CHD/non-isolated CHD: AV/AV, other/CoA/VSD/ASD/Sinus venosus ASD/AVSD/TOF/EA/PS/PA, VSD/TGA/ccTGA/ES/LA |
unknown |
|
3330
|
wall thickness of arteries with external diameter=50-100μm |
NA: NA |
unknown |
|
3331
|
wall thickness of arteries with external diameter=50-100μm |
NA: NA |
unknown |
|
3332
|
wall thickness of arteries with external diameter=100-200μm |
NA: NA |
unknown |
|
3333
|
wall thickness of arteries with external diameter=100-200μm |
NA: NA |
unknown |
|
3334
|
cells expression level of caspase-3 |
NA: NA |
unknown |
|
3335
|
cells expression level of p53 |
NA: NA |
unknown |
|
3336
|
cells expression level of caspase-3 by inflammatory cells |
NA: NA |
unknown |
|
3337
|
cells expression level of p53 by inflammatory cells |
NA: NA |
unknown |
|
3338
|
pulmonary vascular iNOS expression level |
NA: NA |
unknown |
|
3339
|
pulmonary vascular iNOS expression level |
NA: NA |
unknown |
|
3340
|
eNOS scores |
NA: NA |
unknown |
|
3341
|
eNOS expression level |
NA: NA |
unknown |
|
3342
|
vascular endothelial growth factor expression |
NA: NA |
unknown |
|
3343
|
correlation between eNOS expression and VEGF expression |
NA: NA |
unknown |
|
3345
|
Reexploration all (including reexploration for bleeding and reintervention |
isolated CHD/non-isolated CHD: SV/HLHS/PA, IVS/AVC/CAT/TOF/DORV/TAPVC/IAA, VSD/PA, VSD |
unknown |
|
3346
|
MSOF |
isolated CHD/non-isolated CHD: SV/HLHS/PA, IVS/AVC/CAT/TOF/DORV/TAPVC/IAA, VSD/PA, VSD |
unknown |
|
3347
|
No complications |
isolated CHD/non-isolated CHD: SV/HLHS/PA, IVS/AVC/CAT/TOF/DORV/TAPVC/IAA, VSD/PA, VSD |
unknown |
|
3348
|
>2 complications |
isolated CHD/non-isolated CHD: SV/HLHS/PA, IVS/AVC/CAT/TOF/DORV/TAPVC/IAA, VSD/PA, VSD |
unknown |
|
3349
|
Duration >120h |
isolated CHD/non-isolated CHD: SV/HLHS/PA, IVS/AVC/CAT/TOF/DORV/TAPVC/IAA, VSD/PA, VSD |
unknown |
|
3350
|
BMI |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3351
|
maternal tHcy concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3352
|
serum folate concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3353
|
serum Vitamin B12 concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3354
|
educational level |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3355
|
smoking behavior |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3356
|
serum and RBC folate concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3357
|
formula fed |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3358
|
serum folate concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3359
|
RBC folate concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3360
|
serum folate concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3361
|
RBC folate concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3362
|
increasing maternal tHcy concentration |
isolated CHD: TOF/TGA/AVSD/VSD/CoA/AVS/PVS/HLHS |
unknown |
|
3364
|
Gender (% male) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3365
|
Deaths |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3366
|
NYHA functional class I/II/III (%) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3367
|
Cyanosis (%) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3368
|
Class I-IV anti-arrhythmic drugs (%) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3369
|
Antiarrhythmic drugs incl. digoxin (%) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3370
|
Amiodarone (%) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3371
|
Sotalol (%) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3372
|
ACE inhibitors (%) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3373
|
Heart rate reserve (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3374
|
Chronotropic index |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3375
|
Peak VO2 (ml/kg/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3376
|
Percentage age-predicted heart rate (ml/kg/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3377
|
Peak pulse (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3378
|
Resting pulse (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3379
|
correlation between heart rate reserve and peak heart rate |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3400
|
heart rate reserve |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
unknown |
|
3424
|
Gender (% male) |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3425
|
BMI (kg/m2) |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3426
|
NYHA (% in class I/II/III) |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3427
|
Oxygen saturation (resting) % |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3428
|
VE/VCO2 slope |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3429
|
Peak VCO2 mL/kg/min |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3430
|
RER at peak exercise |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3431
|
Mean VE/VCO2 slope |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3432
|
VE/VCO2 slope |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3433
|
correlation between VE/VCO2 slope and resting oxygen saturations in the cyanotic group |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3434
|
Peak VO2 mL/kg/min |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3436
|
VE/VCO2 slope |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3440
|
correlation between VE/VCO2 slope and cumulative survival rate |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unknown |
|
3441
|
age (months) |
NA: NA |
unknown |
|
3442
|
Duration of PICU stay (days) |
NA: NA |
unknown |
|
3444
|
open-heart surgery |
NA: NA |
unknown |
|
3446
|
PRISM score: 7 days after admission |
NA: NA |
unknown |
|
3454
|
antibiotic treatment (Duration, days) |
NA: NA |
unknown |
|
3458
|
VO2max (mL/min/kg) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3459
|
NT-pro-BNP (pg/mL) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3460
|
QRS duration (ms) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3461
|
Heart rate at rest (1/min) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3462
|
maximum heart rate (1/min) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3463
|
maximum systolic blood pressure (mmHg) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3464
|
right ventricular ED (mm) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3465
|
TV insufficiency velocity (m/s) |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3466
|
heart failure occurance |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3467
|
chronotropic incompetence |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3470
|
heart failure occurance |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3471
|
heart failure occurance |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3472
|
heart failure occurance |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3473
|
chronotropic incompetence occurance |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3474
|
chronotropic incompetence occurance |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3475
|
chronotropic incompetence occurance |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
unknown |
|
3476
|
VO2max (mL/min/kg) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3477
|
NT-pro-BNP (pg/mL) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3478
|
Age (yrs) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3479
|
age at operation (yrs) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3480
|
reoperation (%) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3481
|
NYHA class I/II/III/IV (%) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3482
|
QRS complex duration (ms) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3483
|
maximum heart rate under exercise (beats/min) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3484
|
maximum SBP under exercise (mmHg) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3485
|
right ventricular ED (mm) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3486
|
TV insufficiency velocity (m/s) |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3487
|
β blocker treatment |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3488
|
Digoxin treatment |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3489
|
ACE inhibitor treatment |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3490
|
Diuretic treatment |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
unknown |
|
3497
|
MV time (hours) |
isolated CHD/non-isolated CHD: VSD/TOF/ASD/PDA/SS/TA/PA, VSD/TAPVC/CoA/CAVC/PA, IVS/DORV/D-TGA/TA/other |
unknown |
|
3498
|
MV time (hours) |
isolated CHD/non-isolated CHD: VSD/TOF/ASD/PDA/SS/TA/PA, VSD/TAPVC/CoA/CAVC/PA, IVS/DORV/D-TGA/TA/other |
unknown |
|
3500
|
correlation between factor V Leiden and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3501
|
correlation between arterial saturation (%) and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3502
|
correlation between age (<6months) and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3503
|
correlation between Factor VIII (C level) and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3504
|
correlation between female gender and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3505
|
correlation between constant and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3506
|
correlation between Factor V Leiden and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3507
|
correlation between arterial saturation (%) and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3508
|
correlation between FVIII (C level, % normal plasma) and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3509
|
correlation between female gender and aPC ratio |
isolated CHD/non-isolated CHD: ASD/PDA/TGA/AS/HLHS/TOF/AVC/DORV/PA, VSD/PS/TA/TAS/DILV/SAS/EA/other/PA, IVS/CoA/MAS/MVP/AVSD/CACA |
unknown |
|
3534
|
outcome measured by death |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
unknown |
|
3535
|
outcome measured by cardiovascular compromise |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
unknown |
|
3536
|
outcome measured by end organ dysfunction |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
unknown |
|
3543
|
DV-PIV (median of Mo95th) |
isolated CHD/non-isolated CHD: AVSD/PA/PA, TA, VSD/DORV, TGA, VSD/CAT/TA, PA, VSD, HRV/TA, VSD/HLHS/HLHS, ECFE |
unknown |
|
3544
|
association between DV-PIV (median of Mo95th) with mortality of AVSD |
isolated CHD/non-isolated CHD: AVSD/PA/PA, TA, VSD/DORV, TGA, VSD/CAT/TA, PA, VSD, HRV/TA, VSD/HLHS/HLHS, ECFE |
unknown |
|
3545
|
association between DV-PIV (median of Mo95th) with mortality of abnormalities affecting predominantly the right ventricle |
isolated CHD/non-isolated CHD: AVSD/PA/PA, TA, VSD/DORV, TGA, VSD/CAT/TA, PA, VSD, HRV/TA, VSD/HLHS/HLHS, ECFE |
unknown |
|
3546
|
correlation between linear analogue scale and the satisfaction with life scale |
isolated CHD: TOF/VSD/CoA/AVS/PVS/ccTGA |
unknown |
|
3547
|
correlation between linear analogue scale and SEIQoL-DW |
isolated CHD: TOF/VSD/CoA/AVS/PVS/ccTGA |
unknown |
|
3548
|
correlation between low cut-off boundaries (0.1-0.3) |
isolated CHD: TOF/VSD/CoA/AVS/PVS/ccTGA |
unknown |
|
3549
|
correlation between moderate cut-off boundaries (0.3-0.5) |
isolated CHD: TOF/VSD/CoA/AVS/PVS/ccTGA |
unknown |
|
3550
|
health status |
isolated CHD: TOF/VSD/CoA/AVS/PVS/ccTGA |
unknown |
|
3551
|
infundibulectomy |
isolated CHD/non-isolated CHD: TOF, PA/TOF/VSD, DCRV/VSD/ASD, VSD, PDA/TGA, VSD, PS |
unknown |
|
3552
|
TOF |
isolated CHD/non-isolated CHD: TOF, PA/TOF/VSD, DCRV/VSD/ASD, VSD, PDA/TGA, VSD, PS |
unknown |
|
3553
|
intraventricular re-routing vs. arterial switch |
isolated CHD/non-isolated CHD: TOF, PA/TOF/VSD, DCRV/VSD/ASD, VSD, PDA/TGA, VSD, PS |
unknown |
|
3554
|
reoperation |
isolated CHD/non-isolated CHD: TOF, PA/TOF/VSD, DCRV/VSD/ASD, VSD, PDA/TGA, VSD, PS |
unknown |
|
3555
|
false-negative results |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/total AVSD/p-AVSD/TAPVD/PAPVD/AC/AOS/CoA/HLHS/HRHS/EA/PS/PA/TOF/TGA/ccTGA/DORV/SV/other |
unknown |
|
3556
|
accuracy rate |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/total AVSD/p-AVSD/TAPVD/PAPVD/AC/AOS/CoA/HLHS/HRHS/EA/PS/PA/TOF/TGA/ccTGA/DORV/SV/other |
unknown |
|
3557
|
Baseline HR (heart rate) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3558
|
Baseline HR (heart rate) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3559
|
Baseline HR (heart rate) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3560
|
Baseline HR (heart rate) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3561
|
NCR (negative chronotropic response) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3562
|
NCR (negative chronotropic response) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3563
|
NCR (negative chronotropic response) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3564
|
NCR (negative chronotropic response) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3565
|
NCR (negative chronotropic response) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3566
|
cNCR [corrected NCR] |
isolated CHD: ASD/VSD/other |
unknown |
|
3567
|
cNCR [corrected NCR] |
isolated CHD: ASD/VSD/other |
unknown |
|
3568
|
cNCR [corrected NCR] |
isolated CHD: ASD/VSD/other |
unknown |
|
3569
|
cNCR [corrected NCR] |
isolated CHD: ASD/VSD/other |
unknown |
|
3570
|
cNCR [corrected NCR] |
isolated CHD: ASD/VSD/other |
unknown |
|
3571
|
cNCR [corrected NCR] |
isolated CHD: ASD/VSD/other |
unknown |
|
3572
|
PST (cardiac parasympathetic nervous tone) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3573
|
PST (cardiac parasympathetic nervous tone) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3574
|
PST (cardiac parasympathetic nervous tone) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3575
|
PST (cardiac parasympathetic nervous tone) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3576
|
PST (cardiac parasympathetic nervous tone) (bpm) |
isolated CHD: ASD/VSD/other |
unknown |
|
3577
|
cPST (corrected parasympathetic nervous tone) |
isolated CHD: ASD/VSD/other |
unknown |
|
3578
|
cPST (corrected parasympathetic nervous tone) |
isolated CHD: ASD/VSD/other |
unknown |
|
3579
|
cPST (corrected parasympathetic nervous tone) |
isolated CHD: ASD/VSD/other |
unknown |
|
3580
|
cPST (corrected parasympathetic nervous tone) |
isolated CHD: ASD/VSD/other |
unknown |
|
3581
|
cPST (corrected parasympathetic nervous tone) |
isolated CHD: ASD/VSD/other |
unknown |
|
3582
|
β sensitivity of the sinus node |
isolated CHD: ASD/VSD/other |
unknown |
|
3583
|
β sensitivity of the sinus node |
isolated CHD: ASD/VSD/other |
unknown |
|
3584
|
β sensitivity of the sinus node |
isolated CHD: ASD/VSD/other |
unknown |
|
3585
|
β sensitivity of the sinus node |
isolated CHD: ASD/VSD/other |
unknown |
|
3586
|
log LF (low frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3587
|
log LF (low frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3588
|
log LF (low frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3589
|
log LF (low frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3590
|
log LF (low frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3591
|
log HF (high frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3592
|
log HF (high frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3593
|
log HF (high frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3594
|
log HF (high frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3595
|
log HF (high frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3596
|
log HF (high frequency component of the heart rate variability) |
isolated CHD: ASD/VSD/other |
unknown |
|
3597
|
BRS (baroreflex sensitivity) (msec/mm Hg) |
isolated CHD: ASD/VSD/other |
unknown |
|
3598
|
BRS (baroreflex sensitivity) (msec/mm Hg) |
isolated CHD: ASD/VSD/other |
unknown |
|
3599
|
BRS (baroreflex sensitivity) (msec/mm Hg) |
isolated CHD: ASD/VSD/other |
unknown |
|
3600
|
BRS (baroreflex sensitivity) (msec/mm Hg) |
isolated CHD: ASD/VSD/other |
unknown |
|
3601
|
BRS (baroreflex sensitivity) (msec/mm Hg) |
isolated CHD: ASD/VSD/other |
unknown |
|
3602
|
NE (norepinephrine level) (pg/mL) |
isolated CHD: ASD/VSD/other |
unknown |
|
3603
|
NE (norepinephrine level) (pg/mL) |
isolated CHD: ASD/VSD/other |
unknown |
|
3604
|
NE (norepinephrine level) (pg/mL) |
isolated CHD: ASD/VSD/other |
unknown |
|
3605
|
Endurance time (min) |
isolated CHD: ASD/VSD/other |
unknown |
|
3606
|
Endurance time (min) |
isolated CHD: ASD/VSD/other |
unknown |
|
3607
|
Endurance time (min) |
isolated CHD: ASD/VSD/other |
unknown |
|
3608
|
Endurance time (min) |
isolated CHD: ASD/VSD/other |
unknown |
|
3609
|
Endurance time (min) |
isolated CHD: ASD/VSD/other |
unknown |
|
3610
|
Endurance time (min) |
isolated CHD: ASD/VSD/other |
unknown |
|
3611
|
Peak VO2 |
isolated CHD: ASD/VSD/other |
unknown |
|
3612
|
Peak VO2 |
isolated CHD: ASD/VSD/other |
unknown |
|
3613
|
Peak VO2 |
isolated CHD: ASD/VSD/other |
unknown |
|
3614
|
Peak VO2 |
isolated CHD: ASD/VSD/other |
unknown |
|
3615
|
Peak VO2 |
isolated CHD: ASD/VSD/other |
unknown |
|
3616
|
Heart rate (rest) |
isolated CHD: ASD/VSD/other |
unknown |
|
3617
|
Heart rate (rest) |
isolated CHD: ASD/VSD/other |
unknown |
|
3618
|
Heart rate (rest) |
isolated CHD: ASD/VSD/other |
unknown |
|
3619
|
Heart rate (peak) |
isolated CHD: ASD/VSD/other |
unknown |
|
3620
|
Heart rate (peak) |
isolated CHD: ASD/VSD/other |
unknown |
|
3621
|
Heart rate (peak) |
isolated CHD: ASD/VSD/other |
unknown |
|
3622
|
Heart rate (peak) |
isolated CHD: ASD/VSD/other |
unknown |
|
3623
|
Heart rate (peak) |
isolated CHD: ASD/VSD/other |
unknown |
|
3624
|
Heart rate (Delta-HRp) |
isolated CHD: ASD/VSD/other |
unknown |
|
3625
|
Heart rate (Delta-HRp) |
isolated CHD: ASD/VSD/other |
unknown |
|
3626
|
Heart rate (Delta-HRp) |
isolated CHD: ASD/VSD/other |
unknown |
|
3627
|
Heart rate (Delta-HRp) |
isolated CHD: ASD/VSD/other |
unknown |
|
3628
|
Heart rate (Delta-HRp) |
isolated CHD: ASD/VSD/other |
unknown |
|
3629
|
major determinants of a higher cNCR (impaired NCR) in the complex patients: log LF |
isolated CHD: ASD/VSD/other |
unknown |
|
3630
|
major determinants of a higher cNCR (impaired NCR) in the complex patients: log HF |
isolated CHD: ASD/VSD/other |
unknown |
|
3631
|
major determinants of a higher cNCR (impaired NCR) in the complex patients: cPST |
isolated CHD: ASD/VSD/other |
unknown |
|
3632
|
major determinants of a higher cNCR (impaired NCR) in the complex patients:ANP(natriuretic peptides) |
isolated CHD: ASD/VSD/other |
unknown |
|
3633
|
major determinants of a higher cNCR (impaired NCR) in the fontan patients:cPST |
isolated CHD: ASD/VSD/other |
unknown |
|
3634
|
major determinants of a higher cNCR (impaired NCR) in the fontan patients: c-β |
isolated CHD: ASD/VSD/other |
unknown |
|
3635
|
Supplemental O2 (%) |
NA: NA |
unknown |
|
3636
|
Duration of supplemental O2 |
NA: NA |
unknown |
|
3637
|
ICU admission (%)` |
NA: NA |
unknown |
|
3638
|
Duration of ICU stay |
NA: NA |
unknown |
|
3639
|
Mechanical ventilation (%) |
NA: NA |
unknown |
|
3640
|
Duration of mechanical ventilation |
NA: NA |
unknown |
|
3641
|
Death (%) |
NA: NA |
unknown |
|
3642
|
RSV hospitalisation rates in CHD of age <6 months |
NA: NA |
unknown |
|
3643
|
RSV hospitalisation rates in CHD of age <12 months |
NA: NA |
unknown |
|
3644
|
RSV hospitalisation rates in CHD of age with 12-24 months |
NA: NA |
unknown |
|
3645
|
RSV hospitalisation rates in CHD of age <24 months |
NA: NA |
unknown |
|
3646
|
Numbers of CHD patients needed to treat (NNT) with palivizumab for prevention of one hospitalisation: < 6 months |
NA: NA |
unknown |
|
3647
|
Numbers of CHD patients needed to treat (NNT) with palivizumab for prevention of one hospitalisation: <12 months |
NA: NA |
unknown |
|
3648
|
Numbers of CHD patients needed to treat (NNT) with palivizumab for prevention of one hospitalisation: 12 -24 months |
NA: NA |
unknown |
|
3649
|
Numbers of CHD patients needed to treat (NNT) with palivizumab for prevention of one hospitalisation: <24 months |
NA: NA |
unknown |
|
3650
|
prediction of YASR(Young adult self reported)internalising :sex(male) |
NA: NA |
unknown |
|
3651
|
prediction of YASR(Young adult self reported)internalising : restrictions by scar experienced by patients |
NA: NA |
unknown |
|
3652
|
prediction of YASR(Young adult self reported)internalising : maximum exercise capacity in |
NA: NA |
unknown |
|
3653
|
prediction of YASR(Young adult self reported)externalising: cardiac diagnosis:VSD |
isolated CHD: VSD/ASD |
unknown |
|
3654
|
prediction of YASR(Young adult self reported)externalising: cardiac diagnosis:TGA |
isolated CHD: VSD/ASD |
unknown |
|
3655
|
prediction of YASR(Young adult self reported)externalising: scar judged by physician |
isolated CHD: NA |
unknown |
|
3656
|
prediction of YASR(Young adult self reported)externalising: restricions by scar experienced by patients |
isolated CHD: NA |
unknown |
|
3657
|
prediction of YASR(Young adult self reported) total problems:sex(male) |
NA: NA |
unknown |
|
3658
|
prediction of YASR(Young adult self reported) total problems: restricions imposed by physician |
isolated CHD: NA |
unknown |
|
3659
|
prediction of YASR(Young adult self reported) total problems: cardiac diagnosis: scar judged by physician |
isolated CHD: NA |
unknown |
|
3660
|
prediction of YASR(Young adult self reported) total problems: restricions by scar experienced by patients |
isolated CHD: NA |
unknown |
|
3661
|
prediction of YASR(Young adult self reported) total problems: maximum exercise capacity in |
isolated CHD: NA |
unknown |
|
3662
|
prediction of YABCL(Young adult behavior checklist) internalising:hospitalisations without reoperations |
isolated CHD: NA |
unknown |
|
3663
|
prediction of YABCL(Young adult behavior checklist) internalising: hospitalisations with reoperations |
isolated CHD: NA |
unknown |
|
3664
|
prediction of YABCL(Young adult behavior checklist) externalising: hospitalisations with reoperations |
isolated CHD: NA |
unknown |
|
3665
|
prediction of YABCL(Young adult behavior checklist) externalising: restricions by scar experienced by patients |
isolated CHD: NA |
unknown |
|
3666
|
prediction of YABCL(Young adult behavior checklist) externalising: pacemaker |
isolated CHD: NA |
unknown |
|
3667
|
prediction of YABCL(Young adult behavior checklist) total problems: cardiac diagnosis:VSD |
isolated CHD: VSD/ASD |
unknown |
|
3668
|
prediction of YABCL(Young adult behavior checklist) total problems: hospitalisations without reoperations |
isolated CHD: VSD/ASD |
unknown |
|
3669
|
prediction of YABCL(Young adult behavior checklist) total problems: hospitalisations with reoperations |
isolated CHD: VSD/ASD |
unknown |
|
3670
|
prediction of YABCL(Young adult behavior checklist) total problems: restricions by scar experienced by patients |
isolated CHD: VSD/ASD |
unknown |
|
3675
|
ADM (adrenomedullin) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3676
|
ADM (adrenomedullin) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3677
|
ADM (adrenomedullin) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3678
|
endothelin-1(ET-1) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3679
|
endothelin-1(ET-1) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3680
|
nitric oxide (NO) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3681
|
nitric oxide (NO) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3682
|
ADM (adrenomedullin) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3683
|
endothelin-1(ET-1) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3684
|
ADM (adrenomedullin) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3685
|
ADM (adrenomedullin) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3686
|
endothelin-1(ET-1) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3687
|
endothelin-1(ET-1) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3688
|
nitric oxide (NO) |
isolated CHD: VSD/ASD/PDA |
unknown |
|
3689
|
symptomatic |
isolated CHD/non-isolated CHD: LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
unknown |
|
3690
|
The prevalence of effusion |
isolated CHD/non-isolated CHD: LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
unknown |
|
3692
|
Types of operation: Left to right shunt repair |
isolated CHD/non-isolated CHD: LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
unknown |
|
3694
|
Magnesium values at 6 hours after bypass |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
unknown |
|
3695
|
Magnesium values at 18 hours after bypass |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
unknown |
|
3696
|
No. of postoperative arrhythmias |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
unknown |
|
3697
|
Lower patient weight |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
unknown |
|
3698
|
longer cardiopulmonary bypass time |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
unknown |
|
3699
|
Aortic cross-clamp time (min) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
unknown |
|
3700
|
deeper body temperature during extracorporeal circulation |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
unknown |
|
3701
|
Age |
isolated CHD/non-isolated CHD: AP window/ASD/VSD/AVSD/MVD/other/PDA/PAH/TOF/VSD, RVOTO |
unknown |
|
3702
|
Weight |
isolated CHD/non-isolated CHD: AP window/ASD/VSD/AVSD/MVD/other/PDA/PAH/TOF/VSD, RVOTO |
unknown |
|
3703
|
BSA (body surface area) |
isolated CHD/non-isolated CHD: AP window/ASD/VSD/AVSD/MVD/other/PDA/PAH/TOF/VSD, RVOTO |
unknown |
|
3704
|
Heart rate |
isolated CHD/non-isolated CHD: AP window/ASD/VSD/AVSD/MVD/other/PDA/PAH/TOF/VSD, RVOTO |
unknown |
|
3705
|
VO2(oxygen consumption)/BSA |
isolated CHD/non-isolated CHD: AP window/ASD/VSD/AVSD/MVD/other/PDA/PAH/TOF/VSD, RVOTO |
unknown |
|
3714
|
risk factors for conduit failure: age at conduit operation |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
unknown |
|
3715
|
risk factors for conduit failure: age at conduit operation |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
unknown |
|
3723
|
Duration of heart failure (months) |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
unknown |
|
3725
|
Status I at initial listing |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
unknown |
|
3726
|
Multi-system organ failure |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
unknown |
|
3727
|
Mean number of surgeries |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
unknown |
|
3728
|
Fifty-day actuarial survival on the waiting list |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
unknown |
|
3729
|
died waiting |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
unknown |
|
3730
|
NO |
NA: NA |
unknown |
|
3731
|
Patients who underwent palliation |
NA: AF/intra-atrial reentry tachycardia |
unknown |
|
3732
|
Patients with residual (Resid) left ventricular (LV) valvular lesions |
NA: AF/intra-atrial reentry tachycardia |
unknown |
|
3733
|
underwent ≥ 3 cardioversions |
NA: AF/intra-atrial reentry tachycardia |
unknown |
|
3734
|
Myocardial gene expression: β1-receptor |
isolated CHD/non-isolated CHD: AVSD/VSD/PA/RV-PA-Cd/TOF/PI/DILV/L-TGA/PAB/TA/AP window/DILV, L-TGA/DORV, SPS/MA/AVSD, CoA, PAB/TA, CoA, PAB |
unknown |
|
3735
|
Myocardial gene expression: β2-receptor |
isolated CHD/non-isolated CHD: AVSD/VSD/PA/RV-PA-Cd/TOF/PI/DILV/L-TGA/PAB/TA/AP window/DILV, L-TGA/DORV, SPS/MA/AVSD, CoA, PAB/TA, CoA, PAB |
unknown |
|
3736
|
SaO2(%) |
isolated CHD/non-isolated CHD: AVSD/VSD/PA/RV-PA-Cd/TOF/PI/DILV/L-TGA/PAB/TA/AP window/DILV, L-TGA/DORV, SPS/MA/AVSD, CoA, PAB/TA, CoA, PAB |
unknown |
|
3737
|
Myocardial β2-receptor gene expression |
isolated CHD/non-isolated CHD: AVSD/VSD/PA/RV-PA-Cd/TOF/PI/DILV/L-TGA/PAB/TA/AP window/DILV, L-TGA/DORV, SPS/MA/AVSD, CoA, PAB/TA, CoA, PAB |
unknown |
|
3738
|
Correlation between Ross score and β2-receptor gene expression |
isolated CHD/non-isolated CHD: AVSD/VSD/PA/RV-PA-Cd/TOF/PI/DILV/L-TGA/PAB/TA/AP window/DILV, L-TGA/DORV, SPS/MA/AVSD, CoA, PAB/TA, CoA, PAB |
unknown |
|
3740
|
arterial gradient |
isolated CHD: TOF/PA/CBPS/TR |
unknown |
|
3741
|
the RV/FA ratio |
isolated CHD: TOF/PA/CBPS/TR |
unknown |
|
3742
|
mean systolic gradient |
isolated CHD: TOF/PA |
unknown |
|
3743
|
mean vessel diameter |
isolated CHD: TOF/PA |
unknown |
|
3744
|
mean RV/FA pressure ratio |
isolated CHD: TOF/PA |
unknown |
|
3745
|
mean systolic gradient |
isolated CHD: CBPS |
unknown |
|
3746
|
mean vessel diameter |
isolated CHD: CBPS |
unknown |
|
3747
|
RV/FA pressure ratio |
isolated CHD: CBPS |
unknown |
|
3748
|
mean systolic gradient |
isolated CHD: NA |
unknown |
|
3749
|
mean vessel diameter |
isolated CHD: NA |
unknown |
|
3750
|
mean systolic gradient |
isolated CHD: TOF/PA/CBPS/TR |
unknown |
|
3751
|
mean vessel diameter |
isolated CHD: TOF/PA/CBPS/TR |
unknown |
|
3752
|
mean RV/FA pressure ratio |
isolated CHD: TOF/PA/CBPS/TR |
unknown |
|
3753
|
mean vessel diameter |
isolated CHD: Iliofemoral vein occlusion |
unknown |
|
3754
|
Comparison of proportion of first Cousins in CHD |
isolated CHD: TOF/AVSD/D-TGA/TA/PA/MA/PS/AS/CoA/VSD/ASD/PDA/EA/other |
unknown |
|
3755
|
Proportion of AVSD with first cousins |
isolated CHD: AVSD |
unknown |
|
3756
|
Proportion of Pulmonary atresia with first cousins |
isolated CHD: PA |
unknown |
|
3757
|
Proportion of Pulmonary stenosis with first cousins |
isolated CHD: PS |
unknown |
|
3758
|
Proportion of VSD with first cousins |
isolated CHD: VSD |
unknown |
|
3759
|
Proportion of ASD with first cousins |
isolated CHD: ASD |
unknown |
|
3760
|
breathlessness |
isolated CHD: VSD/ASD/TOF/CoA/persistent ducts/PVS/AVS/complete TGA/STPVCA |
unknown |
|
3762
|
spitting food |
isolated CHD: VSD/ASD/TOF/CoA/persistent ducts/PVS/AVS/complete TGA/STPVCA |
unknown |
|
3763
|
preferring drink to solids |
isolated CHD: VSD/ASD/TOF/CoA/persistent ducts/PVS/AVS/complete TGA/STPVCA |
unknown |
|
3768
|
Gestational age at birth(week) |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
unknown |
|
3773
|
the duration of hospital stay in survivors with NEC |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
unknown |
|
3774
|
Mean initial lactate level |
isolated CHD/non-isolated CHD: HLHS/DILV, HRV, SAS, HAA/IAA/IAA, VSD, AS/AVSD, HLV, TAPVR/IAA, VSD, SAS/IAA, VSD, SAS/CoA, VSD, AS/CoA, VSD/D-TGA/D-TGA, VSD, CoA/DORV, D-MGA, CoA/TA, D-MGA, HRV/L-TGA, PA, CAVV, TAPVR/TOF, APV |
unknown |
|
3775
|
an increasing lactate level over time |
isolated CHD/non-isolated CHD: HLHS/DILV, HRV, SAS, HAA/IAA/IAA, VSD, AS/AVSD, HLV, TAPVR/IAA, VSD, SAS/IAA, VSD, SAS/CoA, VSD, AS/CoA, VSD/D-TGA/D-TGA, VSD, CoA/DORV, D-MGA, CoA/TA, D-MGA, HRV/L-TGA, PA, CAVV, TAPVR/TOF, APV |
unknown |
|
3776
|
correlation between admission lactate levels and bicarbonate measures |
isolated CHD/non-isolated CHD: HLHS/DILV, HRV, SAS, HAA/IAA/IAA, VSD, AS/AVSD, HLV, TAPVR/IAA, VSD, SAS/IAA, VSD, SAS/CoA, VSD, AS/CoA, VSD/D-TGA/D-TGA, VSD, CoA/DORV, D-MGA, CoA/TA, D-MGA, HRV/L-TGA, PA, CAVV, TAPVR/TOF, APV |
unknown |
|
3777
|
cardiopulmonary bypass time |
isolated CHD/non-isolated CHD: HLHS/DILV, HRV, SAS, HAA/IAA/IAA, VSD, AS/AVSD, HLV, TAPVR/IAA, VSD, SAS/IAA, VSD, SAS/CoA, VSD, AS/CoA, VSD/D-TGA/D-TGA, VSD, CoA/DORV, D-MGA, CoA/TA, D-MGA, HRV/L-TGA, PA, CAVV, TAPVR/TOF, APV |
unknown |
|
3778
|
Oxygen saturation(%) |
isolated CHD/non-isolated CHD: TOF/DORV, PS/TGA, ASD/VSD, PS, TAPVD/TGA, VSD/PAD, ES/PA, VSD/TA, restrictive VSD/other/ASD |
unknown |
|
3779
|
Hematocrit(%) |
isolated CHD/non-isolated CHD: TOF/DORV, PS/TGA, ASD/VSD, PS, TAPVD/TGA, VSD/PAD, ES/PA, VSD/TA, restrictive VSD/other/ASD |
unknown |
|
3780
|
Bypass time (min) |
isolated CHD/non-isolated CHD: TOF/DORV, PS/TGA, ASD/VSD, PS, TAPVD/TGA, VSD/PAD, ES/PA, VSD/TA, restrictive VSD/other/ASD |
unknown |
|
3781
|
X-clamp time (min) |
isolated CHD/non-isolated CHD: TOF/DORV, PS/TGA, ASD/VSD, PS, TAPVD/TGA, VSD/PAD, ES/PA, VSD/TA, restrictive VSD/other/ASD |
unknown |
|
3782
|
Reperfusion time(min) |
isolated CHD/non-isolated CHD: TOF/DORV, PS/TGA, ASD/VSD, PS, TAPVD/TGA, VSD/PAD, ES/PA, VSD/TA, restrictive VSD/other/ASD |
unknown |
|
3783
|
total protein: pathological analyses range Number |
isolated CHD/non-isolated CHD: TOF/DORV, PS/TGA, ASD/VSD, PS, TAPVD/TGA, VSD/PAD, ES/PA, VSD/TA, restrictive VSD/other/ASD |
unknown |
|
3784
|
Total protein (> 150 mg g-1crea counted as pathological) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3785
|
Albumin (> 35 mg g-1crea counted as pathological) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3786
|
Transferrin (> 0 mg g-1crea counted as pathological) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3787
|
Immunglobulin G (> 0 mg g-1rea counted as pathological) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3788
|
N-acteyl-a-Dglucosaminidase (> 11 Ug-1crea counted as pathological) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3789
|
Oxygen saturation (%) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3790
|
Whole-blood viscosity 11.3s-1(CPS) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3791
|
Whole-blood viscosity 225s-1(CPS) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3792
|
Plasma viscosity 11.3s-1(CPS) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3793
|
Hematocrit (%) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3794
|
MCV(fl) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3795
|
MCH(pg) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3796
|
MCHC(g/dl) |
isolated CHD/non-isolated CHD: TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
unknown |
|
3797
|
bypass time |
isolated CHD/non-isolated CHD: SV, PS/VSD/TGV/TOF, VSD/ASD/DILV, PS/other |
unknown |
|
3798
|
ischemic time |
isolated CHD/non-isolated CHD: SV, PS/VSD/TGV/TOF, VSD/ASD/DILV, PS/other |
unknown |
|
3799
|
prenatal diagnosis |
isolated CHD/non-isolated CHD: HLHS/AVSD/UVH/PA, IVS/TAPVD/TOF/TGA |
unknown |
|
3800
|
relationship with geographical variability and diagnostic rates |
isolated CHD/non-isolated CHD: HLHS/AVSD/UVH/PA, IVS/TAPVD/TOF/TGA |
unknown |
|
3801
|
Age, months |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3802
|
CPB time, min |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3803
|
Cross-clamp time, min |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3804
|
Mechanical ventilation, d |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3805
|
ICU stay, d |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3806
|
Hospital stay, d |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3807
|
Extubation failures |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3808
|
Respiratory complications |
isolated CHD/non-isolated CHD: AS/ASD/AVC/CoA/HLHS/PDA/PA/TGV/TOF/VSD, ASD/TAPVC/other |
unknown |
|
3809
|
mid-diastolic flow reversal |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3810
|
Peak A (m/s) (Postoperative diastolic parameters, day 1 to 3) |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3811
|
Peak E/A (Postoperative diastolic parameters, day 1 to 3) |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3812
|
VTI A (m) (Postoperative diastolic parameters, day 1 to 3) |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3813
|
VTI E/A (Postoperative diastolic parameters, day 1 to 3) |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3814
|
Mid-diastolic flow reversal |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3815
|
stays in intensive care unit |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3816
|
hospital stays |
isolated CHD: TGA/CoA/IAA/AS |
unknown |
|
3817
|
Total problem score: Number of heart operations |
NA: NA |
unknown |
|
3818
|
Total problem score: Hypothermia |
NA: NA |
unknown |
|
3819
|
Internalizing: Number of heart operations |
NA: NA |
unknown |
|
3820
|
Internalizing: Hypothermia |
NA: NA |
unknown |
|
3821
|
Internalizing: Duration pregnancy |
NA: NA |
unknown |
|
3822
|
Internalizing: % Oxygen saturation |
NA: NA |
unknown |
|
3823
|
Internalizing: Age at surgical repair |
NA: NA |
unknown |
|
3824
|
Externalizing: Number of heart operations |
NA: NA |
unknown |
|
3825
|
the frequency of preablation cardioversions |
isolated CHD/non-isolated CHD: TOF, VSD/TGA/ASD/SV/CHD/other |
unknown |
|
3826
|
the frequency of cardioversion after ablation |
isolated CHD/non-isolated CHD: TOF, VSD/TGA/ASD/SV/CHD/other |
unknown |
|
3827
|
the frequency of episodes of documented IART per patient-month after RF ablation |
isolated CHD/non-isolated CHD: TOF, VSD/TGA/ASD/SV/CHD/other |
unknown |
|
3828
|
the frequency of hospital visits per patient-month after RF ablation |
isolated CHD/non-isolated CHD: TOF, VSD/TGA/ASD/SV/CHD/other |
unknown |
|
3829
|
the frequency of episodes of documented IART per patient-month after RF ablation |
isolated CHD/non-isolated CHD: TOF, VSD/TGA/ASD/SV/CHD/other |
unknown |
|
3830
|
the frequency of hospital visits per patient-month after RF ablation |
isolated CHD/non-isolated CHD: TOF, VSD/TGA/ASD/SV/CHD/other |
unknown |
|
3836
|
Pulmonary artery areas were correlated with body surface area |
isolated CHD: TOF |
unknown |
|
3837
|
PV areas were correlated with body surface area |
isolated CHD: TOF |
unknown |
|
3838
|
right PV area was correlated with right PBF |
isolated CHD: TOF |
unknown |
|
3843
|
Plasma TXB2 levels |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, CoA/VSD, PDA/AS/PDA/DORV/CAVC/TOF, PA/ECD, PDA/EA/other |
unknown |
|
3844
|
Plasma TXB2 levels |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, CoA/VSD, PDA/AS/PDA/DORV/CAVC/TOF, PA/ECD, PDA/EA/other |
unknown |
|
3845
|
Plasma TXB2 levels |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, CoA/VSD, PDA/AS/PDA/DORV/CAVC/TOF, PA/ECD, PDA/EA/other |
unknown |
|
3846
|
pulmonary-to-systemic flow ratio |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, CoA/VSD, PDA/AS/PDA/DORV/CAVC/TOF, PA/ECD, PDA/EA/other |
unknown |
|
3847
|
pulmonary blood flow divided by body surface area |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, CoA/VSD, PDA/AS/PDA/DORV/CAVC/TOF, PA/ECD, PDA/EA/other |
unknown |
|
3848
|
Hematocrit (%) |
NA: NA |
unknown |
|
3849
|
Hemoglobin (g/dL) |
NA: NA |
unknown |
|
3850
|
Mean corpuscular volume (fL) |
NA: NA |
unknown |
|
3851
|
Maternal overall exposure to chemicals at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3852
|
Maternal overall exposure to chemicals at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3853
|
Maternal overall exposure to chemicals at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3854
|
Maternal overall exposure to chemicals at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3855
|
Maternal overall exposure to chemicals at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3856
|
Maternal exposure to dyes, lacquers, or paints at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3857
|
Maternal exposure to dyes, lacquers, or paints at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3858
|
Maternal exposure to dyes, lacquers, or paints at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3859
|
Maternal exposure to organic solvents at work |
isolated CHD: VSD/PDA/CoA/ASD/TGA/HLV/TOF/ECD/TA/other |
unknown |
|
3860
|
Saline contrast echocardiography: The incidence of such shunting |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/TGA/TA/TOF/DORV/PDA/TAPVC/SV, TA/other |
unknown |
|
3861
|
quantitative indexes: TPV |
NA: NA |
unknown |
|
3863
|
quantitative indexes: TPV/RVET |
NA: NA |
unknown |
|
3865
|
quantitative indexes: RPEP |
NA: NA |
unknown |
|
3866
|
quantitative indexes: RPEP correlation with systolic and mean pulmonary artery pressure |
NA: NA |
unknown |
|
3867
|
prevalence of persistent left superior vena cava (PLSVC) |
isolated CHD: VSD/PDA/ASD/CoA/TOF/TGA/PS/AVC/AS/TAS/TA/TAPVC/PA/EA/other/ioslated PLSVC |
unknown |
|
3868
|
high incidence of left axis deviation of the frontal plane P-wave associated with PLSVC |
isolated CHD: PLSVC |
unknown |
|
3869
|
died after operation |
isolated CHD/non-isolated CHD: TOF/VSD, IPS/VSD, IPS-A/VPS, IPS, ASD/VPS, IPS, ASD/VSD, IPS-A/SVSD, VPS, IPS |
unknown |
|
3870
|
right ventrlcular failure |
isolated CHD/non-isolated CHD: TOF/VSD, IPS/VSD, IPS-A/VPS, IPS, ASD/VPS, IPS, ASD/VSD, IPS-A/SVSD, VPS, IPS |
unknown |
|
3871
|
recent necrosis |
isolated CHD: Transposition |
unknown |
|
3872
|
Glial scars |
isolated CHD: Transposition |
unknown |
|
3873
|
recent necrosis |
isolated CHD: PA |
unknown |
|
3874
|
Glial scars |
isolated CHD: PA |
unknown |
|
3875
|
recent necrosis |
isolated CHD: CAT |
unknown |
|
3876
|
Glial scars |
isolated CHD: CAT |
unknown |
|
3877
|
at least two findings among three severe changes pre-operatively(tortuous arteries,DA and DB) |
isolated CHD: VSD, CHD with PAH |
unknown |
|
3878
|
surgery age <3 years old |
isolated CHD: VSD, CHD with PAH |
unknown |
|
3879
|
findings of post-operative WPA |
isolated CHD: VSD, CHD with PAH |
unknown |
|
3880
|
death after operation of VSD |
isolated CHD: VSD |
unknown |
|
3881
|
death after operation of VSD(Pp/Ps>=0.75) |
isolated CHD: VSD |
unknown |
|
3882
|
death after operation of VSD(Pp/Ps>=0.75) |
isolated CHD: VSD |
unknown |
|
3883
|
death after operation of different CHD(Pp/Ps>0.75) |
isolated CHD: ASD/TAPVD |
unknown |
|
3884
|
death after operation of different CHD(Pp/Ps>0.75) |
isolated CHD: PDA/TAPVD |
unknown |
|
3885
|
frequency of hemorrhagic tendency |
isolated CHD: VSD/ASD |
unknown |
|
3886
|
frequency of hemorrhagic tendency |
isolated CHD: VSD/ASD |
unknown |
|
3887
|
frequency of hemorrhagic tendency |
isolated CHD: PS/ASD |
unknown |
|
3888
|
percent of the presence or absence of a circulatory shunt, determined from the intraoperative curves |
NA: NA |
unknown |
|
3889
|
Least-Concentration to the Systemic-Recirculation concentration Ratios (CL/CR) Obtained From Arterial Dilution Curve |
NA: LTRS |
unknown |
|
3890
|
Least-Concentration to the Systemic-Recirculation concentration Ratios (CL/CR) Obtained From Arterial Dilution Curve |
NA: LTRS |
unknown |
|
3891
|
Least-Concentration to the Systemic-Recirculation concentration Ratios (CL/CR) Obtained From Arterial Dilution Curve |
NA: LTRS |
unknown |
|
3892
|
Frequency of distal displacements of palmar axial triradius and Multiple Axial Triradii( palmar main line)(left hand, white race) |
NA: NA |
unknown |
|
3893
|
Frequency of distal displacements of palmar axial triradius and Multiple Axial Triradii( palmar main line)(both hands, white race) |
NA: NA |
unknown |
|
3894
|
Frequency of distal displacements of palmar axial triradius and Multiple Axial Triradii( palmar main line)(both hands, negro race) |
NA: NA |
unknown |
|
3895
|
Frequency of distal displacements of palmar axial triradius and Multiple Axial Triradii( palmar main line)(total, white race) |
NA: NA |
unknown |
|
3896
|
Frequency of distal displacements of palmar axial triradius and Multiple Axial Triradii( palmar main line)(total, negro race) |
NA: NA |
unknown |
|
3897
|
operative results: good |
isolated CHD: AC/PDA/CAF |
unknown |
|
3898
|
operative results: unsatisfied |
isolated CHD: AC/PDA/CAF |
unknown |
|
3899
|
operative results: died |
isolated CHD: AC/PDA/CAF |
unknown |
|
3900
|
operative results: good |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3901
|
operative results: unsatisfied |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3902
|
operative results: died |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3903
|
operative results: good |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3904
|
operative results: unsatisfied |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3905
|
operative results: died |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3906
|
operative results: good |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3907
|
operative results: unsatisfied |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3908
|
operative results: died |
isolated CHD/non-isolated CHD: ASD, PS/ASD, AS/ASD, AVR/VSD/VSD, ASD/VSD, ASD, patent ductus/PS/AS/LVRAS |
unknown |
|
3909
|
amount of dye injected(A)(mg./Kg.) |
isolated CHD: PDA |
unknown |
|
3910
|
amount of dye injected(A)(mg./Kg.) |
isolated CHD: ASD |
unknown |
|
3911
|
amount of dye injected(A)(mg./Kg.) |
isolated CHD: VSD |
unknown |
|
3912
|
amount of dye injected(A)(mg./Kg.) |
isolated CHD: PDA |
unknown |
|
3913
|
peak concentration of dilution curve(B)(mg./L.) |
isolated CHD: PDA |
unknown |
|
3914
|
peak concentration of dilution curve(B)(mg./L.) |
isolated CHD: ASD |
unknown |
|
3915
|
peak concentration of dilution curve(B)(mg./L.) |
isolated CHD: VSD |
unknown |
|
3916
|
peak concentration of dilution curve(B)(mg./L.) |
isolated CHD: PDA |
unknown |
|
3917
|
ratio of B/A(peak concentration of dilution curve/amount of dye injected) |
isolated CHD: PDA |
unknown |
|
3918
|
ratio of B/A(peak concentration of dilution curve/amount of dye injected) |
isolated CHD: ASD |
unknown |
|
3919
|
ratio of B/A(peak concentration of dilution curve/amount of dye injected) |
isolated CHD: VSD |
unknown |
|
3920
|
ratio of B/A(peak concentration of dilution curve/amount of dye injected) |
isolated CHD: PDA |
unknown |
|
3922
|
Anesthesia duration (min) |
isolated CHD/non-isolated CHD: TA/TOF/PA, IVS/D-TGA/PS/D-TGA, DORV |
unknown |
|
3923
|
history of IE(infective endocarditis) |
isolated CHD/non-isolated CHD: TA/TOF/PA, IVS/D-TGA/PS/D-TGA, DORV |
unknown |
|
3924
|
Right ventricular systolic pressure(RVSP) |
isolated CHD/non-isolated CHD: TA/TOF/PA, IVS/D-TGA/PS/D-TGA, DORV |
unknown |
|
3925
|
Five-year freedom from IE |
isolated CHD/non-isolated CHD: TA/TOF/PA, IVS/D-TGA/PS/D-TGA, DORV |
unknown |
|
3926
|
cTnI level on postoperative day |
isolated CHD: HLHS/SV |
unknown |
|
3927
|
cTnI level on postoperative day 1 |
isolated CHD: HLHS/VSD/TOF/AVSD |
unknown |
|
3928
|
cTnI level on postoperative day |
isolated CHD: TGA/VSD/TOF/AVSD |
unknown |
|
3929
|
cTnI level on postoperative day |
isolated CHD: TGA/SV |
unknown |
|
3930
|
cTnI |
isolated CHD: HLHS/TGA/SV/VSD/TOF/AVSD |
unknown |
|
3931
|
cTnI |
isolated CHD: HLHS/TGA/SV/VSD/TOF/AVSD |
unknown |
|
3932
|
aortic cross clamp(ACC) time) |
isolated CHD: HLHS/TGA/SV/VSD/TOF/AVSD |
unknown |
|
3933
|
Binge drinking |
NA: NA |
unknown |
|
3934
|
smoking cigarettes |
NA: NA |
unknown |
|
3935
|
Recreational drug use |
NA: NA |
unknown |
|
3936
|
annual dental visits |
NA: NA |
unknown |
|
3937
|
brush teeth twice a day |
NA: NA |
unknown |
|
3938
|
brush teeth once a day |
NA: NA |
unknown |
|
3939
|
sport participation |
NA: NA |
unknown |
|
3957
|
male |
NA: C-CHD/A-CHD |
unknown |
|
3958
|
Gestational age<36 weeks |
NA: C-CHD/A-CHD |
unknown |
|
3959
|
receiving medical intervention |
NA: C-CHD/A-CHD |
unknown |
|
3960
|
parenting stress |
NA: C-CHD/A-CHD |
unknown |
|
3961
|
internalising problems |
NA: C-CHD/A-CHD |
unknown |
|
3962
|
higher parental education |
NA: C-CHD/A-CHD |
unknown |
|
3963
|
higher family income |
NA: C-CHD/A-CHD |
unknown |
|
3964
|
Higher parenting stress |
NA: C-CHD/A-CHD |
unknown |
|
3965
|
The mediating role of parenting stress in the association between cyanotic CHD and internalising problems |
NA: C-CHD/A-CHD |
unknown |
|
3966
|
clinical index of neurodevelopment(impaired) |
isolated CHD: TGA/TOF/SD/UVH |
unknown |
|
3967
|
clinical index of neurodevelopment |
isolated CHD: TGA/TOF/SD/UVH |
unknown |
|
3968
|
low T1(baseline) PHC(perveived health competence) |
NA: NA |
unknown |
|
3969
|
low T1(baseline) PHC(perveived health competence) |
NA: NA |
unknown |
|
3974
|
Hand grip strength in kg |
isolated CHD/non-isolated CHD: UVH/Palliated UVH/PA, IVS/EA/TGA/ccTGA/DORV, TGA/AVA/AC/PA, VSD/TOF/DORV/PAA/ASD/PAPVC/VSD/AVSD/AP window/MVD/TVD/other |
unknown |
|
3975
|
Hand grip strength in kg |
isolated CHD/non-isolated CHD: UVH/Palliated UVH/PA, IVS/EA/TGA/ccTGA/DORV, TGA/AVA/AC/PA, VSD/TOF/DORV/PAA/ASD/PAPVC/VSD/AVSD/AP window/MVD/TVD/other |
unknown |
|
3976
|
Hand grip strength in kg |
isolated CHD/non-isolated CHD: UVH/Palliated UVH/PA, IVS/EA/TGA/ccTGA/DORV, TGA/AVA/AC/PA, VSD/TOF/DORV/PAA/ASD/PAPVC/VSD/AVSD/AP window/MVD/TVD/other |
unknown |
|
3977
|
Hand grip strength in kg |
isolated CHD/non-isolated CHD: PA, VSD/TOF/DORV/PAA |
unknown |
|
3978
|
Hand grip strength in kg |
isolated CHD/non-isolated CHD: UVH |
unknown |
|
3979
|
Serum folate(ng/mL),median (IQR) |
NA: NA |
unknown |
|
3980
|
Red blood cell folate(ng/mL), median (IQR) |
NA: NA |
unknown |
|
3981
|
Homocysteine (μmol/L), median (IQR) |
NA: NA |
unknown |
|
3982
|
prevalence of CHD in live births |
NA: NA |
unknown |
|
3983
|
percent of patients with diaphragm plication |
NA: NA |
unknown |
|
3984
|
higher incidence of plication |
NA: NA |
unknown |
|
3985
|
median length of stay in patients |
NA: NA |
unknown |
|
3986
|
median length of stay in patients |
NA: NA |
unknown |
|
3987
|
prolonged time to plication |
NA: NA |
unknown |
|
3988
|
prolonged time to plication |
NA: NA |
unknown |
|
3989
|
maternal education level(college and above) |
isolated CHD/non-isolated CHD: NA/VSD/TOF |
unknown |
|
3990
|
maternal residence(urban) |
isolated CHD/non-isolated CHD: NA/VSD/TOF |
unknown |
|
3991
|
infant gender(male) |
isolated CHD/non-isolated CHD: NA/VSD/TOF |
unknown |
|
3992
|
with family history of CHD |
isolated CHD/non-isolated CHD: NA/VSD/TOF |
unknown |
|
3993
|
with family history of CHD |
isolated CHD: NA |
unknown |
|
3994
|
Folic acid supplementation |
isolated CHD/non-isolated CHD: NA/VSD/TOF |
unknown |
|
3995
|
smoking/drinking |
isolated CHD: TOF |
unknown |
|
4001
|
Kidney Injury Molecule(KIM 1)(pg/mg) |
isolated CHD: D-TGA/BAV/TOF/CoA/NA/AVSD/AS/VSD |
unknown |
|
4002
|
TIMP2(Tissue Inhibitor of Metalloproteinases 2) |
isolated CHD: D-TGA/BAV/TOF/CoA/NA/AVSD/AS/VSD |
unknown |
|
4003
|
IGFBP7(Insulin-Like Growth Factor Binding Protein) (ng/mL) |
isolated CHD: D-TGA/BAV/TOF/CoA/NA/AVSD/AS/VSD |
unknown |
|
4004
|
[(TIMP2 • IGFBP7)/1000] |
isolated CHD: D-TGA/BAV/TOF/CoA/NA/AVSD/AS/VSD |
unknown |
|
4008
|
NLRP3(nucleotide-binding oligomerization domain-like (NOD)-like receptor protein 3), ng/ml |
NA: NA |
unknown |
|
4009
|
HMGB1(high-mobility group box 1), ng/ml |
NA: NA |
unknown |
|
4010
|
NT-pro-BNP, ng/l |
NA: NA |
unknown |
|
4011
|
Cardiac death |
NA: NA |
unknown |
|
4012
|
Hospitalization |
NA: NA |
unknown |
|
4013
|
New onset of arrhythmias |
NA: NA |
unknown |
|
4014
|
Surgical or percutaneous intervention |
NA: NA |
unknown |
|
4015
|
Cardiac death |
NA: NA |
unknown |
|
4016
|
Hospitalization |
NA: NA |
unknown |
|
4017
|
New onset of arrhythmias |
NA: NA |
unknown |
|
4018
|
Surgical or percutaneous intervention |
NA: NA |
unknown |
|
4021
|
Working memory:Mean (standard deviation) |
isolated CHD: TGA/TOF/PA/DILV/TAPVC/TA/TA/AVSD/AS/PS/AC/other |
unknown |
|
4022
|
The association between Fractional anisotropy and working memory |
isolated CHD: TGA/TOF/PA/DILV/TAPVC/TA/TA/AVSD/AS/PS/AC/other |
unknown |
|
4023
|
mean Fractional anisotropy of all significant clusters in cyanotic CHD |
isolated CHD: TGA/TOF/PA/DILV/TAPVC/TA/TA/AVSD/AS/PS/AC/other |
unknown |
|
4024
|
mean Fractional anisotropy of all significant clusters in acyanotic CHD |
isolated CHD: TGA/TOF/PA/DILV/TAPVC/TA/TA/AVSD/AS/PS/AC/other |
unknown |
|
4025
|
CaO2(ml/L)(arterial oxygen delivery) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4026
|
Cardiac Index(L/min/m2) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4027
|
eGFR(estimated glomerular filtration rate)(ml/min/1.73m2) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4028
|
GDF-15(Growth differentiation factor 15)(pg/ml) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4029
|
Hemoglobin(g/dL) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4030
|
LVEDP(left ventricular end-diastolic pressure)(mmHg) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4031
|
Mean Pap(pulmonary artery pressure)(mmHg) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4032
|
Modified Ross score |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4033
|
NT-pro-BNP(pg/ml)(N-terminal pro type brain natriuretic peptide) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4034
|
DO2(oxygen delivery) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4035
|
Serum Creatinine(mg/dL) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4037
|
mean PAP(pulmonary artery pressure) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4039
|
Ln(log transformed) NT-pro BNP |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4040
|
SvO2 |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4041
|
Hemoglobin |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unknown |
|
4047
|
relative miR-204 expression before surgery |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4048
|
relative miR-204 expression before surgery |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4049
|
relative miR-204 expression after surgery |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4050
|
relative miR-204 expression after surgery |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4051
|
relative miR-204 expression in mild group |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4052
|
relative miR-204 expression in severe group |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4053
|
PASP(pulmonary artery systolic pressure )mmHg |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4054
|
PASP(pulmonary artery systolic pressure )mmHg |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unknown |
|
4058
|
prevalence of ASD among CHD patients |
isolated CHD: ASD |
unknown |
|
4059
|
age group of ASD |
isolated CHD: ASD |
unknown |
|
4064
|
Cardiopulmonary bypass time |
NA: NA |
unknown |
|
4065
|
aortic cross clamp(ACC) time) |
NA: NA |
unknown |
|
4066
|
length of stay in ICU(hours) |
NA: NA |
unknown |
|
4067
|
post operative infection, n |
NA: NA |
unknown |
|
4070
|
Cardiopulmonary bypass time |
NA: NA |
unknown |
|
4071
|
Length of stay in hospital, days |
NA: NA |
unknown |
|
4072
|
Time to extubation, hours |
NA: NA |
unknown |
|
4074
|
volumns of cerebellum(CBL) |
NA: NA |
unknown |
|
4075
|
volumns of cerebellum(CBL) |
NA: NA |
unknown |
|
4096
|
WBC counts(<cut off value)(children) |
NA: NA |
unknown |
|
4109
|
prevalence of CHD in different altitudes |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
unknown |
|
4110
|
Ethnic group:Tibetan |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
unknown |
|
4111
|
Ethnic group:Hani |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
unknown |
|
4112
|
Ethnic group:Yi |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
unknown |
|
4113
|
Ethnic group:Lisu |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
unknown |
|
4114
|
Ethnic group:Jingpo |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
unknown |
|
4115
|
Ethnic group:Achang |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
unknown |
|
4130
|
aortic shunt(none) |
NA: NA |
unknown |
|
4134
|
atrial shunt(none) |
NA: NA |
unknown |
|
4138
|
ventricular level shunt(none) |
NA: NA |
unknown |
|
4140
|
ventricular level shunt(right-to-left) |
NA: NA |
unknown |
|
4152
|
circulating temperature(normal temperature) |
NA: NA |
unknown |
|
4159
|
circulation method(parallel CPB) |
NA: NA |
unknown |
|
4160
|
circulation method(full flow) |
NA: NA |
unknown |
|
4161
|
myocardial preservation(HTK: histidine-tryptophan-ketoglutarate) |
NA: NA |
unknown |
|
4168
|
post-operative mortality |
NA: NA |
unknown |
|
4169
|
Length of ICU stay(>3 days) |
NA: NA |
unknown |
|
4170
|
Duration of Medical ventilator(>48 h) |
NA: NA |
unknown |
|
4174
|
mortality at 10 years stratified by age under and over 35 at pulmonary valve replacement(observed) |
isolated CHD: TOF |
unknown |
|
4175
|
mortality at 10 years stratified by age under and over 35 at pulmonary valve replacement(expected) |
isolated CHD: TOF |
unknown |
|
4176
|
percent of requiring ECMO(extracorporeal membrane oxygenation) |
isolated CHD/non-isolated CHD: HLHS/SV/TGA, DORV/TGA, IVS/TGA, VSD |
unknown |
|
4177
|
Surgery start (day of life) |
isolated CHD/non-isolated CHD: HLHS/SV/TGA, DORV/TGA, IVS/TGA, VSD |
unknown |
|
4178
|
Mortality |
isolated CHD/non-isolated CHD: HLHS/SV/TGA, DORV/TGA, IVS/TGA, VSD |
unknown |
|
4179
|
Cardiac arrest |
isolated CHD/non-isolated CHD: HLHS/SV/TGA, DORV/TGA, IVS/TGA, VSD |
unknown |
|
4180
|
brain volumn |
isolated CHD/non-isolated CHD: HLHS/SV/TGA, DORV/TGA, IVS/TGA, VSD |
unknown |
|
4181
|
brain volumn |
isolated CHD/non-isolated CHD: HLHS/SV/TGA, DORV/TGA, IVS/TGA, VSD |
unknown |
|
4185
|
risk of preterm birth of different age(30-34 years) |
isolated CHD: NA |
unknown |
|
4188
|
risk of bearing birth to SGA of different age(<25 years) |
isolated CHD: NA |
unknown |
|
4189
|
risk of preterm birth birth to SGA of different age(30-34 years) |
isolated CHD: NA |
unknown |
|
4194
|
age(days) |
isolated CHD: AVSD/TOF/VSD |
unknown |
|
4195
|
Body surface area(m2) |
isolated CHD: AVSD/TOF/VSD |
unknown |
|
4197
|
Cardiopulmonary bypass time(min) |
isolated CHD: AVSD/TOF/VSD |
unknown |
|
4199
|
with 1 or 2+ variants in PRA gene |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4200
|
with 1 or 2+ variants in PRA gene |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4201
|
Small for gestational age |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4202
|
Birth weight |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4203
|
Birth length, cm |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4204
|
birth head circumference |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4205
|
Length z score |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4206
|
Head circumference z score |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4207
|
Age at the first operation, days |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4208
|
Weight at the first operation, kg |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4209
|
Factors associated with weight z score: Race |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4210
|
Factors associated with weight z score: Gestational hypertension |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4211
|
Factors associated with height z score: Gestational hypertension |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4212
|
Factors associated with height z score: PRA gene variatnts |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4213
|
Factors associated with Head circumference z score: Race |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4214
|
Factors associated with Head circumference z score: PRA gene variatnts |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4215
|
Factors associated with weight z score: Race |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4216
|
Factors associated with weight z score: pregnancy-induced hypertension |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4217
|
Factors associated with height z score: pregnancy-induced hypertension |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4218
|
Factors associated with height z score: PRA gene variatnts |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4219
|
Factors associated with Head circumference z score: Race |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4220
|
Factors associated with Head circumference z score: PRA gene variatnts |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4221
|
Factors associated with UA-PI z score: PRA gene variatnts |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4222
|
Factors associated with CPR z score: CHD diagnosis |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4223
|
Factors associated with CPR z score: CHD diagnosis |
isolated CHD: HLHS/IAA/TGA/TOF/other |
unknown |
|
4224
|
Maternal vitamin D level |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4225
|
Maternal vitamin D status: Deficient |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4226
|
Maternal vitamin D receptor gene Fok1 genotype: F/F |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4230
|
Maternal vitamin D receptor gene Fok1 alleles: f |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4231
|
Relation between Maternal vitamin D level and VDR gene Fok1 polymorphism among cases: Maternal vitamin D level |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4232
|
Relation between Maternal vitamin D level and VDR gene Fok1 polymorphism among cases: Maternal vitamin D level |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4233
|
Relation between Maternal vitamin D status and VDR gene Fok1 polymorphism among cases: Defieient |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4234
|
Relation between Maternal vitamin D status and VDR gene Fok1 polymorphism among cases: Defieient |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4235
|
Maternal vitamin D level |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
|
4236
|
Maternal vitamin D status: insufficient |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
unknown |
